PKACB
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A4FU28 | S140 | Sugiyama | CTAGE9 | AAAEEARSLEATCEKLSRsNsELEDEILCLEKDLKEEKSKH |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| O00141 | T369 | ELM | SGK1 SGK | IKSHVFFSLINWDDLINKKItPPFNPNVsGPNDLRHFDPEF |
| O00168 | S83 | ELM | FXYD1 PLM | KFNQQQRTGEPDEEEGtFRssIRRLstRRR___________ |
| O00273 | S28 | Sugiyama | DFFA DFF1 DFF45 H13 | GVPESGEIRTLKPCLLRRNysREQHGVAAsCLEDLRSKACD |
| O00299 | S211 | Sugiyama | CLIC1 G6 NCC27 | CKKYRGFTIPEAFRGVHRYLsNAyAREEFAstCPDDEEIEL |
| O00429 | S637 | SIGNOR|ELM | DNM1L DLP1 DRP1 | PQKGHAVNLLDVPVPVARKLsAREQRDCEVIERLIKSYFLI |
| O00458 | T9 | Sugiyama | IFRD1 | ____________MPKNKKRNtPHRGssAGGGGsGAAAATAA |
| O00482 | S510 | SIGNOR | NR5A2 B1F CPF FTF | PQQTEKFGQLLLRLPEIRAIsMQAEEYLYYKHLNGDVPYNN |
| O00571 | S83 | Sugiyama | DDX3X DBX DDX3 | sKDKDAyssFGsRsDsRGKssFFsDRGsGsRGRFDDRGRsD |
| O00750 | S225 | Sugiyama | PIK3C2B | HRILEEEEVLGGGGQGRLLGsVDyDGINDAITRLNLKSTYD |
| O14617 | S658 | Sugiyama | AP3D1 PRO0039 | DERPRAVFHEEEQRRPKHRPsEADEEELARRREARKQEQAN |
| O14737 | S42 | Sugiyama | PDCD5 TFAR19 | GDPGDAAQQEAKHREAEMRNsILAQVLDQsARARLsNLALV |
| O14965 | T288 | ELM | AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6 | GELKIADFGWsVHAPssRRttLCGTLDYLPPEMIEGRMHDE |
| O14974 | S695 | Sugiyama | PPP1R12A MBS MYPT1 | DEEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSR |
| O14974 | S995 | Sugiyama | PPP1R12A MBS MYPT1 | ADRSLLEMEKRERRALERRIsEMEEELKMLPDLKADNQRLK |
| O14974 | T696 | Sugiyama | PPP1R12A MBS MYPT1 | EEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSRS |
| O14980 | S1055 | Sugiyama | XPO1 CRM1 | LEEREIALRQADEEKHKRQMsVPGIFNPHEIPEEMCD____ |
| O15067 | S1053 | Sugiyama | PFAS KIAA0361 | RGLRERMGPSYCLPPTFPKAsVPREPGGPsPRVAILREEGS |
| O15067 | S215 | Sugiyama | PFAS KIAA0361 | LDSWDLDFYTKRFQELQRNPstVEAFDLAQsNsEHSRHWFF |
| O15143 | S310 | Sugiyama | ARPC1B ARC41 | QSSQRGLTARERFQNLDKKAssEGGtAAGAGLDsLHKNsVs |
| O15217 | S189 | SIGNOR | GSTA4 | EKIPNILSAFPFLQEYTVKLsNIPtIKRFLEPGSKKKPPPD |
| O15226 | S618 | Sugiyama | NKRF ITBA4 NRF | VNKIAKRDIEQIIRNYARsEsHtDLtFsRELTNDERKQIHQ |
| O15357 | S43 | Sugiyama | INPPL1 SHIP2 | HRDLSRAAAEELLARAGRDGsFLVRDSESVAGAFALCVLYQ |
| O15372 | S290 | Sugiyama | EIF3H EIF3S3 | QQQQKHQYQQRRQQENMQRQsRGEPPLPEEDLsKLFKPPQP |
| O43493 | S428 | Sugiyama | TGOLN2 TGN46 TGN51 | KIIAFVLEGKRSKVTRRPKAsDyQRLDQKS___________ |
| O43566 | S260 | ELM | RGS14 | LRKSFRRELGGTANAALRREsQGSLNSSASLDLGFLAFVSS |
| O43623 | S247 | SIGNOR | SNAI2 SLUG SLUGH | NLRAHLQTHsDVKKYQCKNCsKTFsRMsLLHKHEESGCCVA |
| O43707 | S423 | Sugiyama | ACTN4 | NEIRRLERLDHLAEKFRQKAsIHEAWtDGKEAMLKHRDyEt |
| O60291 | S515 | Sugiyama | MGRN1 KIAA0544 RNF156 | sFItEEVDESssPQQGTRAAsIENVLQDssPEHCGRGPPAD |
| O60293 | S42 | Sugiyama | ZFC3H1 CCDC131 KIAA0546 PSRC2 | LEDGEIsDDDNNSQIRSRsssSsSGGGLLPYPRRRPPHSAR |
| O60343 | S757 | Sugiyama | TBC1D4 AS160 KIAA0603 | ASESSDGEGRKRtSstCsNEsLsVGGTSVTPRRISWRQRIF |
| O60343 | S759 | Sugiyama | TBC1D4 AS160 KIAA0603 | ESSDGEGRKRtSstCsNEsLsVGGTSVTPRRISWRQRIFLR |
| O60343 | T749 | Sugiyama | TBC1D4 AS160 KIAA0603 | ENEIRQDTASESSDGEGRKRtSstCsNEsLsVGGTSVTPRR |
| O60610 | T768 | SIGNOR | DIAPH1 DIAP1 | PPPPPFGFGVPAAPVLPFGLtPKKLYKPEVQLRRPNWSKLV |
| O60658 | S359 | SIGNOR | PDE8A | VQSDTHTDNQTGKHKDRRKGsLDVKAVASRATEVSSQRRHS |
| O60814 | S37 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| O60841 | S107 | Sugiyama | EIF5B IF2 KIAA0741 | NEEEFtsKDKKKKGQKGKKQsFDDNDsEELEDKDsKSKKTA |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O75151 | S1056 | SIGNOR | PHF2 CENP-35 KIAA0662 | QAGRTSQPMAPGVFLtQRRPsAssPNNNTAAKGKRTKKGMA |
| O75151 | S757 | SIGNOR | PHF2 CENP-35 KIAA0662 | GSLHIDTDTKPGRNARVKKEsGSSAAGILDLLQASEEVGAL |
| O75151 | S899 | SIGNOR | PHF2 CENP-35 KIAA0662 | sLEsDEDNPIFKSRSKKRKGsDDAPYsPtARVGPSVPRQDR |
| O75151 | S954 | SIGNOR | PHF2 CENP-35 KIAA0662 | LAAAAAKLsQQEEQKSKKKKsAKRKLTPNTTSPSTSTSISA |
| O75369 | S1442 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | SKVKIAGPGLGsGVRARVLQsFtVDSSKAGLAPLEVRVLGP |
| O75369 | S2532 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | ASKVTSKGAGLSKAFVGQKssFLVDCSKAGSNMLLIGVHGP |
| O75396 | S137 | Sugiyama | SEC22B SEC22L1 | TFIQKTKKLYIDSRARRNLGsINtELQDVQRIMVANIEEVL |
| O75581 | T1548 | SIGNOR | LRP6 | PtTPCSTDVCDsDyAPsRRMtSVATAKGYTSDLNyDSEPVP |
| O75688 | S195 | SIGNOR | PPM1B PP2CB | REKERIQNAGGsVMIQRVNGsLAVSRALGDYDYKCVDGKGP |
| O75717 | S374 | Sugiyama | WDHD1 AND1 | INDDEDDEDLMMAsGRPRQRsHILEDDENsVDIsMLKtGss |
| O76054 | S289 | SIGNOR | SEC14L2 C22orf6 KIAA1186 KIAA1658 | YVRDQVKQQYEHSVQISRGSsHQVEYEILFPGCVLRWQFMS |
| O76074 | S102 | ELM | PDE5A PDE5 | PLQQsPRADNSAPGTPTRKIsAsEFDRPLRPIVVKDSEGTV |
| O94806 | S731 | SIGNOR | PRKD3 EPK2 PRKCN | EPFPQVKLCDFGFARIIGEKsFRRsVVGtPAyLAPEVLRSK |
| O94808 | S202 | ELM | GFPT2 | FALVFKSVHYPGEAVATRRGsPLLIGVRSKYKLSTEQIPIL |
| O94888 | S280 | Sugiyama | UBXN7 KIAA0794 UBXD7 | EHGQLDGLsssPPKKCARsEsLIDAsEDsQLEAAIRASLQE |
| O95140 | S442 | SIGNOR | MFN2 CPRP1 KIAA0214 | ITEEVERQVSTAMAEEIRRLsVLVDDYQMDFHPSPVVLKVY |
| O95155 | S105 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | LsssPsNsLEtQsQsLsRsQsMDIDGVSCEKsMsQVDVDsG |
| O95302 | S275 | Sugiyama | FKBP9 FKBP60 FKBP63 | NPKDSISIENKVVPENCERIsQsGDFLRYHYNGTLLDGTLF |
| O95453 | S557 | Sugiyama | PARN DAN | KRLNPQCIPYTLQNHYYRNNsFtAPstVGKRNLsPsQEEAG |
| O95477 | S1042 | ELM | ABCA1 ABC1 CERP | PSSKLKSKTSQLSGGMQRKLsVALAFVGGSKVVILDEPTAG |
| O95477 | S2054 | ELM | ABCA1 ABC1 CERP | LVKYGEKYAGNYSGGNKRKLsTAMALIGGPPVVFLDEPTTG |
| O95613 | S1814 | Sugiyama | PCNT KIAA0402 PCNT2 | AALEAKEALSRLLADQERRHsQALEALQQRLQGAEEAAELQ |
| O95644 | S245 | ELM | NFATC1 NFAT2 NFATC | LGACtLLGsPRHsPstsPRAsVTEESWLGARssRPAsPCNK |
| O95644 | S269 | ELM | NFATC1 NFAT2 NFATC | ESWLGARssRPAsPCNKRKYsLNGRQPPysPHHsPtPSPHG |
| O95644 | S294 | ELM | NFATC1 NFAT2 NFATC | QPPysPHHsPtPSPHGsPRVsVTDDSWLGNTTQYTSSAIVA |
| O95817 | S195 | Sugiyama | BAG3 BIS | AAsDCsssSsSAsLPssGRssLGsHQLPRGyISIPVIHEQN |
| O96004 | S109 | ELM | HAND1 BHLHA27 EHAND | GGRLGRRKGsGPKKERRRtEsINSAFAELRECIPNVPADTK |
| O96004 | S98 | ELM | HAND1 BHLHA27 EHAND | PGQSPGRLEALGGRLGRRKGsGPKKERRRtEsINSAFAELR |
| O96004 | T107 | ELM | HAND1 BHLHA27 EHAND | ALGGRLGRRKGsGPKKERRRtEsINSAFAELRECIPNVPAD |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00439 | S16 | ELM | PAH | _____MSTAVLENPGLGRKLsDFGQETSYIEDNCNQNGAIS |
| P00491 | S176 | Sugiyama | PNP NP | GDRFPAMsDAyDRtMRQRALstWKQMGEQRELQEGTYVMVA |
| P00540 | S73 | SIGNOR | MOS | CSIDWEQVCLLQRLGAGGFGsVYKATYRGVPVAIKQVNKCT |
| P00558 | S174 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | LSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKEL |
| P00558 | S175 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | SKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKELN |
| P01023 | S273 | Sugiyama | A2M CPAMD5 FWP007 | LYTYGKPVPGHVTVSICRKYsDAsDCHGEDSQAFCEKFSGQ |
| P02671 | S460 | ELM | FGA | KELRTGKEKVTSGSTTTTRRsCSKTVTKTVIGPDGHKEVTK |
| P03372 | S236 | ELM | ESR1 ESR NR3A1 | HNDyMCPATNQCTIDKNRRKsCQACRLRKCYEVGMMKGGIR |
| P04004 | S397 | ELM | VTN | KGYRsQRGHsRGRNQNsRRPsRAtWLsLFssEEsNLGANNY |
| P04049 | S259 | ELM | RAF1 RAF | tFNtssPSSEGSLSQRQRststPNVHMVsttLPVDSRMIED |
| P04049 | S43 | ELM | RAF1 RAF | DGssCIsPtIVQQFGYQRRAsDDGKLtDPSKTSNTIRVFLP |
| P04049 | S621 | ELM | RAF1 RAF | QILssIELLQHsLPKINRsAsEPsLHRAAHtEDINACtLtt |
| P04075 | S176 | Sugiyama | ALDOA ALDA | EHtPsALAIMENANVLARyAsICQQNGIVPIVEPEILPDGD |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | T216 | ELM | ANXA1 ANX1 LPC1 | EDLADsDARALyEAGERRKGtDVNVFNtILttRSyPQLRRV |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04439 | S336 | ELM | HLA-A HLAA | VLLGAVITGAVVAAVMWRRKssDRKGGsyTQAASSDSAQGS |
| P04439 | S337 | ELM | HLA-A HLAA | LLGAVITGAVVAAVMWRRKssDRKGGsyTQAASSDSAQGSD |
| P04439 | S343 | ELM | HLA-A HLAA | TGAVVAAVMWRRKssDRKGGsyTQAASSDSAQGSDVsLTAC |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04908 | S20 | Sugiyama | H2AC4 H2AFM HIST1H2AB; H2AC8 H2AFA HIST1H2AE | _MSGRGKQGGKARAKAKTRSsRAGLQFPVGRVHRLLRKGNY |
| P05114 | S21 | ELM | HMGN1 HMG14 | MPKRKVssAEGAAKEEPKRRsARLsAKPPAKVEAKPKKAAA |
| P05114 | S25 | ELM | HMGN1 HMG14 | KVssAEGAAKEEPKRRsARLsAKPPAKVEAKPKKAAAKDKS |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05783 | S305 | Sugiyama | KRT18 CYK18 PIG46 | QSAEVGAAETTLTELRRtVQsLEIDLDsMRNLKAsLENsLR |
| P05787 | S330 | Sugiyama | KRT8 CYK8 | MNRNISRLQAEIEGLKGQRAsLEAAIADAEQRGELAIKDAN |
| P06733 | S349 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | AKAVNEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMV |
| P06744 | T109 | Sugiyama | GPI | KINyTEGRAVLHVALRNRsNtPILVDGKDVMPEVNKVLDKM |
| P07101 | S71 | ELM | TH TYH | APAASYTPTPRsPRFIGRRQsLIEDARKEREAAVAAAAAAV |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07339 | S37 | Sugiyama | CTSD CPSD | PASALVRIPLHKFTSIRRtMsEVGGsVEDLIAKGPVSKYSQ |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07384 | S474 | Sugiyama | CAPN1 CANPL1 PIG30 | GQPAVHLKRDFFLANAsRARsEQFINLREVSTRFRLPPGEY |
| P07550 | S262 | ELM | ADRB2 ADRB2R B2AR | VQNLsQVEQDGRTGHGLRRssKFCLKEHKALKTLGIIMGTF |
| P07550 | S345 | ELM | ADRB2 ADRB2R B2AR | IyCRSPDFRIAFQELLCLRRssLKAyGNGyssNGNtGEQsG |
| P07550 | S346 | ELM | ADRB2 ADRB2R B2AR | yCRSPDFRIAFQELLCLRRssLKAyGNGyssNGNtGEQsGY |
| P07602 | S29 | Sugiyama | PSAP GLBA SAP1 | SLLGAALAGPVLGLKECtRGsAVWCQNVKTASDCGAVKHCL |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07737 | S72 | Sugiyama | PFN1 | VGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFsMDLRtKs |
| P07737 | S77 | Sugiyama | PFN1 | ssFyVNGLtLGGQKCsVIRDsLLQDGEFsMDLRtKstGGAP |
| P07814 | S330 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KHRKNPIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGC |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S623 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tyGWTANMERIMKAQALRDNstMGyMAAKKHLEINPDHsII |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P08034 | S233 | ELM | GJB1 CX32 | IIRACARRAQRRSNPPsRKGsGFGHRLSPEyKQNEINKLLS |
| P08138 | S303 | SIGNOR|ELM|iPTMNet|EPSD|PSP | NGFR TNFRSF16 | QGANsRPVNQtPPPEGEKLHsDsGIsVDsQsLHDQQPHTQT |
| P08151 | T374 | SIGNOR | GLI1 GLI | RTHSNEKPYVCKLPGCTKRYtDPSSLRKHVKTVHGPDAHVt |
| P08183 | S667 | ELM | ABCB1 MDR1 PGY1 | EIDALEMssNDsRssLIRKRsTRRsVRGSQAQDRKLsTKEA |
| P08183 | S683 | ELM | ABCB1 MDR1 PGY1 | IRKRsTRRsVRGSQAQDRKLsTKEALDESIPPVSFWRIMKL |
| P08238 | S452 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AFSKNLKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEy |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | S615 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tyGWTANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIV |
| P08670 | S325 | Sugiyama | VIM | NNDALRQAKQESTEYRRQVQsLtCEVDALKGtNEsLERQMR |
| P09525 | S125 | Sugiyama | ANXA4 ANX4 | DEGCLIEILASRTPEEIRRIsQtYQQQYGRSLEDDIRSDTS |
| P09525 | T127 | Sugiyama | ANXA4 ANX4 | GCLIEILASRTPEEIRRIsQtYQQQYGRSLEDDIRSDTSFM |
| P09651 | S199 | ELM | HNRNPA1 HNRPA1 | KALSKQEMAsAsssQRGRsGsGNFGGGRGGGFGGNDNFGRG |
| P09917 | S272 | ELM | ALOX5 LOG5 | LPEKLPVtTEMVECSLERQLsLEQEVQQGNIFIVDFELLDG |
| P09917 | S524 | ELM | ALOX5 LOG5 | PELQDFVNDVYVYGMRGRKSsGFPKSVKSREQLSEYLTVVI |
| P09972 | S176 | Sugiyama | ALDOC ALDC | ERTPSALAILENANVLARyAsICQQNGIVPIVEPEILPDGD |
| P09972 | S45 | Sugiyama | ALDOC ALDC | APGKGILAADEsVGsMAKRLsQIGVENtEENRRLYRQVLFs |
| P0C0S8 | S20 | Sugiyama | H2AC11 H2AFP HIST1H2AG; H2AC13 H2AFC HIST1H2AI; H2AC15 H2AFD HIST1H2AK; H2AC16 H2AFI HIST1H2AL; H2AC17 H2AFN HIST1H2AM | _MsGRGKQGGKARAKAKTRssRAGLQFPVGRVHRLLRKGNY |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG41 | S140 | Sugiyama | CTAGE8 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| P0CG47 | S57 | Sugiyama | UBB | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0CG48 | S57 | Sugiyama | UBC | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0DN86 | S116 | ELM | CGB3 CGB; CGB5; CGB8 | VNPVVSYAVALSCQCALCRRstTDCGGPKDHPLTCDDPRFQ |
| P0DN86 | S86 | ELM | CGB3 CGB; CGB5; CGB8 | QGVLPALPQVVCNYRDVRFEsIRLPGCPRGVNPVVSYAVAL |
| P0DN86 | T117 | ELM | CGB3 CGB; CGB5; CGB8 | NPVVSYAVALSCQCALCRRstTDCGGPKDHPLTCDDPRFQD |
| P10412 | S36 | Sugiyama | H1-4 H1F4 HIST1H1E | EKtPVKKKARKsAGAAKRKAsGPPVsELItKAVAASKERsG |
| P10636 | S531 | ELM | MAPT MAPTL MTBT1 TAU | RsGyssPGsPGtPGsRsRtPsLPtPPTREPKKVAVVRtPPK |
| P11047 | S335 | Sugiyama | LAMC1 LAMB2 | DCEKCLPFFNDRPWRRAtAEsASECLPCDCNGRsQECyFDP |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11168 | S491 | ELM | SLC2A2 GLUT2 | GVLLAFTLFTFFKVPETKGKsFEEIAAEFQKKsGsAHRPKA |
| P11168 | S503 | ELM | SLC2A2 GLUT2 | KVPETKGKsFEEIAAEFQKKsGsAHRPKAAVEMKFLGATET |
| P11168 | S505 | ELM | SLC2A2 GLUT2 | PETKGKsFEEIAAEFQKKsGsAHRPKAAVEMKFLGATETV_ |
| P11473 | S182 | ELM | VDR NR1I1 | GGGSHPSRPNsRHtPSFSGDsSSSCSDHCITSSDMMDSSSF |
| P11532 | S3623 | Sugiyama | DMD | EAKVNGttVssPstsLQRsDssQPMLLRVVGSQTSDSMGEE |
| P12814 | S404 | Sugiyama | ACTN1 | NEIRRLERLDHLAEKFRQKAsIHEAWtDGKEAMLRQKDyEt |
| P12931 | S17 | ELM | SRC SRC1 | ____MGSNKSKPKDAsQRRRsLEPAENVHGAGGGAFPAsQt |
| P12956 | S477 | Sugiyama | XRCC6 G22P1 | EQVGKMKAIVEKLRFtYRsDsFENPVLQQHFRNLEALALDL |
| P12956 | S520 | Sugiyama | XRCC6 G22P1 | PEQAVDLTLPKVEAMNKRLGsLVDEFKELVyPPDyNPEGKV |
| P13224 | S191 | ELM | GP1BB | LLCRLRRLRARARARAAARLsLtDPLVAERAGtDEs_____ |
| P13569 | S660 | ELM | CFTR ABCC7 | FsSKLMGCDSFDQFSAERRNsILTETLHRFsLEGDAPVSWT |
| P13569 | S700 | ELM | CFTR ABCC7 | TEtKKQsFKQTGEFGEKRKNsILNPINsIRKFsIVQKTPLQ |
| P13569 | S737 | ELM | CFTR ABCC7 | TPLQMNGIEEDSDEPLERRLsLVPDSEQGEAILPRIsVIST |
| P13569 | S753 | ELM | CFTR ABCC7 | ERRLsLVPDSEQGEAILPRIsVISTGPTLQARRRQsVLNLM |
| P13569 | S768 | ELM | CFTR ABCC7 | ILPRIsVISTGPTLQARRRQsVLNLMTHSVNQGQNIHRKTT |
| P13569 | S795 | ELM | CFTR ABCC7 | HSVNQGQNIHRKTTAsTRKVsLAPQANLTELDIYsRRLsQE |
| P13569 | S813 | ELM | CFTR ABCC7 | KVsLAPQANLTELDIYsRRLsQEtGLEISEEINEEDLKECF |
| P13612 | S1027 | ELM | ITGA4 CD49D | RQYKsILQEENRRDsWsyINsKSNDD_______________ |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13796 | S5 | ELM | LCP1 PLS2 | ________________MARGsVsDEEMMELREAFAKVDtDG |
| P13796 | S7 | ELM | LCP1 PLS2 | ______________MARGsVsDEEMMELREAFAKVDtDGNG |
| P13861 | S99 | ELM|Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14410 | S7 | SIGNOR|ELM | SI | ______________MARKKFsGLEISLIVLFVIVTIIAIAL |
| P14598 | S303 | ELM | NCF1 NOXO2 SH3PXD1A | sGQDVsQAQRQIKRGAPPRRssIRNAHsIHQRsRKRLsQDA |
| P14598 | S320 | ELM | NCF1 NOXO2 SH3PXD1A | PRRssIRNAHsIHQRsRKRLsQDAYRRNsVRFLQQRRRQAR |
| P14598 | S328 | ELM | NCF1 NOXO2 SH3PXD1A | AHsIHQRsRKRLsQDAYRRNsVRFLQQRRRQARPGPQsPGs |
| P14598 | S348 | ELM | NCF1 NOXO2 SH3PXD1A | sVRFLQQRRRQARPGPQsPGsPLEEERQtQRsKPQPAVPPR |
| P14598 | S359 | ELM | NCF1 NOXO2 SH3PXD1A | ARPGPQsPGsPLEEERQtQRsKPQPAVPPRPsADLILNRCs |
| P14598 | S370 | ELM | NCF1 NOXO2 SH3PXD1A | LEEERQtQRsKPQPAVPPRPsADLILNRCsESTKRKLASAV |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14859 | S385 | ELM | POU2F1 OCT1 OTF1 | PsALNsPGIEGLSRRRKKRtsIETNIRVALEKSFLENQKPT |
| P14866 | S544 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | LGVKRPSSVKVFSGKsERsssGLLEWEsKSDALETLGFLNH |
| P15056 | S429 | ELM | BRAF BRAF1 RAFB1 | SLTNVKALQKsPGPQRERKsssssEDRNRMKtLGRRDssDD |
| P15289 | S372 | Sugiyama | ARSA | TLDGFDLSPLLLGTGKSPRQsLFFYPSYPDEVRGVFAVRTG |
| P15531 | S120 | Sugiyama | NME1 NDPKA NM23 | KPGtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELV |
| P15880 | S190 | Sugiyama | RPS2 RPS4 | WGNKIGKPHTVPCKVTGRCGsVLVRLIPAPRGtGIVsAPVP |
| P15924 | S2849 | ELM | DSP | sRsGsRSGsRsGsRsGsRRGsFDAtGNssYsYSYSFSsssI |
| P16066 | S529 | ELM | NPR1 ANPRA | RVRWEDVEPSsLERHLRSAGsRLtLsGRGsNyGsLLtTEGQ |
| P16070 | S45 | Sugiyama | CD44 LHR MDU2 MDU3 MIC4 | NITCRFAGVFHVEKNGRYsIsRtEAADLCKAFNSTLPTMAQ |
| P16104 | S20 | Sugiyama | H2AX H2AFX | _MSGRGKTGGKARAKAKsRssRAGLQFPVGRVHRLLRKGHY |
| P16220 | S119 | SIGNOR | CREB1 | EsVDsVTDsQKRREILsRRPsYRKILNDLssDAPGVPRIEE |
| P16402 | S37 | Sugiyama | H1-3 H1F3 HIST1H1D | KtPVKKKAKKAGATAGKRKAsGPPVsELItKAVAASKERsG |
| P16403 | S36 | Sugiyama | H1-2 H1F2 HIST1H1C | EKAPVKKKAAKKAGGtPRKAsGPPVsELItKAVAASKERsG |
| P16452 | S248 | ELM | EPB42 E42P | LPTPQTQATQEGALLNKRRGsVPILRQWLTGRGRPVYDGQA |
| P16949 | S63 | ELM | STMN1 C1orf215 LAP18 OP18 | KDLsLEEIQKKLEAAEERRKsHEAEVLKQLAEKREHEKEVL |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17542 | S172 | ELM | TAL1 BHLHA17 SCL TCL5 | FGEPDAFPMFTTNNRVKRRPsPYEMEITDGPHTKVVRRIFT |
| P17544 | S44 | Sugiyama | ATF7 ATFA | LAVHKHKHEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEV |
| P17655 | S369 | ELM | CAPN2 CANPL2 | TSDTYKKWKLTKMDGNWRRGstAGGCRNYPNTFWMNPQYLI |
| P17655 | T370 | ELM | CAPN2 CANPL2 | SDTYKKWKLTKMDGNWRRGstAGGCRNYPNTFWMNPQYLIK |
| P17676 | S288 | ELM | CEBPB TCF5 PP9092 | DKHSDEYKIRRERNNIAVRKsRDKAKMRNLETQHKVLELTA |
| P17752 | S58 | ELM | TPH1 TPH TPRH TRPH | FQEKHVNLLHIESRKSKRRNsEFEIFVDCDINREQLNDIFH |
| P17812 | T455 | ELM | CTPS1 CTPS | DMPEHNPGQMGGTMRLGKRRtLFQTKNsVMRKLyGDADyLE |
| P17858 | T773 | ELM | PFKL | QYRISMAAYVsGELEHVTRRtLsMDKGF_____________ |
| P17987 | S35 | Sugiyama | TCP1 CCT1 CCTA | EtIRsQNVMAAAsIANIVKssLGPVGLDKMLVDDIGDVTIT |
| P18505 | S434 | ELM | GABRB1 | YGRALDRHGVPSKGRIRRRAsQLKVKIPDLTDVNSIDKWSR |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18858 | S901 | Sugiyama | LIG1 | DKQPEQATTSAQVACLYRKQsQIQNQQGEDsGsDPEDTY__ |
| P19174 | S1233 | Sugiyama | PLCG1 PLC1 | PAKENGDLsPFsGtsLRERGsDASGQLFHGRAREGsFEsRy |
| P19174 | S1248 | ELM | PLCG1 PLC1 | LRERGsDASGQLFHGRAREGsFEsRyQQPFEDFRIsQEHLA |
| P19429 | S23 | ELM | TNNI3 TNNC1 | DGSSDAAREPRPAPAPIRRRssNyRAYAtEPHAKKKsKIsA |
| P19429 | S24 | ELM | TNNI3 TNNC1 | GSSDAAREPRPAPAPIRRRssNyRAYAtEPHAKKKsKIsAs |
| P19544 | S365 | ELM | WT1 | RKHTGEKPYQCDFKDCERRFsRSDQLKRHQRRHTGVKPFQC |
| P19544 | S393 | ELM | WT1 | HQRRHTGVKPFQCKTCQRKFsRSDHLKTHTRTHTGKTSEKP |
| P19838 | S337 | ELM | NFKB1 | KYKDINITKPAsVFVQLRRKsDLETSEPKPFLYYPEIKDKE |
| P20020 | S1178 | ELM | ATP2B1 PMCA1 | HIPLIDDTDAEDDAPTKRNSsPPPSPNKNNNAVDSGIHLTI |
| P20671 | S20 | Sugiyama | H2AC7 H2AFG HIST1H2AD | _MSGRGKQGGKARAKAKTRssRAGLQFPVGRVHRLLRKGNY |
| P20810 | S366 | Sugiyama | CAST | DKDGKPLLPEPEEKPKPRsEsELIDELsEDFDRsECKEKPS |
| P21333 | S2152 | Sugiyama | FLNA FLN FLN1 | VKVTGEGRVKEsITRRRRAPsVANVGsHCDLsLKIPEIsIQ |
| P21731 | S331 | Sugiyama | TBXA2R | FRRAVLRRLQPRLsTRPRsLsLQPQLtQRSGLQ________ |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22459 | T601 | SIGNOR | KCNA4 KCNA4L | QNAVSCPYLPSNLLKKFRSStSSSLGDKSEYLEMEEGVKES |
| P23771 | S308 | SIGNOR | GATA3 | GLYHKMNGQNRPLIKPKRRLsAARRAGTSCANCQTTTTTLW |
| P24385 | S197 | ELM | CCND1 BCL1 PRAD1 | IIRKHAQTFVALCATDVKFIsNPPSMVAAGSVVAAVQGLNL |
| P24385 | S234 | ELM | CCND1 BCL1 PRAD1 | GLNLRsPNNFLSYYRLTRFLsRVIKCDPDCLRACQEQIEAL |
| P24385 | S90 | ELM | CCND1 BCL1 PRAD1 | EQKCEEEVFPLAMNYLDRFLsLEPVKKSRLQLLGATCMFVA |
| P24534 | S141 | Sugiyama | EEF1B2 EEF1B EF1B | ERLAQYESKKAKKPALVAKssILLDVKPWDDEtDMAKLEEC |
| P25054 | S2054 | ELM | APC DP2.5 | sEDDLLQECISSAMPKKKKPsRLKGDNEKHsPRNMGGILGE |
| P25098 | S685 | ELM | GRK2 ADRBK1 BARK BARK1 | KNKPRsPVVELsKVPLVQRGsANGL________________ |
| P25205 | S374 | Sugiyama | MCM3 | LLRYVLCTAPRAIPttGRGSsGVGLTAAVtTDQETGERRLE |
| P25205 | S447 | Sugiyama | MCM3 | EQGRVTIAKAGIHARLNARCsVLAAANPVyGRyDQyKTPME |
| P25789 | T10 | Sugiyama | PSMA4 HC9 PSC9 | ___________MSRRyDsRttIFsPEGRLYQVEYAMEAIGH |
| P26038 | T558 | ELM | MSN | KTANDMIHAENMRLGRDKYKtLRQIRQGNTKQRIDEFEsM_ |
| P26232 | T657 | Sugiyama | CTNNA2 CAPR | EDDsDFEQEDYDVRsRtsVQtEDDQLIAGQsARAIMAQLPQ |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26599 | S16 | ELM | PTBP1 PTB | _____MDGIVPDIAVGTKRGsDELFSTCVTNGPFIMSSNSA |
| P26641 | S286 | Sugiyama | EEF1G EF1G PRO1608 | CEQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVA |
| P26678 | S16 | ELM | PLN PLB | _____MEKVQYLTRSAIRRAstIEMPQQARQKLQNLFINFC |
| P27105 | S10 | ELM | STOM BND7 EPB72 | ___________MAEKRHTRDsEAQRLPDsFKDsPSKGLGPC |
| P27708 | S1406 | SIGNOR|ELM | CAD | EKNFELVINLSMRGAGGRRLssFVTKGYRTRRLAADFSVPL |
| P27708 | S1859 | Sugiyama | CAD | RGIPGLPDGRFHLPPRIHRAsDPGLPAEEPKEKSSRKVAEP |
| P27815 | S145 | SIGNOR | PDE4A DPDE2 | sQAsPGLVLHAGAATSQRREsFLYRSDsDYDMsPKTMSRNs |
| P27815 | S89 | SIGNOR | PDE4A DPDE2 | DAMDTSDRPGLRTTRMsWPSsFHGTGTGSGGAGGGSSRRFE |
| P27986 | S83 | SIGNOR | PIK3R1 GRB1 | TGERGDFPGTYVEYIGRKKIsPPTPKPRPPRPLPVAPGSSK |
| P28340 | S1064 | Sugiyama | POLD1 POLD | LNALEERFSRLWTQCQRCQGsLHEDVICTSRDCPIFyMRKK |
| P29401 | S104 | Sugiyama | TKT | AVWAEAGFLAEAELLNLRKIssDLDGHPVPKQAFtDVATGs |
| P29401 | S305 | Sugiyama | TKT | LAtPPQEDAPsVDIANIRMPsLPsyKVGDKIATRKAYGQAL |
| P29401 | S473 | Sugiyama | TKT | AtEKAVELAANTKGICFIRTsRPENAIIyNNNEDFQVGQAK |
| P29474 | S633 | ELM | NOS3 | FNsISCSDPLVssWRRKRKEssNtDSAGALGTLRFCVFGLG |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P29692 | S60 | Sugiyama | EEF1D EF1D | ENGAsVILRDIARARENIQKsLAGssGPGAssGtsGDHGEL |
| P30086 | S139 | Sugiyama | PEBP1 PBP PEBP | RyVWLVyEQDRPLKCDEPILsNRsGDHRGKFKVAsFRKKyE |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30301 | S229 | ELM | MIP AQP0 | IIGGGLGSLLYDFLLFPRLKsIsERLsVLKGAKPDVSNGQP |
| P30301 | S231 | ELM | MIP AQP0 | GGGLGSLLYDFLLFPRLKsIsERLsVLKGAKPDVSNGQPEV |
| P30533 | S242 | Sugiyama | LRPAP1 A2MRAP | TELKEKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWD |
| P31323 | S114 | ELM | PRKAR2B | APADAGAFNAPVINRFTRRAsVCAEAyNPDEEEDDAESRII |
| P31327 | S898 | Sugiyama | CPS1 | LYKMRDILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQIS |
| P32119 | S112 | Sugiyama | PRDX2 NKEFB TDPX1 | KEGGLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFII |
| P32245 | S329 | ELM | MC4R | LRKtFKEIICCYPLGGLCDLssRY_________________ |
| P32245 | S330 | ELM | MC4R | RKtFKEIICCYPLGGLCDLssRY__________________ |
| P32245 | T312 | ELM | MC4R | MCNSIIDPLIYALRSQELRKtFKEIICCYPLGGLCDLssRY |
| P32927 | S601 | ELM | CSF2RB IL3RB IL5RB | EKQASSFDFNGPyLGPPHSRsLPDILGQPEPPQEGGSQKSP |
| P33076 | S1050 | ELM | CIITA MHC2TA | LGAYKLAEALPSLAASLLRLsLYNNCICDVGAESLARVLPD |
| P33076 | S834 | ELM | CIITA MHC2TA | HEAEEAGIWQHVVQELPGRLsFLGTRLTPPDAHVLGKALEA |
| P33240 | S310 | Sugiyama | CSTF2 | VSMERGQVPMQDPRAAMQRGsLPANVPtPRGLLGDAPNDPR |
| P33316 | S120 | Sugiyama | DUT | PsKRARPAEVGGMQLRFARLsEHAtAPTRGsARAAGYDLYS |
| P33993 | S483 | Sugiyama | MCM7 CDC47 MCM2 | EQQTISIAKAGILTTLNARCsILAAANPAyGRYNPRRsLEQ |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P35221 | S641 | Sugiyama | CTNNA1 | GIRDIRKAVLMIRtPEELDDsDFEtEDFDVRsRtsVQtEDD |
| P35221 | T658 | Sugiyama | CTNNA1 | LDDsDFEtEDFDVRsRtsVQtEDDQLIAGQsARAIMAQLPQ |
| P35236 | S44 | ELM | PTPN7 | QPPPEKTPAKKHVRLQERRGsNVALMLDVRSLGAVEPICsV |
| P35240 | S518 | ELM | NF2 SCH | FNLIGDSLSFDFKDTDMKRLsMEIEKEKVEYMEKSKHLQEQ |
| P35367 | S398 | ELM | HRH1 | sGsNtGLDYIKFTWKRLRsHsRQYVSGLHMNRERKAAKQLG |
| P35408 | S222 | ELM | PTGER4 PTGER2 | CNVLVCGALLRMHRQFMRRtsLGtEQHHAAAAASVASRGHP |
| P35408 | S259 | ELM | PTGER4 PTGER2 | RGHPAAsPALPRLSDFRRRRsFRRIAGAEIQMVILLIATSL |
| P35579 | S1808 | Sugiyama | MYH9 | KELKVKLQEMEGtVKsKYKAsITALEAKIAQLEEQLDNEtK |
| P35611 | S408 | ELM | ADD1 ADDA | GYRTGYPYRYPALREKSKKysDVEVPASVtGysFAsDGDsG |
| P35611 | S436 | ELM | ADD1 ADDA | VtGysFAsDGDsGtCsPLRHsFQKQQREKtRWLNSGRGDEA |
| P35611 | S481 | ELM | ADD1 ADDA | QNGssPKsKTKWTKEDGHRtstsAVPNLFVPLNTNPKEVQE |
| P35611 | S59 | ELM | ADD1 ADDA | RNMAPDLRQDFNMMEQKKRVsMILQsPAFCEELESMIQEQF |
| P35612 | T55 | ELM | ADD2 ADDB | RNRAADLRQDFNLMEQKKRVtMILQsPSFREELEGLIQEQM |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37837 | S13 | Sugiyama | TALDO1 TAL TALDO TALDOR | ________MsssPVKRQRMEsALDQLKQFTTVVADTGDFHA |
| P38646 | S148 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | YDDPEVQKDIKNVPFKIVRAsNGDAWVEAHGKLYSPSQIGA |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P39748 | S335 | Sugiyama | FEN1 RAD2 | QFSEERIRSGVKRLSKsRQGsTQGRLDDFFKVTGsLssAKR |
| P39880 | S1215 | ELM | CUX1 CUTL1 | VEKLMDMKRMEKKAYMKRRHssVsDsQPCEPPsVGtEysQG |
| P40818 | S718 | Sugiyama | USP8 KIAA0055 UBPY | AKPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtP |
| P40818 | S719 | Sugiyama | USP8 KIAA0055 UBPY | KPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtPT |
| P41091 | S107 | Sugiyama | EIF2S3 EIF2G | KIYKLDDPSCPRPECyRSCGsstPDEFPtDIPGtKGNFKLV |
| P41161 | S367 | ELM | ETV5 ERM | GKVKQEPTMYREGPPYQRRGsLQLWQFLVTLLDDPANAHFI |
| P41181 | S256 | SIGNOR|ELM|PSP | AQP2 | VLKGLEPDTDWEEREVRRRQsVELHsPQsLPRGtKA_____ |
| P41208 | S170 | ELM | CETN2 CALT CEN2 | DRDGDGEVsEQEFLRIMKKTsLY__________________ |
| P42261 | S863 | ELM | GRIA1 GLUA1 GLUH1 GLUR1 | CLIPQQsINEAIRTStLPRNsGAGASSGGSGENGRVVSHDF |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43243 | S195 | Sugiyama | MATR3 KIAA0723 | RDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyD |
| P43243 | S234 | Sugiyama | MATR3 KIAA0723 | yDRMDyEDDRLRDGERCRDDsFFGEtsHNyHKFDsEyERMG |
| P43243 | T150 | Sugiyama | MATR3 KIAA0723 | EDKItPENLPQILLQLKRRRtEEGPtLsyGRDGRsAtREPP |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P43490 | S472 | Sugiyama | NAMPT PBEF PBEF1 | EYGQDLLHTVFKNGKVTKsysFDEIRKNAQLNIELEAAHH_ |
| P43694 | S262 | SIGNOR | GATA4 | GLYHKMNGINRPLIKPQRRLsASRRVGLSCANCQTTTTTLW |
| P46013 | S648 | Sugiyama | MKI67 | RVSISRsQHDILQMICSKRRsGAsEANLIVAKSWADVVKLG |
| P46459 | S207 | Sugiyama | NSF | KAENSSLNLIGKAKTKENRQsIINPDWNFEKMGIGGLDKEF |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S230 | Sugiyama | RPL5 MSTP030 | yLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAAIREN |
| P46937 | S109 | Sugiyama | YAP1 YAP65 | RKLPDsFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssP |
| P47712 | S727 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | VIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKP |
| P47712 | T416 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | AFSILFNRVLGVSGSQsRGstMEEELENIttKHIVsNDssD |
| P47736 | S490 | ELM | RAP1GAP KIAA0474 RAP1GA1 | LAKAAGIsLIVPGKsPtRKKsGPFGsRRssAIGIENIQEVQ |
| P47736 | S499 | ELM | RAP1GAP KIAA0474 RAP1GA1 | IVPGKsPtRKKsGPFGsRRssAIGIENIQEVQEKREsPPAG |
| P48050 | S443 | SIGNOR | KCNJ4 IRK3 | LDLERMQASLPLDNISYRREsAI__________________ |
| P48058 | S862 | ELM | GRIA4 GluA4 GLUR4 | AEAKRMKLtFSEAIRNKARLsITGSVGENGRVLTPDCPKAV |
| P48436 | S181 | ELM | SOX9 | LRVQHKKDHPDYKYQPRRRKsVKNGQAEAEEATEQtHIsPN |
| P48436 | S64 | ELM | SOX9 | ENTRPQENTFPKGEPDLKKEsEEDKFPVCIREAVSQVLKGY |
| P48736 | T1024 | SIGNOR | PIK3CG | PHFQKFQDICVKAYLALRHHtNLLIILFSMMLMTGMPQLTS |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P48764 | S555 | SIGNOR | SLC9A3 NHE3 | FHELNLKDAISYVAEGERRGsLAFIRsPsTDNVVNVDFTPR |
| P49327 | S1997 | Sugiyama | FASN FAS | DGLLENQTPEFFQDVCKPKYsGtLNLDRVTREACPELDYFV |
| P49419 | S84 | Sugiyama | ALDH7A1 ATQ1 | EVIttyCPANNEPIARVRQAsVADyEEtVKKAREAWKIWAD |
| P49588 | S237 | Sugiyama | AARS1 AARS | LVFIQYNREADGILKPLPKKsIDtGMGLERLVsVLQNKMSN |
| P49588 | S627 | Sugiyama | AARS1 AARS | ATHILNFALRSVLGEADQKGsLVAPDRLRFDFTAKGAMSTQ |
| P49588 | T240 | Sugiyama | AARS1 AARS | IQYNREADGILKPLPKKsIDtGMGLERLVsVLQNKMSNYDT |
| P49736 | S229 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | sHGHNVFKERIsDMCKENREsLVVNyEDLAAREHVLAYFLP |
| P49736 | S754 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | KLNQMDQDKVAKMYSDLRKEsMATGSIPITVRHIESMIRMA |
| P49768 | S310 | ELM | PSEN1 AD3 PS1 PSNL1 | STMVWLVNMAEGDPEAQRRVsKNsKyNAEstEREsQDtVAE |
| P49840 | S21 | ELM | GSK3A | MsGGGPsGGGPGGsGRARtssFAEPGGGGGGGGGGPGGsAs |
| P49841 | S9 | SIGNOR|ELM | GSK3B | ____________MSGRPRttsFAEsCKPVQQPsAFGsMKVS |
| P50454 | S139 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | SNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHS |
| P50454 | S141 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | STARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHSKI |
| P50552 | S157 | ELM | VASP | EVEQQKRQQPGPSEHIERRVsNAGGPPAPPAGGPPPPPGPP |
| P50552 | S239 | ELM | VASP | GGAGAPGLAAAIAGAKLRKVsKQEEAsGGPTAPKAESGRSG |
| P50552 | T278 | ELM | VASP | SGGGGLMEEMNAMLARRRKAtQVGEKtPKDEsANQEEPEAR |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51858 | S107 | Sugiyama | HDGF HMG1L2 | WEIENNPtVKASGYQSsQKKsCVEEPEPEPEAAEGDGDKKG |
| P51858 | S83 | Sugiyama | HDGF HMG1L2 | LFPyEEsKEKFGKPNKRKGFsEGLWEIENNPtVKASGYQSs |
| P52179 | S618 | SIGNOR | MYOM1 | VSEPVAALDPAEKARLKSRPsAPWTGQIIVTEEEPSEGIVP |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P52732 | S36 | Sugiyama | KIF11 EG5 KNSL1 TRIP5 | GKNIQVVVRCRPFNLAERKAsAHsIVECDPVRKEVSVRTGG |
| P52888 | S643 | ELM | THOP1 | FHTRFKQEGVLNSKVGMDYRsCILRPGGSEDASAMLRRFLG |
| P53365 | S260 | Sugiyama | ARFIP2 POR1 | TDLEELsLGPRDAGTRGRLEsAQATFQAHRDKYEKLRGDVA |
| P53396 | S455 | ELM|Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P55036 | S358 | Sugiyama | PSMD4 MCB1 | VLENLPGVDPNNEAIRNAMGsLAsQATKDGKKDKKEEDKK_ |
| P55064 | S156 | SIGNOR | AQP5 | LILTFQLALCIFASTDSRRTsPVGSPALSIGLSVTLGHLVG |
| P56524 | S584 | SIGNOR | HDAC4 KIAA0288 | EsDEEEAEPPREVEPGQRQPsEQELLFRQQALLLEQQRIHQ |
| P56537 | S6 | Sugiyama | EIF6 EIF3A ITGB4BP OK/SW-cl.27 | _______________MAVRAsFENNCEIGCFAKLTNTYCLV |
| P57053 | S37 | Sugiyama | H2BC12L H2BFS H2BS1 | KAVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P58876 | S37 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P60983 | S83 | ELM | GMFB | ERQPRFIVYsYKYQHDDGRVsYPLCFIFSSPVGCKPEQQMM |
| P60983 | T27 | ELM | GMFB | VCDVAEDLVEKLRKFRFRKEtNNAAIIMKIDKDKRLVVLDE |
| P61081 | S175 | Sugiyama | UBE2M UBC12 | NNRRLFEQNVQRSMRGGyIGstyFERCLK____________ |
| P61224 | S179 | ELM | RAP1B OK/SW-cl.11 | yDLVRQINRKTPVPGKARKKssCQLL_______________ |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61353 | S86 | Sugiyama | RPL27 | SKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPAL |
| P61586 | S188 | ELM | RHOA ARH12 ARHA RHO12 | REVFEMAtRAALQARRGKKKsGCLVL_______________ |
| P61916 | S29 | Sugiyama | NPC2 HE1 | LLLALSTAAQAEPVQFKDCGsVDGVIKEVNVsPCPtQPCQL |
| P61978 | S417 | Sugiyama | HNRNPK HNRPK | DLAGsIIGKGGQRIKQIRHEsGAsIKIDEPLEGsEDRIITI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P62241 | S160 | Sugiyama | RPS8 OK/SW-cl.83 | KRSKKIQKKYDERKKNAKIssLLEEQFQQGKLLACIASRPG |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62280 | S74 | Sugiyama | RPS11 | tyIDKKCPFTGNVsIRGRILsGVVTKMKMQRTIVIRRDYLH |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62807 | S15 | ELM | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | ______MPEPAKsAPAPKKGsKKAVTKAQKKDGKKRKRsRK |
| P62807 | S33 | ELM | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KGsKKAVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDT |
| P62807 | S37 | ELM|Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIss |
| P62834 | S180 | ELM | RAP1A KREV1 | DLVRQINRKTPVEKKKPKKKsCLLL________________ |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62937 | S51 | Sugiyama | PPIA CYPA | KtAENFRALSTGEKGFGYKGsCFHRIIPGFMCQGGDFtRHN |
| P62979 | S57 | Sugiyama | RPS27A UBA80 UBCEP1 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGA |
| P62987 | S57 | Sugiyama | UBA52 UBCEP2 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGI |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | S58 | ELM | YWHAZ | NEERNLLsVAyKNVVGARRssWRVVssIEQKTEGAEKKQQM |
| P63146 | S142 | Sugiyama | UBE2B RAD6B UBCH1 | ANSQAAQLYQENKREYEKRVsAIVEQsWNDS__________ |
| P63252 | S425 | SIGNOR | KCNJ2 IRK1 | DIDLHNQASVPLEPRPLRREsEI__________________ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P78348 | S479 | ELM | ASIC1 ACCN2 BNAC2 | EVIKHKLCRRGKCQKEAKRSsADKGVALsLDDVKRHNPCEs |
| P78371 | S60 | Sugiyama | CCT2 99D8.1 CCTB | KSTLGPKGMDKILLsSGRDAsLMVtNDGAtILKNIGVDNPA |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| Q00536 | S110 | ELM | CDK16 PCTAIRE1 PCTK1 | sDEVQsPVRVRMRNHPPRKIstEDINKRLsLPADIRLPEGY |
| Q00536 | S119 | ELM | CDK16 PCTAIRE1 PCTK1 | VRMRNHPPRKIstEDINKRLsLPADIRLPEGYLEKLTLNsP |
| Q00536 | S12 | ELM | CDK16 PCTAIRE1 PCTK1 | _________MDRMKKIKRQLsMTLRGGRGIDKTNGAPEQIG |
| Q00536 | S153 | ELM | CDK16 PCTAIRE1 PCTK1 | KLTLNsPIFDKPLsRRLRRVsLsEIGFGKLETYIKLDKLGE |
| Q00587 | S350 | Sugiyama | CDC42EP1 BORG5 CEP1 MSE55 | HyPEMDARQERVEVLPQARAsWEsLDEEWRAPQAGsRtPVP |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01130 | S121 | PSP | SRSF2 SFRS2 | sRRGPPPRRYGGGGYGRRSRsPRRRRRsRsRSRSRSRSRSR |
| Q01130 | S128 | PSP | SRSF2 SFRS2 | RRYGGGGYGRRSRsPRRRRRsRsRSRSRSRSRSRSRYSRSK |
| Q01130 | S130 | PSP | SRSF2 SFRS2 | YGGGGYGRRSRsPRRRRRsRsRSRSRSRSRSRSRYSRSKSR |
| Q01130 | S171 | PSP | SRSF2 SFRS2 | SRTRSRSRSTSKSRSARRSKsKSSSVSRSRSRSRSRsRsRs |
| Q01970 | S1105 | ELM | PLCB3 | EMNEREKKELQKILDRKRHNsIsEAKMRDKHKKEAELTEIN |
| Q02543 | S123 | Sugiyama | RPL18A | AGAVtQCyRDMGARHRARAHsIQIMKVEEIAASKCRRPAVK |
| Q04206 | S276 | Sugiyama | RELA NFKB3 | PYADPsLQAPVRVsMQLRRPsDRELsEPMEFQYLPDTDDRH |
| Q04206 | S281 | Sugiyama | RELA NFKB3 | sLQAPVRVsMQLRRPsDRELsEPMEFQYLPDTDDRHRIEEK |
| Q04695 | S32 | Sugiyama | KRT17 | SsIKGSSGLGGGsSRTsCRLsGGLGAGsCRLGSAGGLGSTL |
| Q04917 | S145 | Sugiyama | YWHAH YWHA1 | KMKGDYYRYLAEVASGEKKNsVVEAsEAAyKEAFEISKEQM |
| Q05209 | S39 | ELM | PTPN12 | sPDHNGEDNFARDFMRLRRLsTKYRTEKIyPTATGEKEENV |
| Q05209 | S435 | ELM | PTPN12 | LPGKNESTIEQIDKKLERNLsFEIKKVPLQEGPKsFDGNtL |
| Q05469 | S853 | ELM | LIPE | ELSGRKSQKMSEPIAEPMRRsVsEAALAQPQGPLGTDSLKN |
| Q05469 | S855 | ELM | LIPE | SGRKSQKMSEPIAEPMRRsVsEAALAQPQGPLGTDSLKNLT |
| Q05469 | S950 | SIGNOR|ELM | LIPE | PMDRGLGVRAAFPEGFHPRRssQGATQMPLYSSPIVKNPFM |
| Q05469 | S951 | SIGNOR|ELM | LIPE | MDRGLGVRAAFPEGFHPRRssQGATQMPLYSSPIVKNPFMS |
| Q06124 | S134 | Sugiyama | PTPN11 PTP2C SHPTP2 | HGHLSGKEAEKLLTEKGKHGsFLVREsQsHPGDFVLSVRTG |
| Q06124 | S189 | SIGNOR | PTPN11 PTP2C SHPTP2 | HVMIRCQELKYDVGGGERFDsLTDLVEHYKKNPMVETLGTV |
| Q06124 | T73 | SIGNOR | PTPN11 PTP2C SHPTP2 | HIKIQNTGDyYDLYGGEKFAtLAELVQYYMEHHGQLKEKNG |
| Q06210 | S205 | ELM | GFPT1 GFAT GFPT | FALVFKSVHFPGQAVGTRRGsPLLIGVRSEHKLSTDHIPIL |
| Q06210 | S235 | ELM | GFPT1 GFAT GFPT | HKLSTDHIPILYRTARTQIGsKFTRWGsQGERGKDKKGSCN |
| Q06210 | S261 | Sugiyama | GFPT1 GFAT GFPT | GsQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDA |
| Q06830 | S152 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | IIDDKGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEV |
| Q07002 | S14 | SIGNOR | CDK18 PCTAIRE3 PCTK3 | _______MIMNKMKNFKRRFsLSVPRTETIEESLAEFTEQF |
| Q07021 | S106 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | LsDEIKEERKIQKHKTLPKMsGGWELELNGTEAKLVRKVAG |
| Q07343 | S133 | SIGNOR|ELM | PDE4B DPDE4 | SSSAGLVLHATFPGHSQRREsFLYRsDsDYDLsPKAMSRNS |
| Q07666 | S20 | Sugiyama | KHDRBS1 SAM68 | _MQRRDDPAARMsRssGRsGsMDPsGAHPsVRQtPsRQPPL |
| Q07866 | S445 | Sugiyama | KLC1 KLC KNS2 | PIWMHAEEREECKGKQKDGTsFGEyGGWyKACKVDsPtVTT |
| Q07954 | S4517 | ELM | LRP1 A2MR APR | DKPTNFTNPVyATLYMGGHGsRHsLAsTDEKRELLGRGPED |
| Q07954 | S4520 | ELM | LRP1 A2MR APR | TNFTNPVyATLYMGGHGsRHsLAsTDEKRELLGRGPEDEIG |
| Q08211 | S449 | Sugiyama | DHX9 DDX9 LKP NDH2 | FIQNDRAAECNIVVTQPRRIsAVsVAERVAFERGEEPGKSC |
| Q08289 | S514 | ELM | CACNB2 CACNLB2 MYSB | NsQGSQGDQRTDRSAPIRsAsQAEEEPSVEPVKKSQHRSss |
| Q08289 | S533 | ELM | CACNB2 CACNLB2 MYSB | AsQAEEEPSVEPVKKSQHRSssSAPHHNHRSGTSRGLSRQE |
| Q08289 | S534 | ELM | CACNB2 CACNLB2 MYSB | sQAEEEPSVEPVKKSQHRSssSAPHHNHRSGTSRGLSRQEt |
| Q08289 | T219 | ELM | CACNB2 CACNLB2 MYSB | KSGGNSSSSLGDIVPSSRKstPPssAIDIDATGLDAEENDI |
| Q08493 | S14 | SIGNOR | PDE4C DPDE1 | _______MENLGVGEGAEACsRLSRSRGRHSMTRAPKHLWR |
| Q08495 | S403 | ELM | DMTN DMT EPB49 | sPEEFGKLALWKRNELKKKAsLF__________________ |
| Q08499 | S125 | SIGNOR | PDE4D DPDE3 | RHRGYSDTERYLYCRAMDRTsYAVETGHRPGLKKSRMSWPS |
| Q09028 | S146 | Sugiyama | RBBP4 RBAP48 | EVNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGE |
| Q09161 | S22 | Sugiyama | NCBP1 CBP80 NCBP | SRRRHsDENDGGQPHKRRKtsDANEtEDHLEsLICKVGEKS |
| Q09470 | S446 | SIGNOR | KCNA1 | QLLHVSSPNLASDSDLSRRSsSTMSKSEYMEIEEDMNNSIA |
| Q12798 | S170 | ELM | CETN1 CEN1 CETN | DRDGDGEVNEEEFLRIMKKTsLY__________________ |
| Q12802 | S1565 | ELM | AKAP13 BRX HT31 LBC | PANCSVLRSSMRSLsPFRRHsWGPGKNAASDAEMNHRSSMR |
| Q12802 | S2733 | ELM | AKAP13 BRX HT31 LBC | PSIAKsGsLDsELsVsPKRNsISRTHKDKGPFHILSSTSQT |
| Q12805 | S196 | Sugiyama | EFEMP1 FBLN3 FBNL | ECTAGTHNCRADQVCINLRGsFACQCPPGYQKRGEQCVDID |
| Q12809 | S1137 | ELM | KCNH2 ERG ERG1 HERG | CEELPPGAPELPQEGPTRRLsLPGQLGALTSQPLHRHGSDP |
| Q12809 | S283 | ELM | KCNH2 ERG ERG1 HERG | SSCSLARTRSRESCASVRRAssADDIEAMRAGVLPPPPRHA |
| Q12906 | S20 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | _MRPMRIFVNDDRHVMAKHssVyPTQEELEAVQNMVsHtER |
| Q12965 | T939 | Sugiyama | MYO1E MYO1C | SIGPGLPKNSRPTRRNttQNtGySsGtQNANyPVRAAPPPP |
| Q12972 | S178 | ELM | PPP1R8 ARD1 NIPP1 | EEEtELDNLTEFNTAHNKRIsTLTIEEGNLDIQRPKRKRKN |
| Q12972 | S199 | ELM | PPP1R8 ARD1 NIPP1 | TLTIEEGNLDIQRPKRKRKNsRVtFsEDDEIINPEDVDPSV |
| Q13002 | S697 | ELM | GRIK2 GLUR6 | QTKIEYGAVEDGATMTFFKKsKISTYDKMWAFMSSRRQsVL |
| Q13002 | S715 | ELM | GRIK2 GLUR6 | KKsKISTYDKMWAFMSSRRQsVLVKSNEEGIQRVLTSDYAF |
| Q13098 | S474 | Sugiyama | GPS1 COPS1 CSN1 | MLRAAVLRNQIHVKsPPREGsQGELtPANsQsRMstNM___ |
| Q13112 | S409 | Sugiyama | CHAF1B CAF1A CAF1P60 MPHOSPH7 MPP7 | VLNMRtPDtAKKTKsQtHRGssPGPRPVEGtPASRtQDPss |
| Q13200 | S361 | SIGNOR | PSMD2 TRAP2 | EPKVPDDIyKtHLENNRFGGsGsQVDSARMNLASSFVNGFV |
| Q13224 | S1166 | SIGNOR | GRIN2B NMDAR2B | WEHVDLTDIYKERsDDFKRDsVSGGGPCTNRSHIKHGTGDK |
| Q13247 | S297 | Sugiyama | SRSF6 SFRS6 SRP55 | RSRSPKENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsP |
| Q13370 | S318 | ELM | PDE3B | VsLGETAASYYGSCKIFRRPsLPCISREQMILWDWDLKQWY |
| Q13501 | S28 | Sugiyama | SQSTM1 ORCA OSIL | AYLLGKEDAAREIRRFsFCCsPEPEAEAEAAAGPGPCERLL |
| Q13526 | S16 | ELM | PIN1 | _____MADEEKLPPGWEKRMsRSSGRVyYFNHItNAsQWER |
| Q13576 | T716 | SIGNOR | IQGAP2 | KIQAFWKGYKQRKEYMHRRQtFIDNTDSIVKIQSWFRMATA |
| Q14103 | S87 | ELM | HNRNPD AUF1 HNRPD | KIDAsKNEEDEGHsNssPRHsEAAtAQREEWKMFIGGLSWD |
| Q14135 | S59 | Sugiyama | VGLL4 KIAA0121 | SALsSHRTGPPPIsPSKRKFsMEPGDEDLDCDNDHVSKMSR |
| Q14152 | S1028 | Sugiyama | EIF3A EIF3S10 KIAA0139 | NWRHADDDRPPRRGLDEDRGsWRtADEDRGPRRGMDDDRGP |
| Q14152 | S492 | Sugiyama | EIF3A EIF3S10 KIAA0139 | VDAARHCDLQVRIDHTSRTLsFGsDLNyAtREDAPIGPHLQ |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14152 | S988 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PRRGPEEDRFsRRGADDDRPsWRNTDDDRPPRRIADEDRGN |
| Q14157 | S852 | Sugiyama | UBAP2L KIAA0144 NICE4 | LDyysIPFPtPttPLtGRDGsLAsNPysGDLtKFGRGDASS |
| Q14203 | S31 | Sugiyama | DCTN1 | RTPSGSRMsAEASARPLRVGsRVEVIGKGHRGTVAYVGATL |
| Q14204 | S2384 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | FSEDVLSTDMIFNNFLARLRsIPLDEGEDEAQRRRKGKEDE |
| Q14344 | T203 | ELM | GNA13 | KLGEPDYIPSQQDILLARRPtKGIHEYDFEIKNVPFKMVDV |
| Q14432 | T311 | Sugiyama | PDE3A | RsssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKR |
| Q14494 | S599 | ELM | NFE2L1 HBZ17 NRF1 TCF11 | MAPSALDSADLPPPSALKKGsKEKQADFLDKQMSRDEHRAR |
| Q14524 | S36 | SIGNOR | SCN5A | FtREsLAAIEKRMAEKQARGsTTLQEsREGLPEEEAPRPQL |
| Q14524 | S525 | SIGNOR | SCN5A | AMNHLsLTRGLsRTSMKPRssRGsIFTFRRRDLGsEADFAD |
| Q14524 | S528 | SIGNOR | SCN5A | HLsLTRGLsRTSMKPRssRGsIFTFRRRDLGsEADFADDEN |
| Q14566 | S271 | Sugiyama | MCM6 | VPDVSKLSTPGARAEtNsRVsGVDGyEtEGIRGLRALGVRD |
| Q14566 | S498 | Sugiyama | MCM6 | EQQTISITKAGVKATLNARTsILAAANPIsGHyDRSKSLKQ |
| Q14671 | S709 | Sugiyama | PUM1 KIAA0099 PUMH1 | LGGFGTAVANSNTGSGSRRDsLtGSsDLYKRTSSSLTPIGH |
| Q14749 | S10 | SIGNOR | GNMT | ___________MVDSVYRtRsLGVAAEGLPDQYADGEAARV |
| Q14847 | S146 | ELM|Sugiyama | LASP1 MLN50 | FEKSRMGPsGGEGMEPERRDsQDGssyRRPLEQQQPHHIPt |
| Q14847 | S61 | Sugiyama | LASP1 MLN50 | MKNYKGYEKKPYCNAHyPKQsFtMVADtPENLRLKQQSELQ |
| Q14847 | S99 | Sugiyama | LASP1 MLN50 | ELQsQVRYKEEFEKNKGKGFsVVADtPELQRIKKTQDQIsN |
| Q14896 | S275 | SIGNOR|ELM | MYBPC3 | TVHEAMGTGDLDLLSAFRRTsLAGGGRRIsDSHEDTGILDF |
| Q14896 | S284 | SIGNOR|ELM | MYBPC3 | DLDLLSAFRRTsLAGGGRRIsDSHEDTGILDFSSLLKKRDs |
| Q14896 | S304 | SIGNOR|ELM | MYBPC3 | sDSHEDTGILDFSSLLKKRDsFRTPRDsKLEAPAEEDVWEI |
| Q14896 | S311 | SIGNOR|ELM | MYBPC3 | GILDFSSLLKKRDsFRTPRDsKLEAPAEEDVWEILRQAPPS |
| Q14978 | S623 | ELM | NOLC1 KIAA0035 NS5ATP13 | IKLQtPNtFPKRKKGEKRAssPFRRVREEEIEVDsRVADNs |
| Q15042 | S340 | Sugiyama | RAB3GAP1 KIAA0066 RAB3GAP | PQCLLGDFVTEFFKICRRKEsTDEILGRSAFEEEGKETADI |
| Q15052 | S640 | SIGNOR | ARHGEF6 COOL2 KIAA0006 PIXA | sKsPKTMKKFLHKRKTERKPsEEEyVIRKstAALEEDAQIL |
| Q15052 | S684 | SIGNOR | ARHGEF6 COOL2 KIAA0006 PIXA | EAYCTSANFQQGHGsstRKDsIPQVLLPEEEKLIIEETRsN |
| Q15084 | S375 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | GYPAMAAINARKMKFALLKGsFsEQGINEFLRELsFGRGst |
| Q15139 | S742 | SIGNOR | PRKD1 PKD PKD1 PRKCM | QVKLCDFGFARIIGEKsFRRsVVGtPAyLAPEVLRNKGYNR |
| Q15149 | S4386 | Sugiyama | PLEC PLEC1 | ItEFADMLsGNAGGFRsRsssVGssssyPIsPAVsRtQLAs |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15428 | S153 | Sugiyama | SF3A2 SAP62 | LFQIDYPEIAEGIMPRHRFMsAyEQRIEPPDRRWQYLLMAA |
| Q15746 | S13 | ELM | MYLK MLCK MLCK1 MYLK1 | ________MGDVKLVASSHIsKTsLsVDPSRVDSMPLTEAP |
| Q15785 | S93 | Sugiyama | TOMM34 URCC3 | DCTSALALVPFSIKPLLRRAsAyEALEKYPMAYVDYKTVLQ |
| Q15835 | S21 | SIGNOR|ELM | GRK1 RHOK | MDFGsLETVVANSAFIAARGsFDGSSSQPSRDKKYLAKLKL |
| Q15942 | S505 | Sugiyama | ZYX | DQANRPHCVPDYHKQYAPRCsVCSEPIMPEPGRDETVRVVA |
| Q16513 | S583 | Sugiyama | PKN2 PRK2 PRKCL2 | VTKLDFDLEPEPPPAPPRAssLGEIDEssELRVLDIPGQDs |
| Q16576 | S145 | Sugiyama | RBBP7 RBAP46 | EVNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGE |
| Q16613 | S205 | ELM | AANAT SNAT | SLTFMELHCSLRGHPFLRRNsGC__________________ |
| Q16613 | T31 | ELM | AANAT SNAT | PEAPRLPPGIPESPSCQRRHtLPASEFRCLTPEDAVSAFEI |
| Q16637 | S31 | Sugiyama | SMN1 SMN SMNT; SMN2 SMNC | GVPEQEDsVLFRRGtGQsDDsDIWDDtALIKAYDKAVAsFK |
| Q16637 | T25 | Sugiyama | SMN1 SMN SMNT; SMN2 SMNC | sGGsGGGVPEQEDsVLFRRGtGQsDDsDIWDDtALIKAYDK |
| Q16777 | S20 | Sugiyama | H2AC20 H2AFQ HIST2H2AC | _MSGRGKQGGKARAKAKSRssRAGLQFPVGRVHRLLRKGNY |
| Q16821 | S48 | ELM | PPP1R3A PP1G | DEEVTFQPGFSPQPSRRGsDsSEDIYLDTPSSGTRRVsFAD |
| Q16821 | S65 | ELM | PPP1R3A PP1G | GsDsSEDIYLDTPSSGTRRVsFADSFGFNLVSVKEFDCWEL |
| Q3KQU3 | S112 | Sugiyama | MAP7D1 KIAA1187 PARCC1 RPRC1 PP2464 | KsRGPtPPAMGPRDARPPRRssQPsPtAVPAsDsPPtKQEV |
| Q58FF7 | S488 | Sugiyama | HSP90AB3P HSP90BC | TYGWTANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIM |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q5QNW6 | S37 | Sugiyama | H2BC18 HIST2H2BF | KAVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q5T0N5 | S488 | Sugiyama | FNBP1L C1orf39 TOCA1 | NEAWLSEVEGKTGGRGDRRHssDINHLVtQGREsPEGsytD |
| Q5T1M5 | S1162 | Sugiyama | FKBP15 KIAA0674 | EAGstVAGAALRPsHHsQRssLsGDEEDELFKGATLKALRP |
| Q5T2W1 | S505 | SIGNOR | PDZK1 CAP70 NHERF3 PDZD1 | KEGIVVESNHDSHMAKERAHsTASHSSSNSEDTEM______ |
| Q5T5C0 | S692 | Sugiyama | STXBP5 LLGL3 | YGSNDPYRREPRSPRKsRQPsGAGLCDIsEGtVVPEDRCKS |
| Q5T6F2 | S856 | Sugiyama | UBAP2 KIAA1491 | PVDyyGIPFAAPTALASRDGsLANNPYPGDVTKFGRGDSAS |
| Q676U5 | S269 | SIGNOR | ATG16L1 APG16L UNQ9393/PRO34307 | DHtEEtsPVRAISRAATKRLsQPAGGLLDsITNIFGRRsVs |
| Q68EM7 | S702 | SIGNOR | ARHGAP17 RICH1 MSTP066 MSTP110 | tGQPPGQPSAPSQLSAPRRysssLsPIQAPNHPPPQPPTQA |
| Q6FI13 | S20 | Sugiyama | H2AC18 H2AFO HIST2H2AA HIST2H2AA3; H2AC19 HIST2H2AA4 | _MsGRGKQGGKARAKAKSRssRAGLQFPVGRVHRLLRKGNY |
| Q6GYQ0 | S861 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | EFIAERLRSGNASTMTRRGssPGsLEIPKDLPDILNKQNQM |
| Q6J4K2 | S258 | SIGNOR | SLC8B1 NCKX6 NCLX SLC24A6 | VFYVVTVILCTWIYQRQRRGsLFCPMPVTPEILsDsEEDRV |
| Q6P158 | S54 | Sugiyama | DHX57 | HGSGGGGGGGGGGGGGNRKAssRIWDDGDDFCIFSEsRRPs |
| Q6P158 | S55 | Sugiyama | DHX57 | GSGGGGGGGGGGGGGNRKAssRIWDDGDDFCIFSEsRRPsR |
| Q6P6C2 | S96 | Sugiyama | ALKBH5 ABH5 OFOXD1 | LQKEEEARKVKSGIRQMRLFsQDECAKIEARIDEVVSRAEK |
| Q6PIY7 | S116 | SIGNOR | TENT2 GLD2 PAPD4 | PHQEPtVVNQIVPLsGERRYsMPPLFHTHYVPDIVRCVPPF |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6UXD5 | S719 | Sugiyama | SEZ6L2 PSK UNQ1903/PRO4349 | CQKIMTCADPGEIANGHRTAsDAGFPVGSHVQYRCLPGYSL |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZN18 | S206 | Sugiyama | AEBP2 | DEGYGTGGGGSSATSGGRRGsLEMssDGEPLSRMDSEDSIS |
| Q71RC2 | S382 | Sugiyama | LARP4 PP13296 | AAMNMGRPFQKNRVKPQFRssGGsEHstEGsVsLGDGQLNR |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7KZF4 | S150 | Sugiyama | SND1 TDRD11 | EGLAtRREGMRANNPEQNRLsECEEQAKAAKKGMWSEGNGS |
| Q7L7L0 | S20 | Sugiyama | H2AC25 H2AW HIST3H2A | _MsGRGKQGGKARAKAKSRSsRAGLQFPVGRVHRLLRKGNY |
| Q7Z418 | S252 | SIGNOR | KCNK18 TRESK TRIK | HALEKQNTLQLPPQAMERSNsCPELVLGRLsYsIIsNLDEV |
| Q7Z4V5 | S454 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | VRPEEKQQAKPVKVERTRKRsEGFsMDRKVEKKKEPSVEEK |
| Q7Z5L9 | S455 | Sugiyama | IRF2BP2 | AGGSHASKDANQVHSTTRRNsNsPPsPssMNQRRLGPREVG |
| Q7Z5L9 | S457 | Sugiyama | IRF2BP2 | GSHASKDANQVHSTTRRNsNsPPsPssMNQRRLGPREVGGQ |
| Q7Z7G1 | S331 | Sugiyama | CLNK MIST | IGEYSRQAVEEAFMKENKDGsFLVRDCSTKSKEEPYVLAVF |
| Q86UF2 | S140 | Sugiyama | CTAGE6 CTAGE6P | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q86UR1 | S172 | SIGNOR | NOXA1 P51NOX | WPEGSLNGLDSALDQVQRRGsLPPRQVPRGEVFRPHRWHLK |
| Q86UR1 | S461 | SIGNOR | NOXA1 P51NOX | CDGRIGIFPKCFVVPAGPRMsGAPGRLPRSQQGDQP_____ |
| Q86VM9 | S599 | Sugiyama | ZC3H18 NHN1 | YSSYSSRSSRHSSFSGSRSRsRsFsssPsPsPtPsPHRPsI |
| Q86VM9 | S618 | Sugiyama | ZC3H18 NHN1 | RsRsFsssPsPsPtPsPHRPsIRTKGEPAPPPGKAGEKSVK |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q86W92 | S794 | Sugiyama | PPFIBP1 KIAA1230 | RAIQVLRINNFEPNCLRRRPsDENtIAPSEVQKWTNHRVME |
| Q8IUE6 | S20 | Sugiyama | H2AC21 HIST2H2AB | _MsGRGKQGGKARAKAKSRssRAGLQFPVGRVHRLLRKGNY |
| Q8IWQ3 | T260 | SIGNOR | BRSK2 C11orf7 PEN11B SADA STK29 HUSSY-12 | PPDCQSLLRGMIEVDAARRLtLEHIQKHIWYIGGKNEPEPE |
| Q8IWX8 | S705 | Sugiyama | CHERP DAN26 SCAF6 | RLLAAVEAFYsPPSHDRPRNsEGWEQNGLyEFFRAKMRARR |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8IX94 | S140 | Sugiyama | CTAGE4 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q8IZ21 | S590 | Sugiyama | PHACTR4 PRO2963 | SKEEWNEIRHQIGNTLIRRLsQRPtPEELEQRNILQPKNEA |
| Q8N130 | S348 | Sugiyama | SLC34A3 NPT2C NPTIIC | LAGSLLVLCGCLVLIVKLLNsVLRGRVAQVVRTVINADFPF |
| Q8N201 | S495 | Sugiyama | INTS1 KIAA1440 UNQ1821/PRO3434 | KFLAMVFQDLLTNKDDYLRAsRALLREIIKQTKHEINFQAF |
| Q8N5S9 | T108 | ELM | CAMKK1 CAMKKA | AGPyAtGPAsHIsPRAWRRPtIEsHHVAIsDAEDCVQLNQY |
| Q8N983 | S30 | Sugiyama | MRPL43 | FLASVLHNGLGRYVQQLQRLsFSVSRDGASSRGAREFVERE |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8NE71 | S105 | Sugiyama | ABCF1 ABC50 | KKDVDDDGEEKELMERLKKLsVPtsDEEDEVPAPKPRGGKK |
| Q8TCD5 | S182 | Sugiyama | NT5C DNT1 UMPH2 | LFTCCHNRHLVLPPTRRRLLsWsDNWREILDSKRGAAQRE_ |
| Q8TD08 | S415 | Sugiyama | MAPK15 ERK7 ERK8 | GHDPAEHESPRAAKNVPRQNsAPLLQtALLGNGERPPGAKE |
| Q8TD08 | T175 | Sugiyama | MAPK15 ERK7 ERK8 | DFGLARSLGDLPEGPEDQAVtEyVAtRWyRAPEVLLssHRY |
| Q8TD08 | T421 | Sugiyama | MAPK15 ERK7 ERK8 | HESPRAAKNVPRQNsAPLLQtALLGNGERPPGAKEAPPLtL |
| Q8TD08 | Y177 | Sugiyama | MAPK15 ERK7 ERK8 | GLARSLGDLPEGPEDQAVtEyVAtRWyRAPEVLLssHRYTL |
| Q8TD19 | T333 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | REMEEKVTLLNAPTKRPRsstVtEAPIAVVTSRTSEVYVWG |
| Q8TEW0 | S962 | Sugiyama | PARD3 PAR3 PAR3A | DEGMEtLEEDTEESSRsGREsVstAsDQPsHsLERQMNGNQ |
| Q8TEW0 | Y719 | Sugiyama | PARD3 PAR3 PAR3A | PELPIETALDDRERRIsHsLysGIEGLDEsPsRNAALsRIM |
| Q8WTQ7 | S23 | SIGNOR|ELM | GRK7 GPRK7 | DMGALDNLIANTAYLQARKPsDCDSKELQRRRRsLALPGLQ |
| Q8WTQ7 | S36 | SIGNOR|ELM | GRK7 GPRK7 | YLQARKPsDCDSKELQRRRRsLALPGLQGCAELRQKLSLNF |
| Q8WUI4 | S573 | Sugiyama | HDAC7 HDAC7A | SRLQERGLRSQCECLRGRKAsLEELQSVHSERHVLLYGtNP |
| Q92547 | S998 | Sugiyama | TOPBP1 KIAA0259 | AQECKHLPESLYPHTYNPKMsLDIsAVQDGRLCNSRLLSAV |
| Q92597 | S330 | Sugiyama | NDRG1 CAP43 DRG1 RTP | QGMGYMPsAsMtRLMRsRtAsGssVtsLDGtRsRsHtSEGT |
| Q92688 | S134 | Sugiyama | ANP32B APRIL PHAPI2 | CLKsLDLFNCEVtNLNDyREsVFKLLPQLTYLDGyDREDQE |
| Q92736 | S2031 | ELM | RYR2 | LDEDGSLDGNSDLTIRGRLLsLVEKVTYLKKKQAEKPVESD |
| Q92736 | S2808 | ELM | RYR2 | RIERTREGDSMALYNRTRRIsQTSQVsVDAAHGYSPRAIDM |
| Q92766 | S1167 | Sugiyama | RREB1 FINB | AGTSKKRGRKRGMRSRPRANsGGVDLDssGEFASIEKMLAT |
| Q92777 | S10 | ELM | SYN2 | ___________MMNFLRRRLsDSSFIANLPNGYMTDLQRPE |
| Q92835 | S27 | Sugiyama | INPP5D SHIP SHIP1 | HGNITRSKAEELLSRTGKDGsFLVRAsESISRAYALCVLYR |
| Q92837 | S188 | SIGNOR | FRAT1 | CRRGWLRGAAASRRLQQRRGsQPETRTGDDDPHRLLQQLVL |
| Q92896 | S1091 | Sugiyama | GLG1 CFR1 ESL1 MG160 | CALDIKHHCAAITPGRGRQMsCLMEALEDKRVRLQPECKKR |
| Q92917 | S27 | SIGNOR | GPKOW GPATC5 GPATCH5 T54 | GVLPLTAAsTAPIsFGFtRtsARRRLADsGDGAGPsPEEKD |
| Q92917 | T316 | SIGNOR | GPKOW GPATC5 GPATCH5 T54 | EFDKNTLDLRQQNGTASSRKtLWNQELYIQQDNsERKRKHL |
| Q92934 | S118 | SIGNOR | BAD BBC6 BCL2L8 | RsAPPNLWAAQRYGRELRRMsDEFVDsFKKGLPRPKsAGtA |
| Q92934 | S75 | SIGNOR|ELM | BAD BBC6 BCL2L8 | PTSSSHHGGAGAVEIRsRHssyPAGtEDDEGMGEEPsPFRG |
| Q92934 | S99 | SIGNOR | BAD BBC6 BCL2L8 | GtEDDEGMGEEPsPFRGRsRsAPPNLWAAQRYGRELRRMsD |
| Q92945 | S333 | Sugiyama | KHSRP FUBP2 | DRNEyGsRIGGGIDVPVPRHsVGVVIGRSGEMIKKIQNDAG |
| Q93034 | S730 | ELM | CUL5 VACM1 | LRILRTQEAIIQIMKMRKKIsNAQLQTELVEILKNMFLPQK |
| Q93052 | S537 | Sugiyama | LPP | DAGGLIHCIEDFHKKFAPRCsVCKEPIMPAPGQEETVRIVA |
| Q93077 | S20 | Sugiyama | H2AC6 H2AFL HIST1H2AC | _MsGRGKQGGKARAKAKSRssRAGLQFPVGRVHRLLRKGNY |
| Q93079 | S37 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q93100 | S27 | Sugiyama | PHKB | LTAEVSWKVLERRARTKRsGsVyEPLKsINLPRPDNETLWD |
| Q969F2 | S223 | SIGNOR | NKD2 | ELAEEPRVADRRLSAHVRRPstDPQPCSERGPYCVDENTER |
| Q96A00 | T38 | ELM | PPP1R14A CPI17 PPP1INL | SRARGPGGsPGGLQKRHARVtVKYDRRELQRRLDVEKWIDG |
| Q96CN4 | S493 | Sugiyama | EVI5L | ETLGALREMQDKVLDMEKRNssLPDENNVAQLQEELKALKV |
| Q96CN4 | S494 | Sugiyama | EVI5L | TLGALREMQDKVLDMEKRNssLPDENNVAQLQEELKALKVR |
| Q96D15 | S117 | Sugiyama | RCN3 UNQ239/PRO272 | VsLAELRAWIAHTQQRHIRDsVsAAWDtyDtDRDGRVGWEE |
| Q96D46 | S462 | Sugiyama | NMD3 CGI-07 | FLEDLEEDEAIRKNVNIyRDsAIPVEsDtDDEGAPRISLAE |
| Q96G46 | T240 | Sugiyama | DUS3L | KREVRFERAEQALRRFsQGPtPAAAVPEGTAAEGAPRQENC |
| Q96KK5 | S20 | Sugiyama | H2AC12 HIST1H2AH HIST1H2AI | _MsGRGKQGGKARAKAKTRssRAGLQFPVGRVHRLLRKGNY |
| Q96P20 | S295 | SIGNOR | NLRP3 C1orf7 CIAS1 NALP3 PYPAF1 | LIMSCCPDPNPPIHKIVRKPsRILFLMDGFDELQGAFDEHI |
| Q96PU5 | S342 | ELM | NEDD4L KIAA0439 NEDL3 | NGEQFsSLIQREPssRLRsCsVtDAVAEQGHLPPPSAPAGR |
| Q96PU5 | S448 | ELM | NEDD4L KIAA0439 NEDL3 | sATNSNNHLIEPQIRRPRsLssPtVTLSAPLEGAKDsPVRR |
| Q96PU5 | T367 | ELM | NEDD4L KIAA0439 NEDL3 | VAEQGHLPPPSAPAGRARsstVtGGEEPTPsVAYVHttPGL |
| Q96PX8 | S695 | SIGNOR | SLITRK1 KIAA1910 LRRC12 UNQ233/PRO266 | NGPYNADGAHRVYDCGSHSLsD___________________ |
| Q96QV6 | S20 | Sugiyama | H2AC1 H2AFR HIST1H2AA | _MsGRGKQGGKARAKSKSRSsRAGLQFPVGRIHRLLRKGNY |
| Q96RR4 | S100 | SIGNOR | CAMKK2 CAMKKB KIAA0787 | EVPLDtsGSQARPHLSGRKLsLQERsQGGLAAGGsLDMNGR |
| Q96RR4 | S495 | SIGNOR | CAMKK2 CAMKKB KIAA0787 | VKHIPSLAtVILVKTMIRKRsFGNPFEGsRREERSLsAPGN |
| Q96RR4 | S511 | SIGNOR | CAMKK2 CAMKKB KIAA0787 | IRKRsFGNPFEGsRREERSLsAPGNLLTKKPTRECESLSEL |
| Q96SB3 | S100 | ELM | PPP1R9B PPP1R6 | LAEAPRASERGVRLsLPRASsLNENVDHSALLKLGTSVSER |
| Q96SB3 | S94 | ELM | PPP1R9B PPP1R6 | AGGGAGLAEAPRASERGVRLsLPRASsLNENVDHSALLKLG |
| Q96T58 | S1268 | Sugiyama | SPEN KIAA0929 MINT SHARP | SRQISEDsERtGGsPsVRHGsFHEDEDPIGsPRLLSVKGsP |
| Q99259 | T91 | SIGNOR | GAD1 GAD GAD67 | QSSKNLLSCENSDRDARFRRtETDFSNLFARDLLPAKNGEE |
| Q99584 | S32 | Sugiyama | S100A13 | SIETVVTTFFTFARQEGRKDsLsVNEFKELVTQQLPHLLKD |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99877 | S37 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99878 | S20 | Sugiyama | H2AC14 H2AFE HIST1H2AJ | _MsGRGKQGGKARAKAKTRssRAGLQFPVGRVHRLLRKGNY |
| Q99879 | S37 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99880 | S37 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q9BTC0 | S1456 | Sugiyama | DIDO1 C20orf158 DATF1 KIAA0333 | EAKVTVDDLPNRMCADVRRNsVERPAEPVAGAAtPsLVEQQ |
| Q9BTM1 | S20 | Sugiyama | H2AJ H2AFJ | _MSGRGKQGGKVRAKAKSRSsRAGLQFPVGRVHRLLRKGNY |
| Q9BWD1 | S226 | Sugiyama | ACAT2 ACTL | LVstRKGLIEVKtDEFPRHGsNIEAMSKLKPYFLTDGTGTV |
| Q9BXS5 | S305 | Sugiyama | AP1M1 CLTNM | KHSHSRIEYMIKAKSQFKRRstANNVEIHIPVPNDADsPKF |
| Q9BXS5 | T306 | Sugiyama | AP1M1 CLTNM | HSHSRIEYMIKAKSQFKRRstANNVEIHIPVPNDADsPKFK |
| Q9BY41 | S39 | ELM | HDAC8 HDACL1 CDA07 | IYSPEYVSMCDSLAKIPKRAsMVHSLIEAYALHKQMRIVKP |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BZL6 | S706 | SIGNOR | PRKD2 PKD2 HSPC187 | DPFPQVKLCDFGFARIIGEKsFRRsVVGtPAyLAPEVLLNQ |
| Q9BZL6 | S710 | SIGNOR | PRKD2 PKD2 HSPC187 | QVKLCDFGFARIIGEKsFRRsVVGtPAyLAPEVLLNQGyNR |
| Q9BZL6 | S876 | SIGNOR | PRKD2 PKD2 HSPC187 | DLGGACPPQDHDMQGLAERIsVL__________________ |
| Q9C0C2 | S882 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | LQDQEFGKRDsLGtyssRDVsLGDWEFGKRDsLGAyAsQDA |
| Q9C0C2 | S920 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | QDANEQGQDLGKRDHHGRyssQDADEQDWEFQKRDVsLGTy |
| Q9GZT3 | S15 | Sugiyama | SLIRP C14orf156 DC23 DC50 PD04872 | ______MAASAARGAAALRRsINQPVAFVRRIPWTAASSQL |
| Q9H0B6 | S428 | Sugiyama | KLC2 | NKPIWMHAEEREESKDKRRDsAPyGEyGsWYKACKVDsPtV |
| Q9H3N1 | S270 | Sugiyama | TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268 | EAEsKEGtNKDFPQNAIRQRsLGPsLAtDKs__________ |
| Q9H3Q1 | S309 | Sugiyama | CDC42EP4 BORG4 CEP4 | AAPsPGsARSMGSHTTRDSSsLssCtsGILEERsPAFRGPD |
| Q9H3Z4 | S10 | Sugiyama | DNAJC5 CLN4 | ___________MADQRQRsLstsGEsLyHVLGLDKNATSDD |
| Q9H6T3 | S480 | Sugiyama | RPAP3 | NNPINLANVIAATGTTSKKNssQDDLFPTsDtPRAKVLKIE |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9H7D7 | S121 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | ASSSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLN |
| Q9HAU0 | S410 | Sugiyama | PLEKHA5 KIAA1686 PEPP2 | NRPNTGPLytEADRVIQRtNsMQQLEQWIKIQKGRGHEEET |
| Q9HBA0 | S162 | SIGNOR | TRPV4 VRL2 VROAC | PPPILKVFNRPILFDIVSRGsTADLDGLLPFLLtHKKRLTD |
| Q9HBA0 | S189 | SIGNOR | TRPV4 VRL2 VROAC | LLPFLLtHKKRLTDEEFREPsTGKTCLPKALLNLSNGRNDT |
| Q9HBA0 | T175 | SIGNOR | TRPV4 VRL2 VROAC | FDIVSRGsTADLDGLLPFLLtHKKRLTDEEFREPsTGKTCL |
| Q9HCR9 | S117 | SIGNOR | PDE11A | PLSPSWAGGSRGDGNLQRRAsQKELRKSFARSKAIHVNRtY |
| Q9HCR9 | S162 | SIGNOR | PDE11A | TSRAQEPLSSVRRRALLRKAsSLPPTTAHILSALLESRVNL |
| Q9NP61 | S366 | Sugiyama | ARFGAP3 ARFGAP1 | DDsyFTSSSSYFDEPVELRsssFssWDDssDSyWKKETSKD |
| Q9NPD3 | S240 | Sugiyama | EXOSC4 RRP41 SKI6 | AARDVHTLLDRVVRQHVREAsILLGD_______________ |
| Q9NQY0 | S248 | Sugiyama | BIN3 | HSDEQRERENEAKLSELRALsIVADD_______________ |
| Q9NRA8 | S353 | Sugiyama | EIF4ENIF1 | SASRFSRWFSNPsRsGsRsssLGstPHEELERLAGLEQAIL |
| Q9NRL3 | T338 | Sugiyama | STRN4 ZIN | EFDFLGSGEDGEGAPDPRRCtVDGsPHELESRRVKLQGILA |
| Q9NXH3 | T58 | ELM | PPP1R14D GBPI | ESKSHPDSSKIPRSRRPSRLtVKYDRGQLQRWLEMEQWVDA |
| Q9NYK5 | S57 | Sugiyama | MRPL39 C21orf92 MRPL5 RPML5 MSTP003 PRED22 | PTELTEMRNDLFNKEKARQLsLTPRTEKIEVKHVGKTDPGT |
| Q9NYV4 | S1053 | Sugiyama | CDK12 CRK7 CRKRS KIAA0904 | LPHWQDCHELWSKKRRRQRQsGVVVEEPPPSKTSRKETtsG |
| Q9NZN8 | S242 | Sugiyama | CNOT2 CDC36 NOT2 HSPC131 MSTP046 | VTGLDLSDFPALADRNRREGsGNPtPLINPLAGRAPYVGMV |
| Q9P265 | S203 | Sugiyama | DIP2B KIAA1463 | stsssASSTLSHGEVKGtsGsLADVFANtRIENFSAPPDVT |
| Q9UBT2 | S507 | Sugiyama | UBA2 SAE2 UBLE1B HRIHFB2115 | GTILISsEEGETEANNHKKLsEFGIRNGSRLQADDFLQDYT |
| Q9UD71 | T34 | SIGNOR | PPP1R1B DARPP32 | PAPPSQLDPRQVEMIRRRRPtPAMLFRLsEHssPEEEAsPH |
| Q9UGV2 | S327 | Sugiyama | NDRG3 | KYFLQGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsV |
| Q9UGV2 | S334 | Sugiyama | NDRG3 | GYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsDG |
| Q9UGV2 | S335 | Sugiyama | NDRG3 | YIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsDGt |
| Q9UGV2 | T332 | Sugiyama | NDRG3 | GMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQs |
| Q9UH77 | S433 | SIGNOR | KLHL3 KIAA1129 | AYSYKTNEWFFVAPMNTRRSsVGVGVVEGKLYAVGGYDGAS |
| Q9UH99 | S116 | ELM | SUN2 FRIGG KIAA0668 RAB5IP UNC84B | GEDLRVRRRRGtGGsEssRAsGLVGRKATEDFLGsSSGYss |
| Q9UH99 | S12 | ELM | SUN2 FRIGG KIAA0668 RAB5IP UNC84B | _________MSRRSQRLtRysQGDDDGssssGGSSVAGsQs |
| Q9UH99 | S54 | ELM | SUN2 FRIGG KIAA0668 RAB5IP UNC84B | LFKDsPLRTLKRKSSNMKRLsPAPQLGPssDAHTSYYSESL |
| Q9UHD1 | S200 | Sugiyama | CHORDC1 CHP1 | SGVPIFHEGMKYWSCCRRKtsDFNtFLAQEGCtKGKHMWTK |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UJY1 | S24 | SIGNOR | HSPB8 CRYAC E2IG1 HSP22 PP1629 | GQMPFSCHYPsRLRRDPFRDsPLsSRLLDDGFGMDPFPDDL |
| Q9UJY1 | S57 | SIGNOR | HSPB8 CRYAC E2IG1 HSP22 PP1629 | MDPFPDDLTASWPDWALPRLsSAWPGtLRSGMVPRGPTATA |
| Q9UL62 | S794 | SIGNOR | TRPC5 TRP5 | STELSQRDDNNDGSGGARAKsKsVSFNLGCKKKTCHGPPLI |
| Q9UL62 | S796 | SIGNOR | TRPC5 TRP5 | ELSQRDDNNDGSGGARAKsKsVSFNLGCKKKTCHGPPLIRT |
| Q9UNH7 | S316 | Sugiyama | SNX6 | LKYYLRESQAAKDLLYRRsRsLVDYENANKALDKARAKNKD |
| Q9UNZ2 | S192 | Sugiyama | NSFL1C UBXN2C | KRQHssQDVHVVLKLWKsGFsLDNGELRSyQDPsNAQFLEs |
| Q9UPQ0 | S185 | Sugiyama | LIMCH1 KIAA1102 | DDIEsPKRSIRDsGyIDCWDsERsDsLsPPRHGRDDsFDsL |
| Q9UPQ0 | S190 | Sugiyama | LIMCH1 KIAA1102 | PKRSIRDsGyIDCWDsERsDsLsPPRHGRDDsFDsLDsFGs |
| Q9UPQ0 | S201 | Sugiyama | LIMCH1 KIAA1102 | DCWDsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVV |
| Q9UPQ0 | S377 | Sugiyama | LIMCH1 KIAA1102 | LREEDDKWQDDLARWKSRRRsVsQDLIKKEEERKKMEKLLA |
| Q9UQ35 | S1101 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sEsPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEF |
| Q9UQ35 | S1455 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | PsRRsRsGssPGLRDGsGtPsRHsLsGssPGMKDIPRtPSR |
| Q9UQ35 | S1539 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sEssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEs |
| Q9UQ35 | S1541 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDs |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9Y230 | S43 | Sugiyama | RUVBL2 INO80J TIP48 TIP49B CGI-46 | GAHSHIRGLGLDDALEPRQAsQGMVGQLAARRAAGVVLEMI |
| Q9Y259 | S39 | SIGNOR | CHKB CHETK CHKL | AKDGLQQSKCPDTTPKRRRAssLSRDAERRAYQWCREYLGG |
| Q9Y259 | S40 | SIGNOR | CHKB CHETK CHKL | KDGLQQSKCPDTTPKRRRAssLSRDAERRAYQWCREYLGGA |
| Q9Y266 | S298 | Sugiyama | NUDC | DLDsEtRsMVEKMMYDQRQKsMGLPtsDEQKKQEILKKFMD |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2V2 | S52 | Sugiyama | CARHSP1 | sPLRGNVVPsPLPtRRtRtFsAtVRASQGPVYKGVCKCFCR |
| Q9Y4H2 | S1174 | Sugiyama | IRS2 | stttVtPVsPsFAHNPKRHNsAsVENVsLRKssEGGVGVGP |
| Q9Y6E0 | T18 | ELM | STK24 MST3 STK3 | ___MDSRAQLWGLALNKRRAtLPHPGGSTNLKADPEELFTK |
| Q9Y6R1 | S1026 | SIGNOR|ELM | SLC4A4 NBC NBC1 NBCE1 | IPEKDKKKKEDEKKKKKKKGsLDsDNDDsDCPYSEKVPSIK |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin modifying enzymes | R-HSA-3247509 | 4.123425e-10 | 9.385 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.708129e-09 | 8.767 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.473910e-08 | 7.262 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 6.684672e-08 | 7.175 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.052651e-06 | 5.978 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.636719e-06 | 5.786 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.412921e-06 | 5.617 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.471179e-06 | 5.607 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.986367e-06 | 5.525 | 1 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 8.356899e-06 | 5.078 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.328797e-05 | 4.877 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.400401e-05 | 4.854 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.351126e-05 | 4.869 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.431308e-05 | 4.614 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.295821e-05 | 4.367 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.671502e-05 | 4.331 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 4.902566e-05 | 4.310 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 5.164777e-05 | 4.287 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.956712e-05 | 4.225 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 8.292982e-05 | 4.081 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 9.652358e-05 | 4.015 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.086241e-04 | 3.964 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.173022e-04 | 3.931 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.489491e-04 | 3.827 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.817073e-04 | 3.741 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.355440e-04 | 3.628 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.766577e-04 | 3.558 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.868413e-04 | 3.542 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.956066e-04 | 3.529 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.028203e-04 | 3.519 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.134421e-04 | 3.504 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.239377e-04 | 3.490 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.828790e-04 | 3.417 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.197234e-04 | 3.377 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.329963e-04 | 3.364 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.768178e-04 | 3.322 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.143756e-04 | 3.289 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.097129e-04 | 3.215 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 6.123041e-04 | 3.213 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 6.005481e-04 | 3.221 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 6.091372e-04 | 3.215 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 7.268214e-04 | 3.139 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.879940e-04 | 3.052 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.900374e-04 | 3.051 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 9.056626e-04 | 3.043 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.413016e-04 | 3.026 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 9.451101e-04 | 3.025 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.128583e-03 | 2.947 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.128583e-03 | 2.947 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.152875e-03 | 2.938 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.152712e-03 | 2.938 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.185347e-03 | 2.926 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.390953e-03 | 2.857 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.399268e-03 | 2.854 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.536792e-03 | 2.813 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.642512e-03 | 2.784 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.870958e-03 | 2.728 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.930601e-03 | 2.714 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.981395e-03 | 2.703 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.039296e-03 | 2.691 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.179971e-03 | 2.662 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.311675e-03 | 2.636 | 1 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.542520e-03 | 2.595 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.553148e-03 | 2.593 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.882408e-03 | 2.540 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.917586e-03 | 2.535 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.044237e-03 | 2.517 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.314570e-03 | 2.480 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.402224e-03 | 2.468 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.479168e-03 | 2.459 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.712711e-03 | 2.430 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.712711e-03 | 2.430 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.672684e-03 | 2.435 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.593639e-03 | 2.444 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.776845e-03 | 2.423 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.786009e-03 | 2.422 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.971701e-03 | 2.401 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.005525e-03 | 2.397 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.050154e-03 | 2.393 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.050154e-03 | 2.393 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.747238e-03 | 2.324 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.747238e-03 | 2.324 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.747238e-03 | 2.324 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.810878e-03 | 2.318 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.747238e-03 | 2.324 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.747238e-03 | 2.324 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 4.482405e-03 | 2.348 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.830063e-03 | 2.316 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.914538e-03 | 2.309 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.914538e-03 | 2.309 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.378028e-03 | 2.269 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 5.290380e-03 | 2.277 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.083775e-03 | 2.294 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 5.320556e-03 | 2.274 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.656760e-03 | 2.247 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.679868e-03 | 2.246 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.788703e-03 | 2.237 | 1 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.942863e-03 | 2.226 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 6.210924e-03 | 2.207 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.146115e-03 | 2.211 | 1 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 6.383071e-03 | 2.195 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 6.499579e-03 | 2.187 | 0 | 0 |
| Kinesins | R-HSA-983189 | 6.554680e-03 | 2.183 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 6.662692e-03 | 2.176 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 7.127948e-03 | 2.147 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 7.127948e-03 | 2.147 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 7.254593e-03 | 2.139 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 7.272146e-03 | 2.138 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 7.306449e-03 | 2.136 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 7.331773e-03 | 2.135 | 1 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 7.408619e-03 | 2.130 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 7.408619e-03 | 2.130 | 1 | 1 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 7.465797e-03 | 2.127 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 8.392195e-03 | 2.076 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 8.432295e-03 | 2.074 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 8.170883e-03 | 2.088 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 8.403155e-03 | 2.076 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 8.140279e-03 | 2.089 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 8.432295e-03 | 2.074 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 8.479652e-03 | 2.072 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 9.312071e-03 | 2.031 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.747751e-03 | 2.011 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.136186e-02 | 1.945 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.136186e-02 | 1.945 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.136186e-02 | 1.945 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.136186e-02 | 1.945 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.136186e-02 | 1.945 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.087377e-02 | 1.964 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.121631e-02 | 1.950 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.108366e-02 | 1.955 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.069082e-02 | 1.971 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.089789e-02 | 1.963 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.149272e-02 | 1.940 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.184283e-02 | 1.927 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.201792e-02 | 1.920 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.252563e-02 | 1.902 | 1 | 1 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.258846e-02 | 1.900 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.365129e-02 | 1.865 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.430458e-02 | 1.845 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.417893e-02 | 1.848 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.439581e-02 | 1.842 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 1.439581e-02 | 1.842 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.459027e-02 | 1.836 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.459027e-02 | 1.836 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.463510e-02 | 1.835 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.463510e-02 | 1.835 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.471080e-02 | 1.832 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.477296e-02 | 1.831 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.477296e-02 | 1.831 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.487431e-02 | 1.828 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.567073e-02 | 1.805 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.626150e-02 | 1.789 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.489840e-02 | 1.827 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.502941e-02 | 1.823 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.489840e-02 | 1.827 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.652188e-02 | 1.782 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 1.690128e-02 | 1.772 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.690128e-02 | 1.772 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.802460e-02 | 1.744 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.923297e-02 | 1.716 | 1 | 1 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.982726e-02 | 1.703 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.982726e-02 | 1.703 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.990311e-02 | 1.701 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.993137e-02 | 1.700 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.065819e-02 | 1.685 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.267307e-02 | 1.644 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.267307e-02 | 1.644 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.267307e-02 | 1.644 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.267307e-02 | 1.644 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.267307e-02 | 1.644 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.402390e-02 | 1.619 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.402390e-02 | 1.619 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.405783e-02 | 1.619 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.409003e-02 | 1.618 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.409003e-02 | 1.618 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.409003e-02 | 1.618 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.409003e-02 | 1.618 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.429831e-02 | 1.614 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.547439e-02 | 1.594 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.945613e-02 | 1.531 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.945613e-02 | 1.531 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.945613e-02 | 1.531 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.736177e-02 | 1.563 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.736177e-02 | 1.563 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.904555e-02 | 1.537 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.904555e-02 | 1.537 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.652204e-02 | 1.576 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.666394e-02 | 1.574 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.893062e-02 | 1.539 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.676627e-02 | 1.572 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.733351e-02 | 1.563 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.658927e-02 | 1.575 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.658927e-02 | 1.575 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.857086e-02 | 1.544 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.946458e-02 | 1.531 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.976261e-02 | 1.526 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.080247e-02 | 1.511 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.080247e-02 | 1.511 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.104872e-02 | 1.508 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.104872e-02 | 1.508 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.104872e-02 | 1.508 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 3.282511e-02 | 1.484 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 3.282511e-02 | 1.484 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 3.282511e-02 | 1.484 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 3.282511e-02 | 1.484 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.366106e-02 | 1.473 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 3.399962e-02 | 1.469 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.417557e-02 | 1.466 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.561695e-02 | 1.448 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.914940e-02 | 1.407 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.950640e-02 | 1.403 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 4.734476e-02 | 1.325 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.549803e-02 | 1.342 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.549803e-02 | 1.342 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.365190e-02 | 1.360 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.612158e-02 | 1.336 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.745958e-02 | 1.324 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.754967e-02 | 1.323 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.754967e-02 | 1.323 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.848076e-02 | 1.314 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.942157e-02 | 1.306 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 4.980531e-02 | 1.303 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.980531e-02 | 1.303 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 5.127764e-02 | 1.290 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 5.127764e-02 | 1.290 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.208489e-02 | 1.283 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.417086e-02 | 1.266 | 1 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 5.873575e-02 | 1.231 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.888662e-02 | 1.230 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.942828e-02 | 1.226 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 6.107021e-02 | 1.214 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 6.107021e-02 | 1.214 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.195532e-02 | 1.208 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 6.475473e-02 | 1.189 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 6.475473e-02 | 1.189 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 6.475473e-02 | 1.189 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.599042e-02 | 1.181 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.599042e-02 | 1.181 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.907967e-02 | 1.161 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 7.020162e-02 | 1.154 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.569750e-02 | 1.121 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.599042e-02 | 1.181 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 7.053728e-02 | 1.152 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.628865e-02 | 1.118 | 1 | 0 |
| Semaphorin interactions | R-HSA-373755 | 7.120368e-02 | 1.147 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 6.939075e-02 | 1.159 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 6.994056e-02 | 1.155 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 7.342931e-02 | 1.134 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 7.817334e-02 | 1.107 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 7.817334e-02 | 1.107 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 7.817334e-02 | 1.107 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 7.817334e-02 | 1.107 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 7.823667e-02 | 1.107 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.924194e-02 | 1.101 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 7.946231e-02 | 1.100 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 7.989089e-02 | 1.098 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 8.181622e-02 | 1.087 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.262116e-02 | 1.083 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.335959e-02 | 1.079 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.335959e-02 | 1.079 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.335959e-02 | 1.079 | 1 | 1 |
| Cardiogenesis | R-HSA-9733709 | 8.474277e-02 | 1.072 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 8.660318e-02 | 1.062 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.787550e-02 | 1.056 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.797670e-02 | 1.056 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 8.797670e-02 | 1.056 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 8.797670e-02 | 1.056 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 8.986210e-02 | 1.046 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 8.986210e-02 | 1.046 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 8.986210e-02 | 1.046 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.085349e-01 | 0.964 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.085349e-01 | 0.964 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.085349e-01 | 0.964 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.085349e-01 | 0.964 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.085349e-01 | 0.964 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.085349e-01 | 0.964 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.085349e-01 | 0.964 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 9.732358e-02 | 1.012 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 9.436744e-02 | 1.025 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.009021e-01 | 0.996 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.009021e-01 | 0.996 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 9.439374e-02 | 1.025 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.046448e-01 | 0.980 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.046448e-01 | 0.980 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 9.701084e-02 | 1.013 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 9.701084e-02 | 1.013 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 9.701084e-02 | 1.013 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 9.839431e-02 | 1.007 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 9.982745e-02 | 1.001 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 9.732358e-02 | 1.012 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.046448e-01 | 0.980 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 9.071509e-02 | 1.042 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.648927e-02 | 1.016 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 9.468889e-02 | 1.024 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.035087e-01 | 0.985 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.095598e-01 | 0.960 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 1.095598e-01 | 0.960 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.095598e-01 | 0.960 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.095598e-01 | 0.960 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.095598e-01 | 0.960 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.095598e-01 | 0.960 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.099872e-01 | 0.959 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.107890e-01 | 0.956 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.126457e-01 | 0.948 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.128004e-01 | 0.948 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.135331e-01 | 0.945 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.141077e-01 | 0.943 | 1 | 1 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.145057e-01 | 0.941 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.148228e-01 | 0.940 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.152074e-01 | 0.939 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.154868e-01 | 0.937 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.158165e-01 | 0.936 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.166159e-01 | 0.933 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.172229e-01 | 0.931 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.208816e-01 | 0.918 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.208816e-01 | 0.918 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.230994e-01 | 0.910 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.250747e-01 | 0.903 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.275315e-01 | 0.894 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.284952e-01 | 0.891 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.284952e-01 | 0.891 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.284952e-01 | 0.891 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.284952e-01 | 0.891 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.052956e-01 | 0.688 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.052956e-01 | 0.688 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.052956e-01 | 0.688 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.052956e-01 | 0.688 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.520785e-01 | 0.818 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.520785e-01 | 0.818 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.520785e-01 | 0.818 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 2.915589e-01 | 0.535 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.915589e-01 | 0.535 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.915589e-01 | 0.535 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 2.915589e-01 | 0.535 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.915589e-01 | 0.535 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 2.915589e-01 | 0.535 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 2.915589e-01 | 0.535 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 2.915589e-01 | 0.535 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 2.915589e-01 | 0.535 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 2.915589e-01 | 0.535 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.915589e-01 | 0.535 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.915589e-01 | 0.535 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.915589e-01 | 0.535 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 2.915589e-01 | 0.535 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.927023e-01 | 0.715 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 1.927023e-01 | 0.715 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.927023e-01 | 0.715 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.927023e-01 | 0.715 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.927023e-01 | 0.715 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.345635e-01 | 0.871 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.345635e-01 | 0.871 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 1.345635e-01 | 0.871 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 1.345635e-01 | 0.871 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.345635e-01 | 0.871 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.345635e-01 | 0.871 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 2.345000e-01 | 0.630 | 1 | 1 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.345000e-01 | 0.630 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.684630e-01 | 0.434 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.684630e-01 | 0.434 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 3.684630e-01 | 0.434 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.684630e-01 | 0.434 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.684630e-01 | 0.434 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.684630e-01 | 0.434 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.684630e-01 | 0.434 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.684630e-01 | 0.434 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.684630e-01 | 0.434 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.684630e-01 | 0.434 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 3.684630e-01 | 0.434 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.684630e-01 | 0.434 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) | R-HSA-5619049 | 3.684630e-01 | 0.434 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.684630e-01 | 0.434 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.684630e-01 | 0.434 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.684630e-01 | 0.434 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.684630e-01 | 0.434 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.684630e-01 | 0.434 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.684630e-01 | 0.434 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.344085e-01 | 0.872 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.894747e-01 | 0.722 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.894747e-01 | 0.722 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.767387e-01 | 0.558 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.187694e-01 | 0.660 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.187694e-01 | 0.660 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.771863e-01 | 0.752 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.771863e-01 | 0.752 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.771863e-01 | 0.752 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.771863e-01 | 0.752 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.455861e-01 | 0.837 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.455861e-01 | 0.837 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.352183e-01 | 0.869 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.635880e-01 | 0.786 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.635880e-01 | 0.786 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.635880e-01 | 0.786 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.635880e-01 | 0.786 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.635880e-01 | 0.786 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.000985e-01 | 0.699 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.000985e-01 | 0.699 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 2.489006e-01 | 0.604 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.489006e-01 | 0.604 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 3.188305e-01 | 0.496 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 3.188305e-01 | 0.496 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.188305e-01 | 0.496 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.188305e-01 | 0.496 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.188305e-01 | 0.496 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 3.188305e-01 | 0.496 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.370229e-01 | 0.359 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.370229e-01 | 0.359 | 0 | 0 |
| Defective ABCA3 causes SMDP3 | R-HSA-5688399 | 4.370229e-01 | 0.359 | 0 | 0 |
| Defective ABCA3 causes SMDP3 | R-HSA-5683678 | 4.370229e-01 | 0.359 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.370229e-01 | 0.359 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.370229e-01 | 0.359 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.370229e-01 | 0.359 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.504257e-01 | 0.823 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.824236e-01 | 0.739 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.238331e-01 | 0.650 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.238331e-01 | 0.650 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.663580e-01 | 0.779 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.795979e-01 | 0.553 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.795979e-01 | 0.553 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.795979e-01 | 0.553 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.829657e-01 | 0.738 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.603101e-01 | 0.443 | 1 | 1 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 3.603101e-01 | 0.443 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.662286e-01 | 0.779 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.222623e-01 | 0.653 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.001956e-01 | 0.699 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.001956e-01 | 0.699 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.106118e-01 | 0.508 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.811343e-01 | 0.742 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.430914e-01 | 0.614 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.644087e-01 | 0.578 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.985269e-01 | 0.525 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.981435e-01 | 0.303 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.981435e-01 | 0.303 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.981435e-01 | 0.303 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.981435e-01 | 0.303 | 0 | 0 |
| MPS VI - Maroteaux-Lamy syndrome | R-HSA-2206285 | 4.981435e-01 | 0.303 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.981435e-01 | 0.303 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.981435e-01 | 0.303 | 0 | 0 |
| Defective CP causes aceruloplasminemia (ACERULOP) | R-HSA-5619060 | 4.981435e-01 | 0.303 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.861254e-01 | 0.543 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 3.727058e-01 | 0.429 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.727058e-01 | 0.429 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.727058e-01 | 0.429 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 3.727058e-01 | 0.429 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.400671e-01 | 0.356 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.304084e-01 | 0.481 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 3.304084e-01 | 0.481 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.304084e-01 | 0.481 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 4.034025e-01 | 0.394 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.462791e-01 | 0.609 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.462791e-01 | 0.609 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.756056e-01 | 0.425 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 3.756056e-01 | 0.425 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.528064e-01 | 0.452 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.623218e-01 | 0.581 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.343118e-01 | 0.476 | 1 | 1 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.752681e-01 | 0.426 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 4.336483e-01 | 0.363 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.778622e-01 | 0.321 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.526316e-01 | 0.258 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.526316e-01 | 0.258 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 5.526316e-01 | 0.258 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.526316e-01 | 0.258 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.526316e-01 | 0.258 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.526316e-01 | 0.258 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 5.526316e-01 | 0.258 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.526316e-01 | 0.258 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.977181e-01 | 0.400 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 4.633081e-01 | 0.334 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.200851e-01 | 0.377 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.200851e-01 | 0.377 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.200851e-01 | 0.377 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.140537e-01 | 0.289 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.140537e-01 | 0.289 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 4.423023e-01 | 0.354 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.264519e-01 | 0.370 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.643080e-01 | 0.333 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 5.204304e-01 | 0.284 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.204304e-01 | 0.284 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.485444e-01 | 0.261 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.485444e-01 | 0.261 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.485444e-01 | 0.261 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 5.485444e-01 | 0.261 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 5.485444e-01 | 0.261 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.012066e-01 | 0.221 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.012066e-01 | 0.221 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.012066e-01 | 0.221 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 6.012066e-01 | 0.221 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 6.012066e-01 | 0.221 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.012066e-01 | 0.221 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 6.012066e-01 | 0.221 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.012066e-01 | 0.221 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.012066e-01 | 0.221 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 6.012066e-01 | 0.221 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.012066e-01 | 0.221 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 6.012066e-01 | 0.221 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.556962e-01 | 0.341 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.556962e-01 | 0.341 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 5.285118e-01 | 0.277 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.481654e-01 | 0.261 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.481654e-01 | 0.261 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.491524e-01 | 0.260 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.301449e-01 | 0.276 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.740753e-01 | 0.241 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 5.517667e-01 | 0.258 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.708357e-01 | 0.243 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 5.687803e-01 | 0.245 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 5.687803e-01 | 0.245 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 5.994494e-01 | 0.222 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.122268e-01 | 0.213 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.445099e-01 | 0.191 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.445099e-01 | 0.191 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 6.238093e-01 | 0.205 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.238093e-01 | 0.205 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.238093e-01 | 0.205 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.413949e-01 | 0.193 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.413949e-01 | 0.193 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.413949e-01 | 0.193 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.413949e-01 | 0.193 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 5.890634e-01 | 0.230 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.352201e-01 | 0.869 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.491524e-01 | 0.260 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.662286e-01 | 0.779 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.643080e-01 | 0.333 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.081538e-01 | 0.511 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.977181e-01 | 0.400 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.381667e-01 | 0.860 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.142467e-01 | 0.669 | 1 | 1 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.858644e-01 | 0.731 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.731886e-01 | 0.564 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.635880e-01 | 0.786 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.977181e-01 | 0.400 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.457048e-01 | 0.610 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.756056e-01 | 0.425 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.644668e-01 | 0.784 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.477201e-01 | 0.261 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.355993e-01 | 0.868 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.355993e-01 | 0.868 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.681416e-01 | 0.572 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.086875e-01 | 0.294 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.879673e-01 | 0.541 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.355993e-01 | 0.868 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.169706e-01 | 0.287 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.074490e-01 | 0.390 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.605353e-01 | 0.337 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.269550e-01 | 0.203 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.413949e-01 | 0.193 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.344085e-01 | 0.872 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.085530e-01 | 0.216 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 6.356778e-01 | 0.197 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.066229e-01 | 0.685 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.613052e-01 | 0.792 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 2.861254e-01 | 0.543 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 1.613052e-01 | 0.792 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 2.345000e-01 | 0.630 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.188305e-01 | 0.496 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.482443e-01 | 0.605 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 1.965751e-01 | 0.706 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.936400e-01 | 0.532 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.400671e-01 | 0.356 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.271769e-01 | 0.644 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 4.012583e-01 | 0.397 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.736965e-01 | 0.324 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.348158e-01 | 0.197 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.492527e-01 | 0.603 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 5.481654e-01 | 0.261 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.719220e-01 | 0.243 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.010372e-01 | 0.300 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.423023e-01 | 0.354 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 2.520830e-01 | 0.598 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.133631e-01 | 0.504 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.520785e-01 | 0.818 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 1.613052e-01 | 0.792 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 2.795979e-01 | 0.553 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.603101e-01 | 0.443 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.603101e-01 | 0.443 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.008146e-01 | 0.397 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.936400e-01 | 0.532 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.526316e-01 | 0.258 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 3.972551e-01 | 0.401 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.812771e-01 | 0.236 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.708357e-01 | 0.243 | 1 | 1 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 6.413949e-01 | 0.193 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.226711e-01 | 0.491 | 1 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 2.187694e-01 | 0.660 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.377807e-01 | 0.359 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.081538e-01 | 0.511 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.894747e-01 | 0.722 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.064952e-01 | 0.685 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.861254e-01 | 0.543 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.485444e-01 | 0.261 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.526337e-01 | 0.453 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.531987e-01 | 0.257 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.539022e-01 | 0.343 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.651973e-01 | 0.437 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 4.878725e-01 | 0.312 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.395151e-01 | 0.268 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.345571e-01 | 0.871 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.458931e-01 | 0.351 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.000985e-01 | 0.699 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.568194e-01 | 0.590 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.846691e-01 | 0.233 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.613052e-01 | 0.792 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.345000e-01 | 0.630 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.552420e-01 | 0.809 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.188305e-01 | 0.496 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.603101e-01 | 0.443 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 4.008146e-01 | 0.397 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.936400e-01 | 0.532 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.936400e-01 | 0.532 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.778622e-01 | 0.321 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 4.633081e-01 | 0.334 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.140537e-01 | 0.289 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.707422e-01 | 0.327 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.126151e-01 | 0.290 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.812771e-01 | 0.236 | 1 | 1 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.445099e-01 | 0.191 | 0 | 0 |
| Hydrolysis of LPE | R-HSA-1483152 | 6.445099e-01 | 0.191 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 5.135887e-01 | 0.289 | 1 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 3.853360e-01 | 0.414 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 4.454126e-01 | 0.351 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 4.860452e-01 | 0.313 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.769046e-01 | 0.558 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.518841e-01 | 0.345 | 1 | 1 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.679719e-01 | 0.330 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 4.539022e-01 | 0.343 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.619117e-01 | 0.441 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.349095e-01 | 0.629 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.684484e-01 | 0.434 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.927607e-01 | 0.715 | 1 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.366244e-01 | 0.626 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.474223e-01 | 0.831 | 1 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.338938e-01 | 0.198 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 1.520785e-01 | 0.818 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.927023e-01 | 0.715 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.345000e-01 | 0.630 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.936400e-01 | 0.532 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 4.400671e-01 | 0.356 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.012066e-01 | 0.221 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 6.122268e-01 | 0.213 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.413949e-01 | 0.193 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.376588e-01 | 0.269 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 3.027825e-01 | 0.519 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.125116e-01 | 0.673 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.286637e-01 | 0.202 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.497582e-01 | 0.825 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.812473e-01 | 0.318 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.812473e-01 | 0.318 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.066229e-01 | 0.685 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 5.477201e-01 | 0.261 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.613796e-01 | 0.336 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.767387e-01 | 0.558 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.161296e-01 | 0.500 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.204304e-01 | 0.284 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.244703e-01 | 0.280 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.445099e-01 | 0.191 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.289026e-01 | 0.640 | 1 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.376588e-01 | 0.269 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.740884e-01 | 0.562 | 1 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.188305e-01 | 0.496 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.631735e-01 | 0.580 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.485444e-01 | 0.261 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.376588e-01 | 0.269 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 4.849571e-01 | 0.314 | 1 | 0 |
| CaM pathway | R-HSA-111997 | 2.289026e-01 | 0.640 | 1 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 4.518841e-01 | 0.345 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 6.413949e-01 | 0.193 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.681416e-01 | 0.572 | 1 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.289026e-01 | 0.640 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 5.204304e-01 | 0.284 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.604516e-01 | 0.251 | 1 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.430584e-01 | 0.844 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.518948e-01 | 0.818 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.561206e-01 | 0.255 | 1 | 1 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 4.575865e-01 | 0.340 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.710307e-01 | 0.767 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.052956e-01 | 0.688 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.520785e-01 | 0.818 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 3.684630e-01 | 0.434 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.344085e-01 | 0.872 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.370229e-01 | 0.359 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.370229e-01 | 0.359 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.370229e-01 | 0.359 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.795979e-01 | 0.553 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.430914e-01 | 0.614 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.780143e-01 | 0.750 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.008146e-01 | 0.397 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 4.981435e-01 | 0.303 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 4.981435e-01 | 0.303 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 4.981435e-01 | 0.303 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.400671e-01 | 0.356 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 4.034025e-01 | 0.394 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.756056e-01 | 0.425 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.012583e-01 | 0.397 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 4.336483e-01 | 0.363 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 4.336483e-01 | 0.363 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 5.526316e-01 | 0.258 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.526316e-01 | 0.258 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 5.526316e-01 | 0.258 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.936949e-01 | 0.405 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.180778e-01 | 0.379 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.012066e-01 | 0.221 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.012066e-01 | 0.221 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.012066e-01 | 0.221 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.012066e-01 | 0.221 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.992109e-01 | 0.302 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 5.740753e-01 | 0.241 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 5.708357e-01 | 0.243 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 5.693471e-01 | 0.245 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 6.122268e-01 | 0.213 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 6.141898e-01 | 0.212 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.293382e-01 | 0.276 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 6.086462e-01 | 0.216 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.324595e-01 | 0.199 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 3.344438e-01 | 0.476 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.526337e-01 | 0.453 | 1 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.379016e-01 | 0.195 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.780143e-01 | 0.750 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.839527e-01 | 0.735 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 5.972435e-01 | 0.224 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.597670e-01 | 0.797 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.811092e-01 | 0.742 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.122268e-01 | 0.213 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 5.972435e-01 | 0.224 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 5.972435e-01 | 0.224 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 6.086048e-01 | 0.216 | 1 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.491524e-01 | 0.260 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.413949e-01 | 0.193 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.771863e-01 | 0.752 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.643080e-01 | 0.333 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.920333e-01 | 0.717 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.041846e-01 | 0.297 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.620742e-01 | 0.441 | 1 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 5.517667e-01 | 0.258 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 4.336483e-01 | 0.363 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 4.336483e-01 | 0.363 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 5.485444e-01 | 0.261 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.481654e-01 | 0.261 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.398965e-01 | 0.268 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.708357e-01 | 0.243 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.445099e-01 | 0.191 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.977181e-01 | 0.400 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.066229e-01 | 0.685 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 4.922672e-01 | 0.308 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.460341e-01 | 0.263 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 1.613052e-01 | 0.792 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.345000e-01 | 0.630 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.106118e-01 | 0.508 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.106118e-01 | 0.508 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.008146e-01 | 0.397 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.400671e-01 | 0.356 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 4.860452e-01 | 0.313 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.485444e-01 | 0.261 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.485444e-01 | 0.261 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.485444e-01 | 0.261 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.012066e-01 | 0.221 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.012066e-01 | 0.221 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.531987e-01 | 0.257 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.208678e-01 | 0.207 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 5.399033e-01 | 0.268 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.644124e-01 | 0.438 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 5.994494e-01 | 0.222 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 6.017894e-01 | 0.221 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.417156e-01 | 0.466 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.589097e-01 | 0.445 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.766826e-01 | 0.322 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.574591e-01 | 0.447 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.731886e-01 | 0.564 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.662286e-01 | 0.779 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.936400e-01 | 0.532 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 4.633081e-01 | 0.334 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.980782e-01 | 0.526 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.996484e-01 | 0.398 | 1 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.193686e-01 | 0.208 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 5.850768e-01 | 0.233 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 3.620742e-01 | 0.441 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.074490e-01 | 0.390 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.226711e-01 | 0.491 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.915589e-01 | 0.535 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.684630e-01 | 0.434 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 2.187694e-01 | 0.660 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 4.370229e-01 | 0.359 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 3.603101e-01 | 0.443 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.008146e-01 | 0.397 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.981435e-01 | 0.303 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 4.034025e-01 | 0.394 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 4.336483e-01 | 0.363 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 5.526316e-01 | 0.258 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.526316e-01 | 0.258 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 5.526316e-01 | 0.258 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.339399e-01 | 0.363 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.643080e-01 | 0.333 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.012066e-01 | 0.221 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 5.477201e-01 | 0.261 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.980782e-01 | 0.526 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.994494e-01 | 0.222 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.370974e-01 | 0.270 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.708357e-01 | 0.243 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.644668e-01 | 0.784 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 5.477201e-01 | 0.261 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.855799e-01 | 0.232 | 1 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.881201e-01 | 0.311 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.248834e-01 | 0.280 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.767387e-01 | 0.558 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.936400e-01 | 0.532 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.936400e-01 | 0.532 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.074621e-01 | 0.295 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 6.442169e-01 | 0.191 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.978579e-01 | 0.303 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.215995e-01 | 0.206 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.370515e-01 | 0.359 | 1 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.413949e-01 | 0.193 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 3.727058e-01 | 0.429 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 5.740753e-01 | 0.241 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.843345e-01 | 0.546 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.867906e-01 | 0.232 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.188305e-01 | 0.496 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 4.370229e-01 | 0.359 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 3.603101e-01 | 0.443 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 4.008146e-01 | 0.397 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.981435e-01 | 0.303 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.981435e-01 | 0.303 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.526316e-01 | 0.258 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.526316e-01 | 0.258 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.251764e-01 | 0.647 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.537868e-01 | 0.343 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 5.485444e-01 | 0.261 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 6.012066e-01 | 0.221 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.012066e-01 | 0.221 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.012066e-01 | 0.221 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.812771e-01 | 0.236 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 6.122268e-01 | 0.213 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 6.445099e-01 | 0.191 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.445099e-01 | 0.191 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.445099e-01 | 0.191 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 6.269550e-01 | 0.203 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 6.269550e-01 | 0.203 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.406893e-01 | 0.193 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.297276e-01 | 0.639 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.896527e-01 | 0.538 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.258091e-01 | 0.646 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.861254e-01 | 0.543 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.081538e-01 | 0.511 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 5.477201e-01 | 0.261 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.812473e-01 | 0.318 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 4.790285e-01 | 0.320 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 2.795979e-01 | 0.553 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.603101e-01 | 0.443 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.008146e-01 | 0.397 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.008146e-01 | 0.397 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 4.860452e-01 | 0.313 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 5.890634e-01 | 0.230 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.122268e-01 | 0.213 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.445099e-01 | 0.191 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 6.413949e-01 | 0.193 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.413949e-01 | 0.193 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.731886e-01 | 0.564 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 4.922672e-01 | 0.308 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.491524e-01 | 0.260 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.485444e-01 | 0.261 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 4.400671e-01 | 0.356 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.238093e-01 | 0.205 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 3.525821e-01 | 0.453 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.756056e-01 | 0.425 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 5.140537e-01 | 0.289 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 4.790285e-01 | 0.320 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.731886e-01 | 0.564 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.812771e-01 | 0.236 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 6.000026e-01 | 0.222 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.400671e-01 | 0.356 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 5.204304e-01 | 0.284 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.946475e-01 | 0.404 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 6.450879e-01 | 0.190 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.450879e-01 | 0.190 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 6.471336e-01 | 0.189 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.471336e-01 | 0.189 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.481855e-01 | 0.188 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.547136e-01 | 0.184 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.547136e-01 | 0.184 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.547136e-01 | 0.184 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.589490e-01 | 0.181 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 6.623716e-01 | 0.179 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 6.626571e-01 | 0.179 | 1 | 1 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 6.626571e-01 | 0.179 | 1 | 1 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 6.626571e-01 | 0.179 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 6.636457e-01 | 0.178 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.636457e-01 | 0.178 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.636457e-01 | 0.178 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.636457e-01 | 0.178 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.636457e-01 | 0.178 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.636457e-01 | 0.178 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.672299e-01 | 0.176 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.688032e-01 | 0.175 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.688032e-01 | 0.175 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.688032e-01 | 0.175 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 6.688032e-01 | 0.175 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 6.688032e-01 | 0.175 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 6.688032e-01 | 0.175 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.688032e-01 | 0.175 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.688032e-01 | 0.175 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 6.694110e-01 | 0.174 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.705210e-01 | 0.174 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.720858e-01 | 0.173 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 6.764641e-01 | 0.170 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.769523e-01 | 0.169 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 6.796513e-01 | 0.168 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.796513e-01 | 0.168 | 1 | 1 |
| Integration of energy metabolism | R-HSA-163685 | 6.800322e-01 | 0.167 | 1 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.831133e-01 | 0.166 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.831133e-01 | 0.166 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.831133e-01 | 0.166 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 6.831133e-01 | 0.166 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.831133e-01 | 0.166 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.831133e-01 | 0.166 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 6.831133e-01 | 0.166 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.831133e-01 | 0.166 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.831133e-01 | 0.166 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.831133e-01 | 0.166 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 6.847028e-01 | 0.164 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.855103e-01 | 0.164 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.855103e-01 | 0.164 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.858993e-01 | 0.164 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.879840e-01 | 0.162 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 6.906396e-01 | 0.161 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.906396e-01 | 0.161 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 6.922637e-01 | 0.160 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 6.922767e-01 | 0.160 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.922767e-01 | 0.160 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.944901e-01 | 0.158 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 6.944901e-01 | 0.158 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 6.944901e-01 | 0.158 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.944901e-01 | 0.158 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.944901e-01 | 0.158 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 6.944901e-01 | 0.158 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.944901e-01 | 0.158 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 6.944901e-01 | 0.158 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.960622e-01 | 0.157 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 6.960622e-01 | 0.157 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 6.985859e-01 | 0.156 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.985859e-01 | 0.156 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.059662e-01 | 0.151 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.059662e-01 | 0.151 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 7.059662e-01 | 0.151 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 7.059662e-01 | 0.151 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.082063e-01 | 0.150 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.108252e-01 | 0.148 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.108252e-01 | 0.148 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.108252e-01 | 0.148 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.113073e-01 | 0.148 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 7.118850e-01 | 0.148 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 7.118850e-01 | 0.148 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 7.118850e-01 | 0.148 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.143407e-01 | 0.146 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 7.152159e-01 | 0.146 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 7.166568e-01 | 0.145 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 7.175268e-01 | 0.144 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.175268e-01 | 0.144 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.175268e-01 | 0.144 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.175268e-01 | 0.144 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.175268e-01 | 0.144 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.175268e-01 | 0.144 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.175268e-01 | 0.144 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 7.175268e-01 | 0.144 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.175268e-01 | 0.144 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.175268e-01 | 0.144 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.175268e-01 | 0.144 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.175268e-01 | 0.144 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.175268e-01 | 0.144 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.175268e-01 | 0.144 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.185060e-01 | 0.144 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 7.185060e-01 | 0.144 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 7.185060e-01 | 0.144 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 7.185060e-01 | 0.144 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.185060e-01 | 0.144 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.185060e-01 | 0.144 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.205190e-01 | 0.142 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.224366e-01 | 0.141 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 7.242191e-01 | 0.140 | 1 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.268337e-01 | 0.139 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 7.268337e-01 | 0.139 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.268337e-01 | 0.139 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.271175e-01 | 0.138 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.271175e-01 | 0.138 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 7.271175e-01 | 0.138 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.299800e-01 | 0.137 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.299800e-01 | 0.137 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 7.373053e-01 | 0.132 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.395280e-01 | 0.131 | 1 | 1 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 7.409109e-01 | 0.130 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.409109e-01 | 0.130 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 7.409109e-01 | 0.130 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 7.409109e-01 | 0.130 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.409109e-01 | 0.130 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.409109e-01 | 0.130 | 1 | 1 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 7.409109e-01 | 0.130 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 7.409109e-01 | 0.130 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.409109e-01 | 0.130 | 1 | 1 |
| Mismatch Repair | R-HSA-5358508 | 7.409109e-01 | 0.130 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.409109e-01 | 0.130 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.409109e-01 | 0.130 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 7.417605e-01 | 0.130 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.417605e-01 | 0.130 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 7.425899e-01 | 0.129 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.425899e-01 | 0.129 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 7.473143e-01 | 0.126 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.481224e-01 | 0.126 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.481224e-01 | 0.126 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.482048e-01 | 0.126 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.482048e-01 | 0.126 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.482048e-01 | 0.126 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 7.482048e-01 | 0.126 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.482048e-01 | 0.126 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.482048e-01 | 0.126 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.482048e-01 | 0.126 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.482048e-01 | 0.126 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.482048e-01 | 0.126 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.482048e-01 | 0.126 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.482048e-01 | 0.126 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.482048e-01 | 0.126 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.482048e-01 | 0.126 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.482048e-01 | 0.126 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.524365e-01 | 0.124 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.558171e-01 | 0.122 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 7.558171e-01 | 0.122 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.559815e-01 | 0.121 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.559815e-01 | 0.121 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.584085e-01 | 0.120 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.611495e-01 | 0.119 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.617715e-01 | 0.118 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 7.617715e-01 | 0.118 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.617715e-01 | 0.118 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.617715e-01 | 0.118 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.652749e-01 | 0.116 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 7.652749e-01 | 0.116 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.652749e-01 | 0.116 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 7.652749e-01 | 0.116 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 7.652749e-01 | 0.116 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.652749e-01 | 0.116 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.660585e-01 | 0.116 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.667888e-01 | 0.115 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.670021e-01 | 0.115 | 1 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.680206e-01 | 0.115 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 7.681702e-01 | 0.115 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.702247e-01 | 0.113 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 7.755526e-01 | 0.110 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.755526e-01 | 0.110 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 7.755526e-01 | 0.110 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.755526e-01 | 0.110 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 7.755526e-01 | 0.110 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.755526e-01 | 0.110 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.755526e-01 | 0.110 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.755526e-01 | 0.110 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.755526e-01 | 0.110 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.755526e-01 | 0.110 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.755526e-01 | 0.110 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 7.755526e-01 | 0.110 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 7.755526e-01 | 0.110 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.755526e-01 | 0.110 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.755526e-01 | 0.110 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.755526e-01 | 0.110 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.755526e-01 | 0.110 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.800143e-01 | 0.108 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.800632e-01 | 0.108 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.811587e-01 | 0.107 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.811587e-01 | 0.107 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 7.814642e-01 | 0.107 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.814642e-01 | 0.107 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.814642e-01 | 0.107 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.814642e-01 | 0.107 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.814642e-01 | 0.107 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.814642e-01 | 0.107 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.814642e-01 | 0.107 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.819805e-01 | 0.107 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.819805e-01 | 0.107 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.852708e-01 | 0.105 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 7.868607e-01 | 0.104 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 7.870477e-01 | 0.104 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.870790e-01 | 0.104 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.902599e-01 | 0.102 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.928696e-01 | 0.101 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.940112e-01 | 0.100 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.945294e-01 | 0.100 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.945294e-01 | 0.100 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.967202e-01 | 0.099 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.967202e-01 | 0.099 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 7.991466e-01 | 0.097 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.991466e-01 | 0.097 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.991466e-01 | 0.097 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.991466e-01 | 0.097 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.991466e-01 | 0.097 | 1 | 1 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.991466e-01 | 0.097 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.991466e-01 | 0.097 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.991466e-01 | 0.097 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 7.999315e-01 | 0.097 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 7.999315e-01 | 0.097 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.999315e-01 | 0.097 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 7.999315e-01 | 0.097 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.999315e-01 | 0.097 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.999315e-01 | 0.097 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.999315e-01 | 0.097 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.999315e-01 | 0.097 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 7.999315e-01 | 0.097 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.999315e-01 | 0.097 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 7.999315e-01 | 0.097 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.999315e-01 | 0.097 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.007214e-01 | 0.097 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 8.007214e-01 | 0.097 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.011951e-01 | 0.096 | 1 | 1 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 8.025852e-01 | 0.096 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 8.107114e-01 | 0.091 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 8.107114e-01 | 0.091 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 8.119842e-01 | 0.090 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 8.119842e-01 | 0.090 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.129641e-01 | 0.090 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.129641e-01 | 0.090 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.129641e-01 | 0.090 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.129641e-01 | 0.090 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.129641e-01 | 0.090 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.129641e-01 | 0.090 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.131764e-01 | 0.090 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 8.135263e-01 | 0.090 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.158102e-01 | 0.088 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.158102e-01 | 0.088 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 8.158102e-01 | 0.088 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.158102e-01 | 0.088 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.163387e-01 | 0.088 | 1 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.175487e-01 | 0.087 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.180778e-01 | 0.087 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.216638e-01 | 0.085 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 8.216638e-01 | 0.085 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.216638e-01 | 0.085 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 8.216638e-01 | 0.085 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.216638e-01 | 0.085 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 8.216638e-01 | 0.085 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.216638e-01 | 0.085 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.216638e-01 | 0.085 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 8.216638e-01 | 0.085 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.216638e-01 | 0.085 | 0 | 0 |
| Uptake of dietary cobalamins into enterocytes | R-HSA-9758881 | 8.216638e-01 | 0.085 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.261612e-01 | 0.083 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 8.264834e-01 | 0.083 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.275352e-01 | 0.082 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.282566e-01 | 0.082 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.312251e-01 | 0.080 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 8.312251e-01 | 0.080 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 8.312251e-01 | 0.080 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 8.312251e-01 | 0.080 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 8.312251e-01 | 0.080 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.312251e-01 | 0.080 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.362121e-01 | 0.078 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 8.372172e-01 | 0.077 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.372172e-01 | 0.077 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.372172e-01 | 0.077 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.410365e-01 | 0.075 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.410365e-01 | 0.075 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.410365e-01 | 0.075 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.410365e-01 | 0.075 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.410365e-01 | 0.075 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 8.410365e-01 | 0.075 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.410365e-01 | 0.075 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.410365e-01 | 0.075 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 8.410365e-01 | 0.075 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.410365e-01 | 0.075 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 8.410365e-01 | 0.075 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.410365e-01 | 0.075 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.410365e-01 | 0.075 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.410365e-01 | 0.075 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.413662e-01 | 0.075 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.454657e-01 | 0.073 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.454657e-01 | 0.073 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.454657e-01 | 0.073 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.454657e-01 | 0.073 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 8.454657e-01 | 0.073 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.454657e-01 | 0.073 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.468992e-01 | 0.072 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.469164e-01 | 0.072 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.502376e-01 | 0.070 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 8.519458e-01 | 0.070 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.569911e-01 | 0.067 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.569911e-01 | 0.067 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.569911e-01 | 0.067 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.569911e-01 | 0.067 | 1 | 1 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 8.571342e-01 | 0.067 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.573408e-01 | 0.067 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.573408e-01 | 0.067 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.573408e-01 | 0.067 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 8.583058e-01 | 0.066 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.583058e-01 | 0.066 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.583058e-01 | 0.066 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 8.583058e-01 | 0.066 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 8.583058e-01 | 0.066 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.583058e-01 | 0.066 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.583058e-01 | 0.066 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.583058e-01 | 0.066 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.583058e-01 | 0.066 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 8.583058e-01 | 0.066 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.583058e-01 | 0.066 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 8.583058e-01 | 0.066 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.583058e-01 | 0.066 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.583058e-01 | 0.066 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 8.583058e-01 | 0.066 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.583058e-01 | 0.066 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.583058e-01 | 0.066 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 8.586053e-01 | 0.066 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.586053e-01 | 0.066 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.586053e-01 | 0.066 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 8.586053e-01 | 0.066 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.586053e-01 | 0.066 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.594403e-01 | 0.066 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.601757e-01 | 0.065 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.601757e-01 | 0.065 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 8.601757e-01 | 0.065 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.601757e-01 | 0.065 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.628045e-01 | 0.064 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.665104e-01 | 0.062 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.665104e-01 | 0.062 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.665104e-01 | 0.062 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.665104e-01 | 0.062 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.665104e-01 | 0.062 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 8.666254e-01 | 0.062 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 8.666917e-01 | 0.062 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.689198e-01 | 0.061 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.705520e-01 | 0.060 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.705520e-01 | 0.060 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.705520e-01 | 0.060 | 1 | 1 |
| HSF1 activation | R-HSA-3371511 | 8.705520e-01 | 0.060 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.705520e-01 | 0.060 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.707150e-01 | 0.060 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.707150e-01 | 0.060 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.707150e-01 | 0.060 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.736999e-01 | 0.059 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.736999e-01 | 0.059 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.736999e-01 | 0.059 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 8.736999e-01 | 0.059 | 0 | 0 |
| The activation of arylsulfatases | R-HSA-1663150 | 8.736999e-01 | 0.059 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.736999e-01 | 0.059 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 8.736999e-01 | 0.059 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.736999e-01 | 0.059 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.736999e-01 | 0.059 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.736999e-01 | 0.059 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.736999e-01 | 0.059 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 8.736999e-01 | 0.059 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.736999e-01 | 0.059 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.736999e-01 | 0.059 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.736999e-01 | 0.059 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.736999e-01 | 0.059 | 1 | 1 |
| P2Y receptors | R-HSA-417957 | 8.736999e-01 | 0.059 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.743501e-01 | 0.058 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.743501e-01 | 0.058 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.754802e-01 | 0.058 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.773526e-01 | 0.057 | 1 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.802415e-01 | 0.055 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 8.802415e-01 | 0.055 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 8.818633e-01 | 0.055 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.818633e-01 | 0.055 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.821889e-01 | 0.054 | 1 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 8.822042e-01 | 0.054 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.828217e-01 | 0.054 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.839237e-01 | 0.054 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 8.867947e-01 | 0.052 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.874223e-01 | 0.052 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.874223e-01 | 0.052 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.874223e-01 | 0.052 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.874223e-01 | 0.052 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.874223e-01 | 0.052 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.874223e-01 | 0.052 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 8.874223e-01 | 0.052 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.874223e-01 | 0.052 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.914818e-01 | 0.050 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.918638e-01 | 0.050 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.921162e-01 | 0.050 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.921162e-01 | 0.050 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.921162e-01 | 0.050 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 8.921162e-01 | 0.050 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 8.921162e-01 | 0.050 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 8.921162e-01 | 0.050 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 8.924265e-01 | 0.049 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.927820e-01 | 0.049 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.954787e-01 | 0.048 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.966167e-01 | 0.047 | 1 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.966751e-01 | 0.047 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.977026e-01 | 0.047 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.977026e-01 | 0.047 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.981820e-01 | 0.047 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.996546e-01 | 0.046 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.996546e-01 | 0.046 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.996546e-01 | 0.046 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.996546e-01 | 0.046 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.996546e-01 | 0.046 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.996546e-01 | 0.046 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 8.996546e-01 | 0.046 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.996546e-01 | 0.046 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 8.996546e-01 | 0.046 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.996546e-01 | 0.046 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.003857e-01 | 0.046 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.015366e-01 | 0.045 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.015366e-01 | 0.045 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.022260e-01 | 0.045 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.032388e-01 | 0.044 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.055437e-01 | 0.043 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.055437e-01 | 0.043 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.055437e-01 | 0.043 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.055437e-01 | 0.043 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.055437e-01 | 0.043 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 9.101844e-01 | 0.041 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.101844e-01 | 0.041 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.101844e-01 | 0.041 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.105583e-01 | 0.041 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 9.105583e-01 | 0.041 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.105583e-01 | 0.041 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.105583e-01 | 0.041 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.105583e-01 | 0.041 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.105583e-01 | 0.041 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 9.105583e-01 | 0.041 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.105583e-01 | 0.041 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.128367e-01 | 0.040 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.128923e-01 | 0.040 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.128923e-01 | 0.040 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.133804e-01 | 0.039 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.148347e-01 | 0.039 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.150433e-01 | 0.039 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.190453e-01 | 0.037 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.190453e-01 | 0.037 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.196137e-01 | 0.036 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.196137e-01 | 0.036 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 9.202778e-01 | 0.036 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.202778e-01 | 0.036 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.202778e-01 | 0.036 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.202778e-01 | 0.036 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.202778e-01 | 0.036 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.202778e-01 | 0.036 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.202778e-01 | 0.036 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 9.202778e-01 | 0.036 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 9.202778e-01 | 0.036 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 9.202778e-01 | 0.036 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.202778e-01 | 0.036 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.211534e-01 | 0.036 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.232050e-01 | 0.035 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.242106e-01 | 0.034 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.248060e-01 | 0.034 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.248060e-01 | 0.034 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.253852e-01 | 0.034 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.253852e-01 | 0.034 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.267239e-01 | 0.033 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.277048e-01 | 0.033 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.286342e-01 | 0.032 | 1 | 0 |
| L1CAM interactions | R-HSA-373760 | 9.288132e-01 | 0.032 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 9.289416e-01 | 0.032 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.289416e-01 | 0.032 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.289416e-01 | 0.032 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.289416e-01 | 0.032 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.289416e-01 | 0.032 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.289416e-01 | 0.032 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.289416e-01 | 0.032 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.289416e-01 | 0.032 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 9.289416e-01 | 0.032 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.301951e-01 | 0.031 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.310788e-01 | 0.031 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.316172e-01 | 0.031 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.320420e-01 | 0.031 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.320420e-01 | 0.031 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.324512e-01 | 0.030 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.352326e-01 | 0.029 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.360634e-01 | 0.029 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.366644e-01 | 0.028 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.366644e-01 | 0.028 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.366644e-01 | 0.028 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 9.366644e-01 | 0.028 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.366644e-01 | 0.028 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.371542e-01 | 0.028 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.371542e-01 | 0.028 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 9.374599e-01 | 0.028 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.381338e-01 | 0.028 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.399142e-01 | 0.027 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.399379e-01 | 0.027 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.399550e-01 | 0.027 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.400972e-01 | 0.027 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.435482e-01 | 0.025 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.435482e-01 | 0.025 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.435482e-01 | 0.025 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.435482e-01 | 0.025 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.435482e-01 | 0.025 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.437046e-01 | 0.025 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 9.437046e-01 | 0.025 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.437046e-01 | 0.025 | 1 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.437046e-01 | 0.025 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.437046e-01 | 0.025 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.441417e-01 | 0.025 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.443298e-01 | 0.025 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.449891e-01 | 0.025 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.468052e-01 | 0.024 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.468429e-01 | 0.024 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.468429e-01 | 0.024 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.468429e-01 | 0.024 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.472938e-01 | 0.024 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.484262e-01 | 0.023 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.487958e-01 | 0.023 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.487958e-01 | 0.023 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.487958e-01 | 0.023 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.487958e-01 | 0.023 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.487958e-01 | 0.023 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.487958e-01 | 0.023 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.496841e-01 | 0.022 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.496841e-01 | 0.022 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.496841e-01 | 0.022 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 9.496841e-01 | 0.022 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 9.496841e-01 | 0.022 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.496841e-01 | 0.022 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.496841e-01 | 0.022 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.496841e-01 | 0.022 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.496841e-01 | 0.022 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 9.496841e-01 | 0.022 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.496841e-01 | 0.022 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.510959e-01 | 0.022 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.510959e-01 | 0.022 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 9.522143e-01 | 0.021 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.522443e-01 | 0.021 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.534457e-01 | 0.021 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.534457e-01 | 0.021 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.534457e-01 | 0.021 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.534457e-01 | 0.021 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.545763e-01 | 0.020 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.550618e-01 | 0.020 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.550618e-01 | 0.020 | 1 | 1 |
| Gluconeogenesis | R-HSA-70263 | 9.550618e-01 | 0.020 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.551535e-01 | 0.020 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.551535e-01 | 0.020 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.551535e-01 | 0.020 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.562450e-01 | 0.019 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.562450e-01 | 0.019 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 9.571497e-01 | 0.019 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.576901e-01 | 0.019 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.587250e-01 | 0.018 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.587250e-01 | 0.018 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.589865e-01 | 0.018 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.591114e-01 | 0.018 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.594846e-01 | 0.018 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.595153e-01 | 0.018 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.600286e-01 | 0.018 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.600286e-01 | 0.018 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 9.600286e-01 | 0.018 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.600286e-01 | 0.018 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.600286e-01 | 0.018 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.600286e-01 | 0.018 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.609845e-01 | 0.017 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.615622e-01 | 0.017 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.615622e-01 | 0.017 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.615622e-01 | 0.017 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.615622e-01 | 0.017 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 9.619537e-01 | 0.017 | 1 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.626765e-01 | 0.017 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.626765e-01 | 0.017 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.640584e-01 | 0.016 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.643740e-01 | 0.016 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.643740e-01 | 0.016 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.643740e-01 | 0.016 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.643740e-01 | 0.016 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.643740e-01 | 0.016 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.643740e-01 | 0.016 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.643740e-01 | 0.016 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.643740e-01 | 0.016 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.650544e-01 | 0.015 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.650544e-01 | 0.015 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.652262e-01 | 0.015 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.652262e-01 | 0.015 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.681024e-01 | 0.014 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 9.682473e-01 | 0.014 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.682473e-01 | 0.014 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.682473e-01 | 0.014 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.682473e-01 | 0.014 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.682473e-01 | 0.014 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.682473e-01 | 0.014 | 1 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.683103e-01 | 0.014 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.683662e-01 | 0.014 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.687156e-01 | 0.014 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.687156e-01 | 0.014 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.705600e-01 | 0.013 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 9.707528e-01 | 0.013 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.710442e-01 | 0.013 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.712410e-01 | 0.013 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.712410e-01 | 0.013 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.716996e-01 | 0.012 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.716996e-01 | 0.012 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.716996e-01 | 0.012 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.716996e-01 | 0.012 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.716996e-01 | 0.012 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.716996e-01 | 0.012 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.716996e-01 | 0.012 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.724147e-01 | 0.012 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.730545e-01 | 0.012 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.739093e-01 | 0.011 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.739093e-01 | 0.011 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 9.739093e-01 | 0.011 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.739093e-01 | 0.011 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 9.742140e-01 | 0.011 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.747768e-01 | 0.011 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 9.747768e-01 | 0.011 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 9.747768e-01 | 0.011 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 9.747768e-01 | 0.011 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.747768e-01 | 0.011 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.747768e-01 | 0.011 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.747768e-01 | 0.011 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.750079e-01 | 0.011 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.754405e-01 | 0.011 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.759048e-01 | 0.011 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.760788e-01 | 0.011 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.763376e-01 | 0.010 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.774929e-01 | 0.010 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.775074e-01 | 0.010 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.775195e-01 | 0.010 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.775195e-01 | 0.010 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.775195e-01 | 0.010 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.775195e-01 | 0.010 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.775195e-01 | 0.010 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.775195e-01 | 0.010 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.775195e-01 | 0.010 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.784039e-01 | 0.009 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.785251e-01 | 0.009 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.785464e-01 | 0.009 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.792814e-01 | 0.009 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.794081e-01 | 0.009 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.799642e-01 | 0.009 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.800960e-01 | 0.009 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.805549e-01 | 0.009 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.805549e-01 | 0.009 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.805549e-01 | 0.009 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.809066e-01 | 0.008 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.812628e-01 | 0.008 | 1 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.818656e-01 | 0.008 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.820815e-01 | 0.008 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.821431e-01 | 0.008 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.821431e-01 | 0.008 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.821431e-01 | 0.008 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.821431e-01 | 0.008 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.822531e-01 | 0.008 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.827596e-01 | 0.008 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.827596e-01 | 0.008 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.827596e-01 | 0.008 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.840389e-01 | 0.007 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.840389e-01 | 0.007 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.840389e-01 | 0.007 | 1 | 1 |
| Somitogenesis | R-HSA-9824272 | 9.840389e-01 | 0.007 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.840852e-01 | 0.007 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.840852e-01 | 0.007 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.840852e-01 | 0.007 | 0 | 0 |
| Mucopolysaccharidoses | R-HSA-2206281 | 9.840852e-01 | 0.007 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.842330e-01 | 0.007 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.855266e-01 | 0.006 | 1 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.855266e-01 | 0.006 | 1 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.855853e-01 | 0.006 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.856264e-01 | 0.006 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.856908e-01 | 0.006 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.858162e-01 | 0.006 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.858162e-01 | 0.006 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.858162e-01 | 0.006 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.858162e-01 | 0.006 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.858162e-01 | 0.006 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.858162e-01 | 0.006 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.858162e-01 | 0.006 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.869129e-01 | 0.006 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.869129e-01 | 0.006 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.873589e-01 | 0.006 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.878927e-01 | 0.005 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.882963e-01 | 0.005 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.885057e-01 | 0.005 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.887340e-01 | 0.005 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.887340e-01 | 0.005 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.887474e-01 | 0.005 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.888687e-01 | 0.005 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.890304e-01 | 0.005 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.897694e-01 | 0.004 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.899596e-01 | 0.004 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.899596e-01 | 0.004 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.899596e-01 | 0.004 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.899621e-01 | 0.004 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.906879e-01 | 0.004 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.910519e-01 | 0.004 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.910519e-01 | 0.004 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.910519e-01 | 0.004 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.910519e-01 | 0.004 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.910519e-01 | 0.004 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.910519e-01 | 0.004 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.910519e-01 | 0.004 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.910519e-01 | 0.004 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.910519e-01 | 0.004 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.910519e-01 | 0.004 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.912573e-01 | 0.004 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.913660e-01 | 0.004 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.916387e-01 | 0.004 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.916387e-01 | 0.004 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.920254e-01 | 0.003 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.920254e-01 | 0.003 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.920254e-01 | 0.003 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.920254e-01 | 0.003 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.923721e-01 | 0.003 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.923721e-01 | 0.003 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.928202e-01 | 0.003 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.928930e-01 | 0.003 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.928930e-01 | 0.003 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.936663e-01 | 0.003 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.936663e-01 | 0.003 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.936663e-01 | 0.003 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.936663e-01 | 0.003 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.938433e-01 | 0.003 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.939305e-01 | 0.003 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.942179e-01 | 0.003 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.942179e-01 | 0.003 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.943555e-01 | 0.002 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.943555e-01 | 0.002 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.943555e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.943555e-01 | 0.002 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.947307e-01 | 0.002 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.948474e-01 | 0.002 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.949698e-01 | 0.002 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.949698e-01 | 0.002 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.949698e-01 | 0.002 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.952178e-01 | 0.002 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.952199e-01 | 0.002 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.952422e-01 | 0.002 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.954275e-01 | 0.002 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.955172e-01 | 0.002 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.956273e-01 | 0.002 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.960051e-01 | 0.002 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.960181e-01 | 0.002 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.960996e-01 | 0.002 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.962405e-01 | 0.002 | 1 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.963919e-01 | 0.002 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.964785e-01 | 0.002 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.966060e-01 | 0.001 | 1 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.968211e-01 | 0.001 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.968274e-01 | 0.001 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.968274e-01 | 0.001 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.968354e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.969974e-01 | 0.001 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.971077e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.971309e-01 | 0.001 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.971728e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.974109e-01 | 0.001 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.974805e-01 | 0.001 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.974805e-01 | 0.001 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.974805e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.974805e-01 | 0.001 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.975153e-01 | 0.001 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.979993e-01 | 0.001 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.980993e-01 | 0.001 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.981031e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.982859e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.984112e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.984544e-01 | 0.001 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.985842e-01 | 0.001 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.987092e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.988405e-01 | 0.001 | 1 | 1 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.988445e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.988679e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.988758e-01 | 0.000 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.988758e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.989798e-01 | 0.000 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.990476e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.990509e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.990563e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.990807e-01 | 0.000 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.991356e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.991441e-01 | 0.000 | 1 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.991718e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.992027e-01 | 0.000 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.992830e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.992912e-01 | 0.000 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.992912e-01 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.993398e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.993473e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.993536e-01 | 0.000 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.993544e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.993684e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.994179e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.994551e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.994551e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.994551e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.994690e-01 | 0.000 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.994887e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.994887e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.995875e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.996019e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.996044e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.996453e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.996453e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.996453e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.997018e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.997056e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.997102e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.997184e-01 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.997334e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.997491e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.997764e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.998101e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.998377e-01 | 0.000 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.998745e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.998745e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.998758e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.998996e-01 | 0.000 | 1 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.998997e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999098e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999109e-01 | 0.000 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.999295e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999295e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999390e-01 | 0.000 | 1 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999472e-01 | 0.000 | 1 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999472e-01 | 0.000 | 1 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.999560e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999648e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999755e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999786e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999860e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999889e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999902e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999930e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999955e-01 | 0.000 | 1 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999956e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.999959e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999960e-01 | 0.000 | 1 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999965e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999971e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999974e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999977e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999980e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999985e-01 | 0.000 | 1 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999988e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999990e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999991e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999992e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999997e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999997e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999998e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999999e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999999e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999999e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999999e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 1 | 0 |
| Translation | R-HSA-72766 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 1 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 1 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 1 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Attenuation phase | R-HSA-3371568 | 4.772682e-11 | 10.321 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.207826e-10 | 9.656 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.963804e-10 | 9.099 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.006504e-09 | 8.997 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 7.031547e-09 | 8.153 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.249040e-08 | 7.903 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.295336e-08 | 7.888 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.122656e-08 | 7.505 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.880807e-08 | 7.411 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 6.392079e-08 | 7.194 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 6.668945e-08 | 7.176 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 7.777000e-08 | 7.109 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.768556e-07 | 6.752 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.982349e-07 | 6.525 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.728441e-07 | 6.428 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.043649e-07 | 6.393 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.606297e-07 | 6.337 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 6.987264e-07 | 6.156 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 9.349941e-07 | 6.029 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.673099e-06 | 5.776 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.588800e-06 | 5.587 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.609679e-06 | 5.583 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.121238e-06 | 5.506 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.013243e-06 | 5.521 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.077377e-06 | 5.512 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.414801e-06 | 5.467 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.414801e-06 | 5.467 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.436309e-06 | 5.353 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.403147e-06 | 5.356 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.986603e-06 | 5.399 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.319603e-06 | 5.365 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.825288e-06 | 5.316 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.865909e-06 | 5.313 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.825288e-06 | 5.316 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 6.536145e-06 | 5.185 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 7.000402e-06 | 5.155 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.661548e-06 | 5.116 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 9.986183e-06 | 5.001 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.006573e-05 | 4.997 | 1 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.041394e-05 | 4.982 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.180284e-05 | 4.928 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.269260e-05 | 4.896 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.338966e-05 | 4.873 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.589042e-05 | 4.799 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.001103e-05 | 4.699 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.539270e-05 | 4.595 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.700039e-05 | 4.569 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.415379e-05 | 4.467 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.484524e-05 | 4.458 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.647035e-05 | 4.438 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.672329e-05 | 4.435 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 4.493247e-05 | 4.347 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 4.742387e-05 | 4.324 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.342893e-05 | 4.272 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 6.122574e-05 | 4.213 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 6.122574e-05 | 4.213 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.912599e-05 | 4.160 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 6.858927e-05 | 4.164 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 7.131118e-05 | 4.147 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 7.168931e-05 | 4.145 | 0 | 0 |
| M Phase | R-HSA-68886 | 7.508063e-05 | 4.124 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.547910e-05 | 4.122 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.909856e-05 | 4.102 | 0 | 0 |
| Depurination | R-HSA-73927 | 7.823311e-05 | 4.107 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.044722e-05 | 4.094 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 8.561523e-05 | 4.067 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.043860e-04 | 3.981 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.249839e-04 | 3.903 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.336794e-04 | 3.874 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.514633e-04 | 3.820 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.626877e-04 | 3.789 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.715269e-04 | 3.766 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.860195e-04 | 3.730 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.860195e-04 | 3.730 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.866702e-04 | 3.729 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.956990e-04 | 3.708 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.124113e-04 | 3.673 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.124113e-04 | 3.673 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.132387e-04 | 3.671 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.321389e-04 | 3.634 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.519425e-04 | 3.599 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.771190e-04 | 3.557 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.697275e-04 | 3.569 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.696102e-04 | 3.569 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.929631e-04 | 3.533 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.940970e-04 | 3.532 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.022463e-04 | 3.520 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.259182e-04 | 3.487 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.712842e-04 | 3.430 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.846410e-04 | 3.415 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.412803e-04 | 3.355 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.005033e-04 | 3.301 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 5.005033e-04 | 3.301 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.005033e-04 | 3.301 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.980005e-04 | 3.223 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.167901e-04 | 3.210 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.423775e-04 | 3.192 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.055608e-04 | 3.151 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 7.387850e-04 | 3.131 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 7.387850e-04 | 3.131 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.588749e-04 | 3.120 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 8.118855e-04 | 3.091 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 7.992255e-04 | 3.097 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 8.289932e-04 | 3.081 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.633782e-04 | 3.064 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 8.693723e-04 | 3.061 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 9.651279e-04 | 3.015 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.004239e-03 | 2.998 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.011675e-03 | 2.995 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.011675e-03 | 2.995 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 9.724236e-04 | 3.012 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.034088e-03 | 2.985 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.040506e-03 | 2.983 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.100904e-03 | 2.958 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.249414e-03 | 2.903 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.353904e-03 | 2.868 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.262476e-03 | 2.899 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.271651e-03 | 2.896 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.500823e-03 | 2.824 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.555930e-03 | 2.808 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.571883e-03 | 2.804 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.755376e-03 | 2.756 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.763082e-03 | 2.754 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.810394e-03 | 2.742 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.002504e-03 | 2.698 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 2.021366e-03 | 2.694 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.115520e-03 | 2.675 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.301549e-03 | 2.638 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.312405e-03 | 2.636 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.312405e-03 | 2.636 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.468417e-03 | 2.608 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.672288e-03 | 2.573 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 3.450963e-03 | 2.462 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.433830e-03 | 2.464 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.434546e-03 | 2.464 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.317064e-03 | 2.479 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.367527e-03 | 2.473 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.582549e-03 | 2.446 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 3.830791e-03 | 2.417 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.990562e-03 | 2.399 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.155730e-03 | 2.381 | 1 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.426362e-03 | 2.354 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.893335e-03 | 2.310 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.893335e-03 | 2.310 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.711263e-03 | 2.327 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.709476e-03 | 2.327 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.450450e-03 | 2.352 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.958343e-03 | 2.305 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 5.055665e-03 | 2.296 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.077483e-03 | 2.294 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.604489e-03 | 2.251 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 5.607150e-03 | 2.251 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 5.607150e-03 | 2.251 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.607150e-03 | 2.251 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 5.607150e-03 | 2.251 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 5.745391e-03 | 2.241 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.889044e-03 | 2.230 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.909750e-03 | 2.228 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.967843e-03 | 2.224 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.968187e-03 | 2.224 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.088960e-03 | 2.215 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 6.253408e-03 | 2.204 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 7.209947e-03 | 2.142 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 7.216303e-03 | 2.142 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 8.099289e-03 | 2.092 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 8.099289e-03 | 2.092 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 8.099289e-03 | 2.092 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 8.099289e-03 | 2.092 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 8.099289e-03 | 2.092 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 8.099289e-03 | 2.092 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 8.099289e-03 | 2.092 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 8.099289e-03 | 2.092 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 8.099289e-03 | 2.092 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 8.099289e-03 | 2.092 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 8.099289e-03 | 2.092 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.277944e-03 | 2.082 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 8.507178e-03 | 2.070 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 7.680383e-03 | 2.115 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 8.277944e-03 | 2.082 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 8.026149e-03 | 2.095 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.003614e-03 | 2.097 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 8.172079e-03 | 2.088 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 7.680383e-03 | 2.115 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.158325e-03 | 2.088 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 8.564104e-03 | 2.067 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 8.564104e-03 | 2.067 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 9.321995e-03 | 2.030 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 9.321995e-03 | 2.030 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 9.321995e-03 | 2.030 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 9.321995e-03 | 2.030 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 9.321995e-03 | 2.030 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.935447e-03 | 2.003 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.935447e-03 | 2.003 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.935447e-03 | 2.003 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 9.976378e-03 | 2.001 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.013030e-02 | 1.994 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.030053e-02 | 1.987 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.073451e-02 | 1.969 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.073451e-02 | 1.969 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.073451e-02 | 1.969 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.202712e-02 | 1.920 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.238267e-02 | 1.907 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.163123e-02 | 1.934 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.217117e-02 | 1.915 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.098987e-02 | 1.959 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.238267e-02 | 1.907 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.238267e-02 | 1.907 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.176745e-02 | 1.929 | 1 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.195049e-02 | 1.923 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.252467e-02 | 1.902 | 1 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.266332e-02 | 1.897 | 1 | 0 |
| Nervous system development | R-HSA-9675108 | 1.271910e-02 | 1.896 | 1 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.348548e-02 | 1.870 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.366704e-02 | 1.864 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.366704e-02 | 1.864 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.366704e-02 | 1.864 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.366704e-02 | 1.864 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 1.381094e-02 | 1.860 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.428383e-02 | 1.845 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.428383e-02 | 1.845 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.433773e-02 | 1.844 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.468326e-02 | 1.833 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.468326e-02 | 1.833 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.503997e-02 | 1.823 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.503997e-02 | 1.823 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.584979e-02 | 1.800 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.630664e-02 | 1.788 | 1 | 1 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.912729e-02 | 1.718 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.779583e-02 | 1.750 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.779583e-02 | 1.750 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.817656e-02 | 1.740 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.912729e-02 | 1.718 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.817656e-02 | 1.740 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.817656e-02 | 1.740 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.749116e-02 | 1.757 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.683195e-02 | 1.774 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.912729e-02 | 1.718 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.844041e-02 | 1.734 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.855626e-02 | 1.732 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.930297e-02 | 1.714 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.030221e-02 | 1.692 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.038063e-02 | 1.691 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.112264e-02 | 1.675 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.112264e-02 | 1.675 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.130969e-02 | 1.671 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.174993e-02 | 1.663 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.196299e-02 | 1.658 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.224223e-02 | 1.653 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.353477e-02 | 1.628 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.359658e-02 | 1.627 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.359658e-02 | 1.627 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.359658e-02 | 1.627 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.437371e-02 | 1.613 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 2.437371e-02 | 1.613 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.437371e-02 | 1.613 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.468788e-02 | 1.608 | 1 | 1 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.527792e-02 | 1.597 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.548878e-02 | 1.594 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.630365e-02 | 1.580 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.638999e-02 | 1.579 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.638999e-02 | 1.579 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.638999e-02 | 1.579 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.640779e-02 | 1.578 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.688268e-02 | 1.571 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.689347e-02 | 1.570 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.093472e-02 | 1.510 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.775421e-02 | 1.557 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.997742e-02 | 1.523 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.758252e-02 | 1.559 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 3.046508e-02 | 1.516 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.296150e-02 | 1.482 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.891630e-02 | 1.539 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.748743e-02 | 1.561 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.954870e-02 | 1.529 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.211333e-02 | 1.493 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.775421e-02 | 1.557 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.194465e-02 | 1.496 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.043568e-02 | 1.517 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.004768e-02 | 1.522 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.282394e-02 | 1.484 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.194465e-02 | 1.496 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.316659e-02 | 1.479 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.433188e-02 | 1.464 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.460259e-02 | 1.461 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.460259e-02 | 1.461 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 3.460259e-02 | 1.461 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.483554e-02 | 1.458 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.543008e-02 | 1.451 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.603713e-02 | 1.443 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 3.679692e-02 | 1.434 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.679692e-02 | 1.434 | 1 | 1 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.713936e-02 | 1.430 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.721408e-02 | 1.429 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 3.743428e-02 | 1.427 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.747514e-02 | 1.426 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 3.749071e-02 | 1.426 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.892796e-02 | 1.410 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.130961e-02 | 1.384 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.413809e-02 | 1.355 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.530429e-02 | 1.344 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 4.530429e-02 | 1.344 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.332564e-02 | 1.363 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.612222e-02 | 1.336 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.704418e-02 | 1.327 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 4.857735e-02 | 1.314 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 4.530429e-02 | 1.344 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.704418e-02 | 1.327 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 4.182656e-02 | 1.379 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.704418e-02 | 1.327 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 4.530429e-02 | 1.344 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.819955e-02 | 1.317 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 4.804285e-02 | 1.318 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 5.217092e-02 | 1.283 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.245719e-02 | 1.372 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.332564e-02 | 1.363 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.465177e-02 | 1.350 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.063188e-02 | 1.296 | 1 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 5.217092e-02 | 1.283 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.885502e-02 | 1.311 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.888386e-02 | 1.311 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.682336e-02 | 1.330 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 5.145688e-02 | 1.289 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.250470e-02 | 1.372 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.217141e-02 | 1.375 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 5.053632e-02 | 1.296 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.680920e-02 | 1.330 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.413809e-02 | 1.355 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.983213e-02 | 1.302 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.221784e-02 | 1.282 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.265897e-02 | 1.279 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.353155e-02 | 1.271 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.408821e-02 | 1.267 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.408821e-02 | 1.267 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 5.454673e-02 | 1.263 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.533224e-02 | 1.257 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.643360e-02 | 1.248 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.712857e-02 | 1.243 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.791922e-02 | 1.237 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 5.843915e-02 | 1.233 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 5.843915e-02 | 1.233 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 5.853968e-02 | 1.233 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 5.933388e-02 | 1.227 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 5.933388e-02 | 1.227 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.933388e-02 | 1.227 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 5.974855e-02 | 1.224 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.974855e-02 | 1.224 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 6.051186e-02 | 1.218 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 6.051186e-02 | 1.218 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 6.244675e-02 | 1.204 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 6.244675e-02 | 1.204 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.407287e-02 | 1.193 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.407287e-02 | 1.193 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 8.181580e-02 | 1.087 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 8.181580e-02 | 1.087 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 8.181580e-02 | 1.087 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 8.181580e-02 | 1.087 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 8.181580e-02 | 1.087 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 6.716627e-02 | 1.173 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 6.716627e-02 | 1.173 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 8.060467e-02 | 1.094 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 8.060467e-02 | 1.094 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 8.060467e-02 | 1.094 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 8.060467e-02 | 1.094 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 8.060467e-02 | 1.094 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 8.060467e-02 | 1.094 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.378948e-02 | 1.195 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.703908e-02 | 1.174 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 6.739668e-02 | 1.171 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.560582e-02 | 1.121 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 7.347300e-02 | 1.134 | 1 | 1 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 6.406012e-02 | 1.193 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.406012e-02 | 1.193 | 1 | 1 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.358171e-02 | 1.133 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 8.174259e-02 | 1.088 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 8.174259e-02 | 1.088 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.271106e-02 | 1.203 | 1 | 1 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 7.440233e-02 | 1.128 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 6.406012e-02 | 1.193 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 6.493732e-02 | 1.188 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.463661e-02 | 1.127 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.623137e-02 | 1.179 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 7.943529e-02 | 1.100 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 6.617008e-02 | 1.179 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 7.059813e-02 | 1.151 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 7.176766e-02 | 1.144 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 6.378948e-02 | 1.195 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.773242e-02 | 1.109 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 6.739668e-02 | 1.171 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.176300e-02 | 1.209 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.492513e-02 | 1.125 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 7.011681e-02 | 1.154 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.718428e-02 | 1.173 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 6.956926e-02 | 1.158 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 8.056761e-02 | 1.094 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.703908e-02 | 1.174 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.753619e-02 | 1.110 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 8.181580e-02 | 1.087 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 7.440233e-02 | 1.128 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 7.032381e-02 | 1.153 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.060467e-02 | 1.094 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.060467e-02 | 1.094 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 7.440233e-02 | 1.128 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.060467e-02 | 1.094 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.060467e-02 | 1.094 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.124431e-02 | 1.090 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 6.623137e-02 | 1.179 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 8.437524e-02 | 1.074 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 8.437524e-02 | 1.074 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.437524e-02 | 1.074 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.437524e-02 | 1.074 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 8.487570e-02 | 1.071 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.532328e-02 | 1.069 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 8.591229e-02 | 1.066 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 8.591229e-02 | 1.066 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 8.591229e-02 | 1.066 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 8.624067e-02 | 1.064 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 8.632422e-02 | 1.064 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 8.709422e-02 | 1.060 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 8.709422e-02 | 1.060 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.709422e-02 | 1.060 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 8.829548e-02 | 1.054 | 0 | 0 |
| Kinesins | R-HSA-983189 | 8.829548e-02 | 1.054 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 8.829548e-02 | 1.054 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 8.829548e-02 | 1.054 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 8.829548e-02 | 1.054 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 8.829548e-02 | 1.054 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 8.829548e-02 | 1.054 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.865217e-02 | 1.052 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.948345e-02 | 1.048 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.948345e-02 | 1.048 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 9.147334e-02 | 1.039 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 9.147334e-02 | 1.039 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 9.147334e-02 | 1.039 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 9.370102e-02 | 1.028 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 9.509917e-02 | 1.022 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 9.523423e-02 | 1.021 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 9.526216e-02 | 1.021 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 9.526216e-02 | 1.021 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 9.593490e-02 | 1.018 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 9.593490e-02 | 1.018 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.593490e-02 | 1.018 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 9.593490e-02 | 1.018 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 9.627169e-02 | 1.017 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 9.699408e-02 | 1.013 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 9.829685e-02 | 1.007 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 9.829685e-02 | 1.007 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 9.829685e-02 | 1.007 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.000677e-01 | 1.000 | 1 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.005529e-01 | 0.998 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.005529e-01 | 0.998 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.007566e-01 | 0.997 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.007566e-01 | 0.997 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.007566e-01 | 0.997 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.007566e-01 | 0.997 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.007566e-01 | 0.997 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.014138e-01 | 0.994 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 1.014138e-01 | 0.994 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.014138e-01 | 0.994 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.014138e-01 | 0.994 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.014138e-01 | 0.994 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.019825e-01 | 0.991 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.019974e-01 | 0.991 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.035762e-01 | 0.985 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.035762e-01 | 0.985 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.035762e-01 | 0.985 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.226701e-01 | 0.911 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.226701e-01 | 0.911 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 1.226701e-01 | 0.911 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.453776e-01 | 0.838 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.279641e-01 | 0.893 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.279641e-01 | 0.893 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 1.458487e-01 | 0.836 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.255639e-01 | 0.901 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.403681e-01 | 0.853 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.403681e-01 | 0.853 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.203153e-01 | 0.920 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.558916e-01 | 0.807 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.461328e-01 | 0.835 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.363846e-01 | 0.865 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.375288e-01 | 0.862 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.072314e-01 | 0.970 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.073523e-01 | 0.969 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.472805e-01 | 0.832 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.337130e-01 | 0.874 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.073523e-01 | 0.969 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.115262e-01 | 0.953 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.566486e-01 | 0.805 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.226701e-01 | 0.911 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.279641e-01 | 0.893 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.170631e-01 | 0.932 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.083307e-01 | 0.965 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.239540e-01 | 0.907 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.233297e-01 | 0.909 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.226701e-01 | 0.911 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.163593e-01 | 0.934 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.558916e-01 | 0.807 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 1.249320e-01 | 0.903 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.195396e-01 | 0.922 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.110738e-01 | 0.954 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.249320e-01 | 0.903 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 1.115262e-01 | 0.953 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.105156e-01 | 0.957 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.203153e-01 | 0.920 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.147149e-01 | 0.940 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.226701e-01 | 0.911 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.275331e-01 | 0.894 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.275331e-01 | 0.894 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.529064e-01 | 0.816 | 1 | 1 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.484460e-01 | 0.828 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.083307e-01 | 0.965 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.280200e-01 | 0.893 | 1 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.461328e-01 | 0.835 | 1 | 1 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.139908e-01 | 0.943 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.446857e-01 | 0.840 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.453776e-01 | 0.838 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.318207e-01 | 0.880 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 1.144871e-01 | 0.941 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 1.453776e-01 | 0.838 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.183140e-01 | 0.927 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.255639e-01 | 0.901 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.176136e-01 | 0.930 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.363846e-01 | 0.865 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.399557e-01 | 0.854 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.090396e-01 | 0.962 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.558916e-01 | 0.807 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.110738e-01 | 0.954 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.483305e-01 | 0.829 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.453776e-01 | 0.838 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.279641e-01 | 0.893 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.458487e-01 | 0.836 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.403681e-01 | 0.853 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.411379e-01 | 0.850 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.279641e-01 | 0.893 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.322324e-01 | 0.879 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.458487e-01 | 0.836 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.127957e-01 | 0.948 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.576957e-01 | 0.802 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.576957e-01 | 0.802 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.578555e-01 | 0.802 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.578555e-01 | 0.802 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.578555e-01 | 0.802 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.578555e-01 | 0.802 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.597293e-01 | 0.797 | 1 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.599096e-01 | 0.796 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.599096e-01 | 0.796 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.607497e-01 | 0.794 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.607497e-01 | 0.794 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.612634e-01 | 0.792 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 1.646372e-01 | 0.783 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 1.646372e-01 | 0.783 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.646372e-01 | 0.783 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.659216e-01 | 0.780 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.660342e-01 | 0.780 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.684568e-01 | 0.774 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.684892e-01 | 0.773 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.693258e-01 | 0.771 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.693258e-01 | 0.771 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.693258e-01 | 0.771 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.693258e-01 | 0.771 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.693258e-01 | 0.771 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 1.693258e-01 | 0.771 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.714848e-01 | 0.766 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.714848e-01 | 0.766 | 1 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.714848e-01 | 0.766 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.720835e-01 | 0.764 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.742228e-01 | 0.759 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.755409e-01 | 0.756 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.786586e-01 | 0.748 | 1 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 1.786586e-01 | 0.748 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.810095e-01 | 0.742 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.826714e-01 | 0.738 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.826714e-01 | 0.738 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.826714e-01 | 0.738 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.826714e-01 | 0.738 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.826714e-01 | 0.738 | 0 | 0 |
| Defective ACTH causes obesity and POMCD | R-HSA-5579031 | 1.826714e-01 | 0.738 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.826714e-01 | 0.738 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 1.826714e-01 | 0.738 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 1.826714e-01 | 0.738 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.826714e-01 | 0.738 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 1.826714e-01 | 0.738 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.826714e-01 | 0.738 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 1.835733e-01 | 0.736 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.835733e-01 | 0.736 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.857043e-01 | 0.731 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.857043e-01 | 0.731 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 1.869172e-01 | 0.728 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.869172e-01 | 0.728 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.890374e-01 | 0.723 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.936333e-01 | 0.713 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.936333e-01 | 0.713 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.936392e-01 | 0.713 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 1.936392e-01 | 0.713 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 1.936392e-01 | 0.713 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 1.936392e-01 | 0.713 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.936392e-01 | 0.713 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.936392e-01 | 0.713 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 1.936392e-01 | 0.713 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.943061e-01 | 0.712 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.943061e-01 | 0.712 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.943061e-01 | 0.712 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.963600e-01 | 0.707 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 2.610910e-01 | 0.583 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 2.610910e-01 | 0.583 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 2.610910e-01 | 0.583 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.610910e-01 | 0.583 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 2.610910e-01 | 0.583 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.610910e-01 | 0.583 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 2.610910e-01 | 0.583 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 2.610910e-01 | 0.583 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 2.610910e-01 | 0.583 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 2.610910e-01 | 0.583 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.319907e-01 | 0.479 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 3.319907e-01 | 0.479 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.319907e-01 | 0.479 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) | R-HSA-5619049 | 3.319907e-01 | 0.479 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.319907e-01 | 0.479 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.319907e-01 | 0.479 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.319907e-01 | 0.479 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 2.303111e-01 | 0.638 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.303111e-01 | 0.638 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.673719e-01 | 0.573 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 2.673719e-01 | 0.573 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 3.960912e-01 | 0.402 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.960912e-01 | 0.402 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 3.960912e-01 | 0.402 | 0 | 0 |
| Defective ABCA3 causes SMDP3 | R-HSA-5683678 | 3.960912e-01 | 0.402 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.960912e-01 | 0.402 | 0 | 0 |
| Defective ABCA3 causes SMDP3 | R-HSA-5688399 | 3.960912e-01 | 0.402 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.960912e-01 | 0.402 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 3.960912e-01 | 0.402 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 3.960912e-01 | 0.402 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 3.960912e-01 | 0.402 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 3.960912e-01 | 0.402 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.045434e-01 | 0.689 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.254647e-01 | 0.647 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 2.734554e-01 | 0.563 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.410878e-01 | 0.467 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.469001e-01 | 0.607 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.469001e-01 | 0.607 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.469001e-01 | 0.607 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.469001e-01 | 0.607 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.006320e-01 | 0.522 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.687524e-01 | 0.571 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.771347e-01 | 0.424 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.424150e-01 | 0.615 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.909270e-01 | 0.536 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.610942e-01 | 0.583 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.610942e-01 | 0.583 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.610942e-01 | 0.583 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.361121e-01 | 0.627 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 2.291074e-01 | 0.640 | 1 | 1 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 2.291074e-01 | 0.640 | 1 | 1 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 2.525481e-01 | 0.598 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.800919e-01 | 0.553 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.993485e-01 | 0.524 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 2.862897e-01 | 0.543 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.823407e-01 | 0.418 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.823407e-01 | 0.418 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.823407e-01 | 0.418 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.584914e-01 | 0.446 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 2.896479e-01 | 0.538 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.769571e-01 | 0.558 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.209139e-01 | 0.494 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.053465e-01 | 0.515 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.912823e-01 | 0.536 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.810837e-01 | 0.419 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.258239e-01 | 0.646 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.384544e-01 | 0.470 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.384544e-01 | 0.470 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.384544e-01 | 0.470 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.918012e-01 | 0.535 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.918012e-01 | 0.535 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.366368e-01 | 0.626 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.204346e-01 | 0.494 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.668329e-01 | 0.574 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.042770e-01 | 0.517 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.327824e-01 | 0.478 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.300829e-01 | 0.481 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 3.896911e-01 | 0.409 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 3.836800e-01 | 0.416 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.242857e-01 | 0.649 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.358333e-01 | 0.474 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.560937e-01 | 0.448 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.035122e-01 | 0.518 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.533005e-01 | 0.452 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.268308e-01 | 0.644 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.358333e-01 | 0.474 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 3.189941e-01 | 0.496 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.469001e-01 | 0.607 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 3.006320e-01 | 0.522 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 3.823407e-01 | 0.418 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.896479e-01 | 0.538 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 3.771347e-01 | 0.424 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.500946e-01 | 0.456 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 3.856832e-01 | 0.414 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.045434e-01 | 0.689 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.232006e-01 | 0.651 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 3.771347e-01 | 0.424 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 2.525481e-01 | 0.598 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 3.384063e-01 | 0.471 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.384063e-01 | 0.471 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.384063e-01 | 0.471 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 2.610942e-01 | 0.583 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 2.882355e-01 | 0.540 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.212085e-01 | 0.493 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.274156e-01 | 0.643 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 3.939844e-01 | 0.405 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.741439e-01 | 0.562 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.741439e-01 | 0.562 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.112954e-01 | 0.675 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.201154e-01 | 0.657 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 2.692878e-01 | 0.570 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.560937e-01 | 0.448 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.584914e-01 | 0.446 | 1 | 1 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.960642e-01 | 0.402 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 2.356685e-01 | 0.628 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.560770e-01 | 0.592 | 1 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.575831e-01 | 0.589 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 3.560937e-01 | 0.448 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.560937e-01 | 0.448 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.289281e-01 | 0.483 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.061205e-01 | 0.514 | 1 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.384063e-01 | 0.471 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.465596e-01 | 0.608 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.062526e-01 | 0.686 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 3.584914e-01 | 0.446 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.303111e-01 | 0.638 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.384544e-01 | 0.470 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.384544e-01 | 0.470 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.560937e-01 | 0.448 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.774259e-01 | 0.423 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 3.810837e-01 | 0.419 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 2.356685e-01 | 0.628 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.957202e-01 | 0.403 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.737929e-01 | 0.427 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 2.769571e-01 | 0.558 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.939368e-01 | 0.405 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.279319e-01 | 0.484 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.580952e-01 | 0.446 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.752686e-01 | 0.426 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 3.319907e-01 | 0.479 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.319907e-01 | 0.479 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.960912e-01 | 0.402 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 3.044096e-01 | 0.517 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 2.465596e-01 | 0.608 | 1 | 1 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.734554e-01 | 0.563 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 3.410878e-01 | 0.467 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 3.771347e-01 | 0.424 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.133326e-01 | 0.504 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.652504e-01 | 0.576 | 1 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.666027e-01 | 0.574 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.580952e-01 | 0.446 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.384544e-01 | 0.470 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.951196e-01 | 0.403 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.241718e-01 | 0.649 | 1 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.692878e-01 | 0.570 | 1 | 0 |
| CaM pathway | R-HSA-111997 | 2.692878e-01 | 0.570 | 1 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.751737e-01 | 0.560 | 1 | 0 |
| Signal attenuation | R-HSA-74749 | 3.771347e-01 | 0.424 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.909270e-01 | 0.536 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.858825e-01 | 0.414 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 3.212085e-01 | 0.493 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.915145e-01 | 0.407 | 1 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.747270e-01 | 0.561 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.303111e-01 | 0.638 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.673719e-01 | 0.573 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.673719e-01 | 0.573 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.044096e-01 | 0.517 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.410878e-01 | 0.467 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.410878e-01 | 0.467 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.410878e-01 | 0.467 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.469001e-01 | 0.607 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 3.823407e-01 | 0.418 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.784358e-01 | 0.555 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.778194e-01 | 0.423 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.026814e-01 | 0.693 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.466726e-01 | 0.460 | 1 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.410878e-01 | 0.467 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.045434e-01 | 0.689 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 3.578290e-01 | 0.446 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.043164e-01 | 0.690 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.610910e-01 | 0.583 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 3.960912e-01 | 0.402 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 2.734554e-01 | 0.563 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.410878e-01 | 0.467 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.410878e-01 | 0.467 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 3.006320e-01 | 0.522 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.771347e-01 | 0.424 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.279319e-01 | 0.484 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.384544e-01 | 0.470 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.779808e-01 | 0.423 | 1 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.133326e-01 | 0.504 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.784358e-01 | 0.555 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.734554e-01 | 0.563 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.442660e-01 | 0.463 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 3.960912e-01 | 0.402 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.771347e-01 | 0.424 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.606450e-01 | 0.443 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.361121e-01 | 0.627 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.552114e-01 | 0.450 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.209139e-01 | 0.494 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 3.810837e-01 | 0.419 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.673719e-01 | 0.573 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.673719e-01 | 0.573 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 3.960912e-01 | 0.402 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.044096e-01 | 0.517 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.771347e-01 | 0.424 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 3.279319e-01 | 0.484 | 1 | 1 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.006158e-01 | 0.698 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 2.909270e-01 | 0.536 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.146886e-01 | 0.668 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.580952e-01 | 0.446 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.762655e-01 | 0.425 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.062526e-01 | 0.686 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.725539e-01 | 0.429 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.462832e-01 | 0.461 | 1 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.960642e-01 | 0.402 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.865095e-01 | 0.543 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.530937e-01 | 0.452 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.465596e-01 | 0.608 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.410878e-01 | 0.467 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.687524e-01 | 0.571 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.687524e-01 | 0.571 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.835959e-01 | 0.416 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 3.737929e-01 | 0.427 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 3.973876e-01 | 0.401 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.975283e-01 | 0.401 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 3.975283e-01 | 0.401 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.975283e-01 | 0.401 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.975283e-01 | 0.401 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.975283e-01 | 0.401 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 4.010374e-01 | 0.397 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 4.035857e-01 | 0.394 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.057886e-01 | 0.392 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 4.092039e-01 | 0.388 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 4.092039e-01 | 0.388 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 4.092039e-01 | 0.388 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 4.092039e-01 | 0.388 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 4.092039e-01 | 0.388 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 4.092039e-01 | 0.388 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 4.092039e-01 | 0.388 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 4.092039e-01 | 0.388 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.092222e-01 | 0.388 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.092222e-01 | 0.388 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.092222e-01 | 0.388 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.101783e-01 | 0.387 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.101783e-01 | 0.387 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.123339e-01 | 0.385 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 4.123339e-01 | 0.385 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.142149e-01 | 0.383 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 4.171736e-01 | 0.380 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.171736e-01 | 0.380 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 4.171736e-01 | 0.380 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.259300e-01 | 0.371 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.259300e-01 | 0.371 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.259300e-01 | 0.371 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 4.259300e-01 | 0.371 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.260162e-01 | 0.371 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.268813e-01 | 0.370 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.276358e-01 | 0.369 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.343017e-01 | 0.362 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 4.356984e-01 | 0.361 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 4.356984e-01 | 0.361 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 4.356984e-01 | 0.361 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.367102e-01 | 0.360 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.367102e-01 | 0.360 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 4.367102e-01 | 0.360 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 4.424549e-01 | 0.354 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 4.444586e-01 | 0.352 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.444586e-01 | 0.352 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.444586e-01 | 0.352 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.444586e-01 | 0.352 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.451474e-01 | 0.351 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.451474e-01 | 0.351 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.465163e-01 | 0.350 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 4.465163e-01 | 0.350 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.465163e-01 | 0.350 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.465163e-01 | 0.350 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.480545e-01 | 0.349 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.480545e-01 | 0.349 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 4.480545e-01 | 0.349 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 4.529040e-01 | 0.344 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.533973e-01 | 0.344 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.540443e-01 | 0.343 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.540443e-01 | 0.343 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.540443e-01 | 0.343 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.540443e-01 | 0.343 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.540443e-01 | 0.343 | 0 | 0 |
| Defective CP causes aceruloplasminemia (ACERULOP) | R-HSA-5619060 | 4.540443e-01 | 0.343 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.540443e-01 | 0.343 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.540443e-01 | 0.343 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 4.540443e-01 | 0.343 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.540443e-01 | 0.343 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 4.540443e-01 | 0.343 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 4.540443e-01 | 0.343 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.540443e-01 | 0.343 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.540443e-01 | 0.343 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.540443e-01 | 0.343 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.540443e-01 | 0.343 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.542056e-01 | 0.343 | 1 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 4.560954e-01 | 0.341 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.588665e-01 | 0.338 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.617345e-01 | 0.336 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 4.617345e-01 | 0.336 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.619226e-01 | 0.335 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.619226e-01 | 0.335 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.664336e-01 | 0.331 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.664336e-01 | 0.331 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.664336e-01 | 0.331 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.666950e-01 | 0.331 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.699027e-01 | 0.328 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.699027e-01 | 0.328 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 4.757518e-01 | 0.323 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.792437e-01 | 0.319 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.792437e-01 | 0.319 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.795531e-01 | 0.319 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.795531e-01 | 0.319 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.795531e-01 | 0.319 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.795531e-01 | 0.319 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.795531e-01 | 0.319 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.795531e-01 | 0.319 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.795531e-01 | 0.319 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 4.795531e-01 | 0.319 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.795531e-01 | 0.319 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.795531e-01 | 0.319 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.863976e-01 | 0.313 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 4.870241e-01 | 0.312 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.872348e-01 | 0.312 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 4.872348e-01 | 0.312 | 1 | 1 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.914237e-01 | 0.309 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 4.919793e-01 | 0.308 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.942565e-01 | 0.306 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 4.942565e-01 | 0.306 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.963940e-01 | 0.304 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.981158e-01 | 0.303 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.981158e-01 | 0.303 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.995635e-01 | 0.301 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.008178e-01 | 0.300 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 5.008178e-01 | 0.300 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.038424e-01 | 0.298 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 5.053807e-01 | 0.296 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 5.064390e-01 | 0.295 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.064390e-01 | 0.295 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.064390e-01 | 0.295 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.064390e-01 | 0.295 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.064390e-01 | 0.295 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.064390e-01 | 0.295 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.064390e-01 | 0.295 | 0 | 0 |
| Hydroxycarboxylic acid-binding receptors | R-HSA-3296197 | 5.064390e-01 | 0.295 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 5.064390e-01 | 0.295 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.064390e-01 | 0.295 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.064390e-01 | 0.295 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.064390e-01 | 0.295 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.113493e-01 | 0.291 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.113493e-01 | 0.291 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.113493e-01 | 0.291 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.113493e-01 | 0.291 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.113493e-01 | 0.291 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 5.113493e-01 | 0.291 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 5.121334e-01 | 0.291 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.121334e-01 | 0.291 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.129622e-01 | 0.290 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 5.133476e-01 | 0.290 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 5.133476e-01 | 0.290 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.145043e-01 | 0.289 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 5.148855e-01 | 0.288 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 5.232096e-01 | 0.281 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 5.271947e-01 | 0.278 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 5.272356e-01 | 0.278 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.275786e-01 | 0.278 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.300804e-01 | 0.276 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 5.313761e-01 | 0.275 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.363751e-01 | 0.271 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 5.363751e-01 | 0.271 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 5.363751e-01 | 0.271 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.418388e-01 | 0.266 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.418388e-01 | 0.266 | 1 | 1 |
| cGMP effects | R-HSA-418457 | 5.418388e-01 | 0.266 | 0 | 0 |
| Vitamin B2 (riboflavin) metabolism | R-HSA-196843 | 5.418388e-01 | 0.266 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 5.418388e-01 | 0.266 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.418388e-01 | 0.266 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.418388e-01 | 0.266 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.427864e-01 | 0.265 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.427864e-01 | 0.265 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.444262e-01 | 0.264 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.444262e-01 | 0.264 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 5.465702e-01 | 0.262 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 5.467059e-01 | 0.262 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 5.494706e-01 | 0.260 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.494921e-01 | 0.260 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 5.535924e-01 | 0.257 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.535924e-01 | 0.257 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.535924e-01 | 0.257 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.535924e-01 | 0.257 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 5.535924e-01 | 0.257 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.538083e-01 | 0.257 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.538083e-01 | 0.257 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.538083e-01 | 0.257 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.538083e-01 | 0.257 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.538083e-01 | 0.257 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.538083e-01 | 0.257 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 5.538083e-01 | 0.257 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.538083e-01 | 0.257 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 5.538083e-01 | 0.257 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.538083e-01 | 0.257 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.538083e-01 | 0.257 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.538083e-01 | 0.257 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.538083e-01 | 0.257 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.538083e-01 | 0.257 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.538083e-01 | 0.257 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.538083e-01 | 0.257 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 5.627968e-01 | 0.250 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.707603e-01 | 0.244 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.709796e-01 | 0.243 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.709796e-01 | 0.243 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 5.709796e-01 | 0.243 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.709796e-01 | 0.243 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 5.709796e-01 | 0.243 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.709796e-01 | 0.243 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.709796e-01 | 0.243 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.730110e-01 | 0.242 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.733990e-01 | 0.242 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.733990e-01 | 0.242 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 5.733990e-01 | 0.242 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.753760e-01 | 0.240 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 5.753760e-01 | 0.240 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 5.753760e-01 | 0.240 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 5.787416e-01 | 0.238 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.827162e-01 | 0.235 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 5.827162e-01 | 0.235 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.827162e-01 | 0.235 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 5.846050e-01 | 0.233 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 5.927004e-01 | 0.227 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.966339e-01 | 0.224 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.966339e-01 | 0.224 | 0 | 0 |
| Hydrolysis of LPE | R-HSA-1483152 | 5.966339e-01 | 0.224 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.966339e-01 | 0.224 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.966339e-01 | 0.224 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.966339e-01 | 0.224 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.966339e-01 | 0.224 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 5.966339e-01 | 0.224 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 5.966339e-01 | 0.224 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.987497e-01 | 0.223 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.987497e-01 | 0.223 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.987497e-01 | 0.223 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.987497e-01 | 0.223 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.987497e-01 | 0.223 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.987497e-01 | 0.223 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.987497e-01 | 0.223 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 5.987497e-01 | 0.223 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.006409e-01 | 0.221 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 6.016037e-01 | 0.221 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 6.020791e-01 | 0.220 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.047518e-01 | 0.218 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 6.047518e-01 | 0.218 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 6.047518e-01 | 0.218 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 6.047518e-01 | 0.218 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.097214e-01 | 0.215 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.097214e-01 | 0.215 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 6.098870e-01 | 0.215 | 1 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 6.171804e-01 | 0.210 | 1 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.182003e-01 | 0.209 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 6.182003e-01 | 0.209 | 1 | 1 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.240389e-01 | 0.205 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.240389e-01 | 0.205 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 6.242334e-01 | 0.205 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.247285e-01 | 0.204 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.251439e-01 | 0.204 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 6.251439e-01 | 0.204 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 6.251439e-01 | 0.204 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.251439e-01 | 0.204 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.251439e-01 | 0.204 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.251439e-01 | 0.204 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 6.251439e-01 | 0.204 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.255823e-01 | 0.204 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.255823e-01 | 0.204 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 6.260012e-01 | 0.203 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 6.260012e-01 | 0.203 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 6.260012e-01 | 0.203 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.260012e-01 | 0.203 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.260012e-01 | 0.203 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 6.260012e-01 | 0.203 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 6.334766e-01 | 0.198 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.343809e-01 | 0.198 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.353514e-01 | 0.197 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.353514e-01 | 0.197 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.353514e-01 | 0.197 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.353514e-01 | 0.197 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.353514e-01 | 0.197 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.353514e-01 | 0.197 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 6.353514e-01 | 0.197 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.353514e-01 | 0.197 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.353514e-01 | 0.197 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.353514e-01 | 0.197 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.353514e-01 | 0.197 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.353514e-01 | 0.197 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 6.353514e-01 | 0.197 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.353514e-01 | 0.197 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.383099e-01 | 0.195 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.393982e-01 | 0.194 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.445004e-01 | 0.191 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.464513e-01 | 0.189 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.464513e-01 | 0.189 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 6.464513e-01 | 0.189 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.501702e-01 | 0.187 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 6.501702e-01 | 0.187 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 6.501702e-01 | 0.187 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.501702e-01 | 0.187 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 6.537205e-01 | 0.185 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.594361e-01 | 0.181 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.594361e-01 | 0.181 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.594361e-01 | 0.181 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.618642e-01 | 0.179 | 1 | 1 |
| Downstream TCR signaling | R-HSA-202424 | 6.660928e-01 | 0.176 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 6.660945e-01 | 0.176 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.676875e-01 | 0.175 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.688250e-01 | 0.175 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 6.703545e-01 | 0.174 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.703545e-01 | 0.174 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.703545e-01 | 0.174 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.703545e-01 | 0.174 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.703545e-01 | 0.174 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.703545e-01 | 0.174 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.703545e-01 | 0.174 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.703545e-01 | 0.174 | 1 | 1 |
| Interleukin-17 signaling | R-HSA-448424 | 6.706041e-01 | 0.174 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.733349e-01 | 0.172 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.738482e-01 | 0.171 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.738482e-01 | 0.171 | 1 | 1 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.738482e-01 | 0.171 | 1 | 1 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.738482e-01 | 0.171 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 6.738482e-01 | 0.171 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 6.803199e-01 | 0.167 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 6.810067e-01 | 0.167 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.810091e-01 | 0.167 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 6.810091e-01 | 0.167 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 6.810091e-01 | 0.167 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 6.810091e-01 | 0.167 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.846651e-01 | 0.165 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.846651e-01 | 0.165 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.849291e-01 | 0.164 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 6.849291e-01 | 0.164 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.849291e-01 | 0.164 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.883339e-01 | 0.162 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.945299e-01 | 0.158 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.962060e-01 | 0.157 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.962060e-01 | 0.157 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.962060e-01 | 0.157 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.962060e-01 | 0.157 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.962060e-01 | 0.157 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.969585e-01 | 0.157 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 6.969585e-01 | 0.157 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.991955e-01 | 0.155 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.992996e-01 | 0.155 | 1 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.019996e-01 | 0.154 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.019996e-01 | 0.154 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.019996e-01 | 0.154 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.019996e-01 | 0.154 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.019996e-01 | 0.154 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.019996e-01 | 0.154 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.019996e-01 | 0.154 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.019996e-01 | 0.154 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.029579e-01 | 0.153 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.029579e-01 | 0.153 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.029579e-01 | 0.153 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.029579e-01 | 0.153 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.071445e-01 | 0.150 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.073962e-01 | 0.150 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.117815e-01 | 0.148 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 7.140226e-01 | 0.146 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.172789e-01 | 0.144 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 7.172789e-01 | 0.144 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 7.172789e-01 | 0.144 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 7.201878e-01 | 0.143 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.271180e-01 | 0.138 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.271180e-01 | 0.138 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.271180e-01 | 0.138 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.273412e-01 | 0.138 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.304474e-01 | 0.136 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 7.304474e-01 | 0.136 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.306085e-01 | 0.136 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 7.306085e-01 | 0.136 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 7.306085e-01 | 0.136 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.306085e-01 | 0.136 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 7.306085e-01 | 0.136 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.306085e-01 | 0.136 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.306085e-01 | 0.136 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.306085e-01 | 0.136 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.306085e-01 | 0.136 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.306085e-01 | 0.136 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.306085e-01 | 0.136 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.306085e-01 | 0.136 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.320061e-01 | 0.135 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.320061e-01 | 0.135 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.357606e-01 | 0.133 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.371074e-01 | 0.132 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.371074e-01 | 0.132 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.371074e-01 | 0.132 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.404052e-01 | 0.131 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.405928e-01 | 0.130 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 7.413329e-01 | 0.130 | 1 | 1 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.414308e-01 | 0.130 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.437479e-01 | 0.129 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 7.478845e-01 | 0.126 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 7.522964e-01 | 0.124 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.522964e-01 | 0.124 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 7.532640e-01 | 0.123 | 1 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.557362e-01 | 0.122 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 7.557362e-01 | 0.122 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.557362e-01 | 0.122 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.564724e-01 | 0.121 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 7.564724e-01 | 0.121 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.564724e-01 | 0.121 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.564724e-01 | 0.121 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.564724e-01 | 0.121 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.564724e-01 | 0.121 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.564724e-01 | 0.121 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.564724e-01 | 0.121 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.586884e-01 | 0.120 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 7.625329e-01 | 0.118 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 7.666534e-01 | 0.115 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 7.672050e-01 | 0.115 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.674009e-01 | 0.115 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 7.680608e-01 | 0.115 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.732129e-01 | 0.112 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.732129e-01 | 0.112 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.732129e-01 | 0.112 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.758900e-01 | 0.110 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 7.796642e-01 | 0.108 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.798545e-01 | 0.108 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.798545e-01 | 0.108 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 7.798545e-01 | 0.108 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.798545e-01 | 0.108 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.798545e-01 | 0.108 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.798545e-01 | 0.108 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 7.798545e-01 | 0.108 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 7.798545e-01 | 0.108 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.798545e-01 | 0.108 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 7.813738e-01 | 0.107 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.813738e-01 | 0.107 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 7.881887e-01 | 0.103 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.895869e-01 | 0.103 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.895869e-01 | 0.103 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 7.895869e-01 | 0.103 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.895869e-01 | 0.103 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.895869e-01 | 0.103 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.895869e-01 | 0.103 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.898921e-01 | 0.102 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 7.925761e-01 | 0.101 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.934051e-01 | 0.101 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.948228e-01 | 0.100 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 7.969152e-01 | 0.099 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 7.969364e-01 | 0.099 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 7.969364e-01 | 0.099 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 7.969364e-01 | 0.099 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.009929e-01 | 0.096 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.009929e-01 | 0.096 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.009929e-01 | 0.096 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.009929e-01 | 0.096 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 8.009929e-01 | 0.096 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.009929e-01 | 0.096 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.009929e-01 | 0.096 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.009929e-01 | 0.096 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 8.009929e-01 | 0.096 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 8.009929e-01 | 0.096 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 8.009929e-01 | 0.096 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.009929e-01 | 0.096 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.009929e-01 | 0.096 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.009929e-01 | 0.096 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.042449e-01 | 0.095 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.049088e-01 | 0.094 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.049088e-01 | 0.094 | 1 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.049088e-01 | 0.094 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.053695e-01 | 0.094 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.075737e-01 | 0.093 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.075737e-01 | 0.093 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.075737e-01 | 0.093 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.076279e-01 | 0.093 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 8.115132e-01 | 0.091 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.149654e-01 | 0.089 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.192296e-01 | 0.087 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.192296e-01 | 0.087 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.192296e-01 | 0.087 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.192296e-01 | 0.087 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 8.196494e-01 | 0.086 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.201026e-01 | 0.086 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.201026e-01 | 0.086 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.201026e-01 | 0.086 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.201026e-01 | 0.086 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.201026e-01 | 0.086 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.201026e-01 | 0.086 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.201026e-01 | 0.086 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.201026e-01 | 0.086 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.237971e-01 | 0.084 | 1 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.296107e-01 | 0.081 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.326003e-01 | 0.080 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.326003e-01 | 0.080 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.326003e-01 | 0.080 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.326003e-01 | 0.080 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.353315e-01 | 0.078 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 8.358922e-01 | 0.078 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.373784e-01 | 0.077 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.373784e-01 | 0.077 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.373784e-01 | 0.077 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.373784e-01 | 0.077 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.373784e-01 | 0.077 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.373784e-01 | 0.077 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.373784e-01 | 0.077 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.373784e-01 | 0.077 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.373784e-01 | 0.077 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 8.391803e-01 | 0.076 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.417387e-01 | 0.075 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.417387e-01 | 0.075 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.419209e-01 | 0.075 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.450712e-01 | 0.073 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.450712e-01 | 0.073 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.468698e-01 | 0.072 | 1 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.478328e-01 | 0.072 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.520635e-01 | 0.070 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.529961e-01 | 0.069 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.529961e-01 | 0.069 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.529961e-01 | 0.069 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.537884e-01 | 0.069 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.537884e-01 | 0.069 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.566917e-01 | 0.067 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.566917e-01 | 0.067 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.608365e-01 | 0.065 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.608365e-01 | 0.065 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.616788e-01 | 0.065 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.623385e-01 | 0.064 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.631134e-01 | 0.064 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.671147e-01 | 0.062 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.671147e-01 | 0.062 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.671147e-01 | 0.062 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.671147e-01 | 0.062 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 8.671147e-01 | 0.062 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 8.671147e-01 | 0.062 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.671147e-01 | 0.062 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.671147e-01 | 0.062 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.675102e-01 | 0.062 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 8.675102e-01 | 0.062 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.675102e-01 | 0.062 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.705658e-01 | 0.060 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.707406e-01 | 0.060 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.707406e-01 | 0.060 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.707406e-01 | 0.060 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.707406e-01 | 0.060 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.731100e-01 | 0.059 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.774871e-01 | 0.057 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.774871e-01 | 0.057 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 8.775735e-01 | 0.057 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.775735e-01 | 0.057 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.792734e-01 | 0.056 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.798781e-01 | 0.056 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.798781e-01 | 0.056 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 8.798781e-01 | 0.056 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 8.798781e-01 | 0.056 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 8.798781e-01 | 0.056 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 8.798781e-01 | 0.056 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 8.798781e-01 | 0.056 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.798781e-01 | 0.056 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.798781e-01 | 0.056 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.798781e-01 | 0.056 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 8.798781e-01 | 0.056 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 8.854617e-01 | 0.053 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.856064e-01 | 0.053 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.869268e-01 | 0.052 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 8.869268e-01 | 0.052 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.869268e-01 | 0.052 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.873015e-01 | 0.052 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.873383e-01 | 0.052 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.876921e-01 | 0.052 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 8.914163e-01 | 0.050 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.914163e-01 | 0.050 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.914163e-01 | 0.050 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.914163e-01 | 0.050 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.914163e-01 | 0.050 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 8.914163e-01 | 0.050 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.914163e-01 | 0.050 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.914163e-01 | 0.050 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.932236e-01 | 0.049 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.932408e-01 | 0.049 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.948488e-01 | 0.048 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.948488e-01 | 0.048 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.953292e-01 | 0.048 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.959106e-01 | 0.048 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.963681e-01 | 0.048 | 1 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.991551e-01 | 0.046 | 1 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.991551e-01 | 0.046 | 1 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.999927e-01 | 0.046 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.013927e-01 | 0.045 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.016029e-01 | 0.045 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.018468e-01 | 0.045 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.018468e-01 | 0.045 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 9.018468e-01 | 0.045 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.018468e-01 | 0.045 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 9.018468e-01 | 0.045 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.018468e-01 | 0.045 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.019386e-01 | 0.045 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.019386e-01 | 0.045 | 1 | 1 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 9.036756e-01 | 0.044 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.047581e-01 | 0.043 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.051218e-01 | 0.043 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.085938e-01 | 0.042 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.085938e-01 | 0.042 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.101901e-01 | 0.041 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 9.111526e-01 | 0.040 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.111526e-01 | 0.040 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.111526e-01 | 0.040 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.111526e-01 | 0.040 | 1 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.112759e-01 | 0.040 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.112759e-01 | 0.040 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.112759e-01 | 0.040 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.112759e-01 | 0.040 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.112759e-01 | 0.040 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 9.112759e-01 | 0.040 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.112759e-01 | 0.040 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.130998e-01 | 0.039 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.148368e-01 | 0.039 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.156578e-01 | 0.038 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.180826e-01 | 0.037 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.197997e-01 | 0.036 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.197997e-01 | 0.036 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.197997e-01 | 0.036 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.197997e-01 | 0.036 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.197997e-01 | 0.036 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.197997e-01 | 0.036 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 9.206889e-01 | 0.036 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.218039e-01 | 0.035 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.245018e-01 | 0.034 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.245018e-01 | 0.034 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.245018e-01 | 0.034 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.245018e-01 | 0.034 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 9.269657e-01 | 0.033 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.275051e-01 | 0.033 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.275051e-01 | 0.033 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.304441e-01 | 0.031 | 1 | 1 |
| RUNX2 regulates bone development | R-HSA-8941326 | 9.304441e-01 | 0.031 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.328994e-01 | 0.030 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.344706e-01 | 0.029 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.344706e-01 | 0.029 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.344706e-01 | 0.029 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.344706e-01 | 0.029 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.359420e-01 | 0.029 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.360186e-01 | 0.029 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.361860e-01 | 0.029 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.407672e-01 | 0.027 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.407672e-01 | 0.027 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.407672e-01 | 0.027 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.407672e-01 | 0.027 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.407672e-01 | 0.027 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.407672e-01 | 0.027 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.407672e-01 | 0.027 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.410260e-01 | 0.026 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.410260e-01 | 0.026 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.437692e-01 | 0.025 | 1 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.445312e-01 | 0.025 | 1 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.446818e-01 | 0.025 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.450851e-01 | 0.025 | 1 | 1 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.457249e-01 | 0.024 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.462139e-01 | 0.024 | 1 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.464591e-01 | 0.024 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.464591e-01 | 0.024 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.464591e-01 | 0.024 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.464591e-01 | 0.024 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.464591e-01 | 0.024 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.464591e-01 | 0.024 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.464591e-01 | 0.024 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.464591e-01 | 0.024 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.464591e-01 | 0.024 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.464591e-01 | 0.024 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.464591e-01 | 0.024 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.464591e-01 | 0.024 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.496465e-01 | 0.022 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.500656e-01 | 0.022 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.500656e-01 | 0.022 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.516043e-01 | 0.022 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.516043e-01 | 0.022 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.516043e-01 | 0.022 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.516043e-01 | 0.022 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.516043e-01 | 0.022 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.540737e-01 | 0.020 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.555743e-01 | 0.020 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.557844e-01 | 0.020 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.560154e-01 | 0.020 | 1 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.562554e-01 | 0.019 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.562554e-01 | 0.019 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.562554e-01 | 0.019 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.562554e-01 | 0.019 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.562554e-01 | 0.019 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.562554e-01 | 0.019 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.562554e-01 | 0.019 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.570274e-01 | 0.019 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.604597e-01 | 0.018 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.604597e-01 | 0.018 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.604597e-01 | 0.018 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.621418e-01 | 0.017 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.627730e-01 | 0.016 | 1 | 1 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 9.642602e-01 | 0.016 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.642602e-01 | 0.016 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.642602e-01 | 0.016 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.642602e-01 | 0.016 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.642602e-01 | 0.016 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.642602e-01 | 0.016 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.642602e-01 | 0.016 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.647004e-01 | 0.016 | 1 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.647004e-01 | 0.016 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.647004e-01 | 0.016 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.660335e-01 | 0.015 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.672335e-01 | 0.014 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.672751e-01 | 0.014 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.672751e-01 | 0.014 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.673937e-01 | 0.014 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.676956e-01 | 0.014 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.676956e-01 | 0.014 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.676956e-01 | 0.014 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 9.676956e-01 | 0.014 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.699065e-01 | 0.013 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.708009e-01 | 0.013 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.708009e-01 | 0.013 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.708009e-01 | 0.013 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.708009e-01 | 0.013 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.719016e-01 | 0.012 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.719016e-01 | 0.012 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.719016e-01 | 0.012 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.723686e-01 | 0.012 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.735834e-01 | 0.012 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.736079e-01 | 0.012 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.736079e-01 | 0.012 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.736079e-01 | 0.012 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.736079e-01 | 0.012 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.753890e-01 | 0.011 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.759035e-01 | 0.011 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.761453e-01 | 0.010 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.761453e-01 | 0.010 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.761453e-01 | 0.010 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.767224e-01 | 0.010 | 1 | 1 |
| Gluconeogenesis | R-HSA-70263 | 9.767224e-01 | 0.010 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.784388e-01 | 0.009 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.784388e-01 | 0.009 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.784388e-01 | 0.009 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.786425e-01 | 0.009 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.786929e-01 | 0.009 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.805119e-01 | 0.009 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.805119e-01 | 0.009 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.805119e-01 | 0.009 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.815140e-01 | 0.008 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.820328e-01 | 0.008 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.820328e-01 | 0.008 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.823858e-01 | 0.008 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.823858e-01 | 0.008 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.827323e-01 | 0.008 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.831223e-01 | 0.007 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.837618e-01 | 0.007 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.840796e-01 | 0.007 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.840796e-01 | 0.007 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.840796e-01 | 0.007 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.840796e-01 | 0.007 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.840796e-01 | 0.007 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.848981e-01 | 0.007 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.856106e-01 | 0.006 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.860504e-01 | 0.006 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.869945e-01 | 0.006 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.869945e-01 | 0.006 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.882454e-01 | 0.005 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.882454e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.882454e-01 | 0.005 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.882454e-01 | 0.005 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.882454e-01 | 0.005 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.893565e-01 | 0.005 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.893760e-01 | 0.005 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.893760e-01 | 0.005 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.893760e-01 | 0.005 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.895562e-01 | 0.005 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.896033e-01 | 0.005 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.903979e-01 | 0.004 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.903979e-01 | 0.004 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.910747e-01 | 0.004 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.913216e-01 | 0.004 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.918290e-01 | 0.004 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.918290e-01 | 0.004 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.918290e-01 | 0.004 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.920231e-01 | 0.003 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.921565e-01 | 0.003 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.925208e-01 | 0.003 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.925208e-01 | 0.003 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.929111e-01 | 0.003 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.929201e-01 | 0.003 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.935931e-01 | 0.003 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.935931e-01 | 0.003 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.935931e-01 | 0.003 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.937368e-01 | 0.003 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.942096e-01 | 0.003 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.942699e-01 | 0.002 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.943592e-01 | 0.002 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.943592e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.947668e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.952060e-01 | 0.002 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.952704e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.956161e-01 | 0.002 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.956161e-01 | 0.002 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.959916e-01 | 0.002 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.961369e-01 | 0.002 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.964746e-01 | 0.002 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.966504e-01 | 0.001 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.969386e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.970275e-01 | 0.001 | 1 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.970275e-01 | 0.001 | 1 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.971485e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.971525e-01 | 0.001 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.972024e-01 | 0.001 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.974702e-01 | 0.001 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.976749e-01 | 0.001 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.977923e-01 | 0.001 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.978592e-01 | 0.001 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.978953e-01 | 0.001 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.980311e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.981895e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.982811e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.983223e-01 | 0.001 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.984466e-01 | 0.001 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.984699e-01 | 0.001 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.987635e-01 | 0.001 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.988125e-01 | 0.001 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.988536e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.989640e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.990638e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.990638e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.992355e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.993091e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.993679e-01 | 0.000 | 1 | 0 |
| Translation | R-HSA-72766 | 9.993855e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.993933e-01 | 0.000 | 1 | 0 |
| Classical antibody-mediated complement activation | R-HSA-173623 | 9.994060e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.994902e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.994902e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.995825e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.996601e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.996601e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.996821e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.996928e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.997225e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.997470e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.997492e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.997595e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.998169e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.998215e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.998521e-01 | 0.000 | 1 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.998767e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.998982e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999116e-01 | 0.000 | 0 | 0 |
| Creation of C4 and C2 activators | R-HSA-166786 | 9.999156e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999436e-01 | 0.000 | 1 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999457e-01 | 0.000 | 1 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999483e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999500e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999553e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.999561e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999565e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.999638e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999810e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999854e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999896e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999935e-01 | 0.000 | 1 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999946e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999954e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999957e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999961e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999965e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999967e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999969e-01 | 0.000 | 1 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999975e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999979e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999984e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999991e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999993e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999994e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999995e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999997e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999998e-01 | 0.000 | 1 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999998e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999999e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999999e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 1 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 1.000000e+00 | 0.000 | 1 | 1 |